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GLOSSARY OF TERMS (USED IN THE CONTEXT OF THIS STUDY) 
TERM DEFINITION 
Allodynia: Pain response from stimuli that do not typically cause pain (1). 
Biopsychosocial: The interaction between biological, psychological and social factors in 
medical practice (1). 
Catastrophic Thinking: To contemplate irrational worst-case scenarios (1). 
Central Sensitization: The continually increase in neural transmission at different areas of the 
central nervous system. After an acute injury, the central nervous system 
reorganises itself resulting in a continuation of pain leading to 
hyperalgesia and allodynia (2). 
Comrades Marathon: This ±90 km ultramarathon is run annually between Durban and 
Pietermaritzburg in the Kwa-Zulu Natal Province, South Africa (3). 
Fear Avoidance 
Behaviour: 
Avoidant behaviour based on fear which can lead to the development of 
chronic pain (2). 
Nociception: The response of the sensory nervous system to painful or potentially 
painful stimuli (1, 2). 
Opioid-Mediated 
Effect: 
Exercise can trigger an analgesic response as a result of the pituitary gland 
and hypothalamus releasing β-endorphins which activate the central and 
peripheral μ-opioid receptors (4). 
Pain-Related Fear: A construct that integrates fear of pain, fear of injury and fear of 
movement (2, 4). 
Psychosocial Factors: The association of social factors, thoughts and behaviour (1, 2). 
x 
Recovery: An important process to enable the positive effects of training (endurance 
running) and to decrease the negative effects of regular training and 
competition (5, 6). 
Self-Efficacy: Belief in one’s own ability to succeed to successfully complete a goal (1, 2). 
Ultramarathon A footrace with a greater distance than the traditional marathon length of 
42,1 km (3). 
xi 
 
ABSTRACT 
 
BACKGROUND 
Participation in ultramarathon races is increasing globally. Although endurance running has numerous 
physical and psychological benefits, due to the excessive volume of training and the physical and 
emotional demands of completing an ultramarathon event, exercise-induced muscle damage and 
delayed-onset muscle soreness are common. Recovery is central to improving performance and is also 
a determining factor in return to training. Recovery requires both physical and psychological 
adaptation. However, there is limited research exploring the effect psychosocial factors play on pain 
recovery following competition, particularly in endurance runners. More specifically, the role fear 
avoidance beliefs, pain catastrophizing and self-efficacy play in pain recovery following an 
ultramarathon race. This information is important to contribute to the limited research on the 
association between psychosocial factors and recovery from pain in endurance runners. Additionally, 
this information may provide insight into pain recovery following the Comrades Marathon and reduce 
time away from running. 
 
AIMS AND OBJECTIVES 
The aim of this study was to investigate the relationship between psychosocial factors (fear avoidance 
beliefs, pain catastrophizing and self-efficacy beliefs) and pain recovery in runners following the 2017 
Comrades Marathon. The specific objectives of the study were to explore whether the psychosocial 
factors of pain catastrophizing, fear avoidance beliefs and self-efficacy beliefs: a) predict pain in 
ultramarathon runners after competing in the Comrades Marathon; and b) affect recovery in runners 
competing in the Comrades Marathon. 
 
METHODS 
This study had a descriptive, longitudinal cohort design. Healthy ultramarathon runners between the 
ages of 20 and 60 who had qualified for and were intending to compete in the 2017 Comrades 
Marathon were included in this study. Participants who failed to provide informed consent, reported 
any signs of illness two weeks prior to the race or any relevant medical or surgical procedure that 
would prevent participation in the race, were diagnosed with a history of chronic pain or who did not 
complete the race were excluded. All participants were required to complete a medical and sports 
history questionnaire and baseline psychosocial questionnaires (Athlete Fear Avoidance 
Questionnaire, Pain Catastrophizing Questionnaire, Self-Efficacy Questionnaire) two weeks prior to 
the race at a presentation evening held at participating running clubs.  
xii 
 
Recovery from pain was recorded by completing a pain logbook (Pain Severity Score of the Brief Pain 
Inventory) starting the evening of the day on which the Comrades Marathon was run and on each 
night for nine days following the race, with a total of 10 entries. The questionnaires were validated in 
previous studies by a panel of experts and were available in both hard copy and electronic format. 
 
RESULTS 
The study sample consisted of 77 participants with a mean age of 41 years, 45 (58%) of whom were 
male and predominantly English speaking (74%). The majority of participants (78%) had completed 
the Comrades Marathon previously with 13% being novices to the ultramarathon distance. The 
average finishing time for the study participants in the 2017 Comrades Marathon was 10 hours and 
16 minutes.  Seventy percent reported that they had previously used pain-relieving medication after 
a race.  The majority of participants (86%) documented a history of injury, with 55% reporting a current 
injury. Only 6% reported currently using chronic pain-relieving medication.  
The baseline psychosocial questionnaires revealed that the majority of the participants demonstrated 
low fear avoidance beliefs (79%), low pain catastrophizing beliefs (88%) and high self-efficacy beliefs 
(97%). It took five days from the day of the Comrades Marathon for 75% of the runners to score a pain 
rating of one or lower in the pain logbook and seven days for 75% of the runners to report no pain. 
There were no correlations between psychosocial factors and pain recovery in this sample of 
Comrades runners. There was no correlation between finishing times and pain during recovery. 
 
CONCLUSION 
In conclusion, this study showed that in this sample of ultramarathon runners pre-race psychosocial 
factors had no effect on recovery following the 2017 Comrades Marathon. High self-efficacy scores, 
previous experience, higher pain tolerance and better coping strategies in ultramarathon runners may 
be contributing factors to these results. Future research needs to explore endurance runners who do 
not complete the race, assess the profile of the ultramarathon race and assess different recovery 
markers. 
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CHAPTER 1: INTRODUCTION AND SCOPE OF DISSERTATION 
1.1. INTRODUCTION 
It is well established that both elite and recreational athletes are continuously trying to improve their 
performance and recovery during training and competition (7, 8). With an emphasis on maximising an 
athlete’s performance, research has focused on improving performance by reducing the risk of injury 
and decreasing recovery time following an injury or competition (7). With this area of research 
receiving a great deal of attention, a shift in focus is required to continue to find new ways of 
improving sporting performance and reducing time away from sport (9). Although it is recognised that 
many factors affecting sporting performance are biomechanical and physiological in nature (10), 
psychosocial factors have also been found to contribute to athletic performance and risk of injury (11, 
12).   
An investigation into changes over a 12-week period following ACL reconstruction in athletes found 
that increased self-efficacy beliefs, decreased pain catastrophizing thoughts and reduced fear 
avoidance beliefs contributed to improved pain levels in the knee and better knee function (13). This 
study highlights that by improving self-efficacy beliefs to complete rehabilitation tasks and reducing 
catastrophizing thoughts and fear avoidance beliefs to improve pain, athletes can return to a pre-
injury performance level sooner. This research also recognised fear avoidance beliefs, pain 
catastrophizing and self-efficacy as inhibitors and predictors of injury recovery following ACL 
reconstruction. Research linking psychosocial factors with functional outcome in musculoskeletal 
injuries (13-17), has sparked interest into understanding the effect these psychosocial factors have on 
recovery in athletes following a race. 
The psychosocial constructs within the Fear Avoidance Model (FAM) are of interest to the sporting 
population (1, 5). The FAM is a biopsychosocial model designed to explain the development of chronic 
disability following a musculoskeletal injury. The model suggests that when pain is perceived as 
threatening following a musculoskeletal injury, several psychosocial concepts, such as fear avoidance 
behaviour, pain catastrophizing and fear of re-injury, are changed, resulting in increased pain levels, 
disuse and disability (1). By recognising the role of the FAM in the sporting population, the predictive 
power of these psychosocial factors can be used to explore factors affecting return to performance 
(recovery) following competition (race).  
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However, the association between fear avoidance beliefs, pain catastrophizing and self-efficacy, and 
recovery from pain in athletes after competition has yet to be explored.  Recovery is a fundamental 
part of training among athletes (5, 6) and allows for adaptation (14) and return to pre-race 
performance levels (14-17). Recovery is an imperative, individualized process which involves both 
physiological and psychological restoration (14). While a large quantity of research has investigated 
the physiological recovery in athletes (5, 6, 14), the few studies in ultramarathon runners have not yet 
investigated the association between psychosocial factors and recovery following an ultramarathon 
race. 
 
Ultramarathon runners push their bodies beyond normal limits in training and during competition 
(14). To complete an ultramarathon event, endurance runners need to train for extensive hours each 
week covering hundreds of kilometres (18). Elite marathon runners cover over 230 km a week in 
training (18). These extensive training loads need to be carefully monitored to ensure adaptation to 
training while preventing overtraining syndrome. The build-up of stress from excessive training or 
competition can result in several days to weeks of recovery to restore performance to its previous 
level (14, 18, 19). Additionally, during the race these endurance runners manage nociceptive feedback 
from muscles, tendons and joints as well as overcome excessive fatigue (14, 19). Upon completion of 
the race, the pain experienced from delayed-onset muscle soreness (DOMS) or exercise-induced 
muscle damage (EIMD) can delay recovery and return to competition (18). To qualify for an 
ultramarathon event, endurance runners are required to complete several qualifying races leading up 
to the main event. This requires quick, effective recovery sessions in between training and qualifying 
races (18, 19). Thus, the discomfort and fatigue that ultramarathon runners need to overcome to 
complete a race (14, 18, 19), make for an interesting population to investigate recovery.   
 
The Comrades Marathon serves as an appropriate platform to examine recovery from pain in 
endurance runners in South Africa (3, 20). The Comrades Marathon is the world's largest and oldest 
ultramarathon race, which is run annually between Durban and Pietermaritzburg in the KwaZulu-Natal 
Province of South Africa (20). The 2017 Comrades Marathon is 86.73 km in distance which can change 
slightly each year depending on the route (3, 20). It alternates between the ‘up’ (Durban to 
Pietermaritzburg) or ‘down’ run (Pietermaritzburg to Durban) (3, 20). The first Comrades Marathon 
took place in 1921 with only 34 runners participating. The 92nd Comrades Marathon (4th June 2017) 
was an ‘up’ run, with a total of 17 031 athletes starting the race and 13 852 (81%) athletes finishing 
within the twelve-hour cut-off time (3, 20).  
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The nature of the Comrades Marathon should give rise to the necessary physical, psychological and 
social stresses required to cause a certain deficit in recovery following the race. This will allow an 
opportunity to investigate the relationships between pain, psychosocial factors and recovery in 
endurance runners (14, 15, 21-23). If psychosocial factors can influence recovery from pain, like 
physical barriers have been found to (14, 15), it will be imperative that these psychosocial factors are 
identified and addressed early in training. This could prevent a delay in return to competition after a 
race (7, 24). 
 
1.2.  AIMS AND OBJECTIVES 
 
1.2.1.  AIMS 
 
The aim of this study was to determine whether there was an association between pain 
catastrophizing, fear avoidance beliefs and self-efficacy beliefs and athlete pain recovery in a cohort 
of ultramarathon runners competing in the 2017 Comrades Marathon (86.73 km) road race. 
 
1.2.2.  SPECIFIC OBJECTIVES 
 
The specific objectives of this study were to explore whether the psychosocial factors of pain 
catastrophizing, fear avoidance beliefs and self-efficacy beliefs: 
1) Predict pain in ultramarathon runners after competing in the Comrades Marathon; and  
2) Affect pain recovery in runners competing in the Comrades Marathon. 
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1.3.  SIGNIFICANCE OF THE DISSERTATION 
 
With the lack of research investigating the role psychosocial factors play in the recovery of athletes, 
there is a need for further investigation into this area. Identifying the role which psychosocial factors, 
namely; fear avoidance beliefs, pain catastrophizing and self-efficacy, play in recovery from pain 
following an ultramarathon race, can allow barriers which hinder return to training to be identified 
and addressed (15, 25). Information obtained from this dissertation aims to contribute to the limited 
research on the association between these psychosocial factors and recovery in endurance runners 
by evaluating the role these psychosocial factors play in pain following the Comrades Marathon.   The 
data reported will provide some insight into pain recovery in endurance runners following the 
ultramarathon. This may have the potential to facilitate a reduction in time to return to competition 
(15, 25). The development of psychologically informed training and recovery programs could be used 
to optimise the duration before returning to performance (15, 26), reduce the potential development 
of chronic pain (27, 28) and improve performance (16). 
 
1.4. PLAN OF DEVELOPMENT  
 
In preparation for the experimental section of this dissertation, a comprehensive review of the 
literature pertaining to endurance running as a sport, recovery in endurance running, psychosocial 
factors and recovery in endurance running, the role of pain in endurance running and fear avoidance 
beliefs, pain catastrophizing and self-efficacy and endurance runners, will be presented (Chapter 2). 
This chapter will be followed by a descriptive, longitudinal study that was designed to explore the 
effects of psychosocial factors, namely pain catastrophizing, fear avoidance beliefs and self-efficacy 
beliefs, on recovery following an ultramarathon race (Chapter 3). A summary and conclusion chapter 
will finalise the dissertation (Chapter 4). 
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CHAPTER 2: LITERATURE REVIEW 
 
2.1.  INTRODUCTION 
 
The primary focus of research on athletic recovery following a competition has been on physical 
factors (2, 6). This is despite the understanding that recovery has both physical and psychosocial 
influences (16, 29, 30). This is due to the misunderstanding that physical and psychosocial recovery in 
sport occurs simultaneously; however, physical and psychosocial readiness to return to performance 
following a race do not always coincide (29, 31).  Although the sporting population are believed to 
have greater conditioned pain modulation than their sedentary counterparts (27, 28), this does not 
clarify why some athletes have a delayed return to performance following competition or reduced 
performance even after an injury has healed (14). This suggests that factors, other than physical, may 
play a role in the recovery process of an athlete.  
 
Pain catastrophizing, fear avoidance beliefs and low self-efficacy scores have been shown to play a key 
role in sporting performance and recovery following an injury (16, 30-33). However, to date, there has 
been little evidence recognising the internal or psychosocial factors that contribute to an athlete’s 
perception of pain intensity during recovery. With extensive literature supporting the role 
psychosocial factors play in recovery following an injury (13-16), there is a need for future research to 
explore the association between psychosocial factors, pain predictability and recovery in the sporting 
population.  
 
Therefore, this literature review will appraise the current literature around psychosocial factors 
affecting sporting performance and recovery, with specific emphasis on pain recovery in endurance 
runners. This review aims to summarise and critically evaluate the current literature in this area. 
 
Online databases searched included: PubMed, EbscoHost, Science Direct, Medline and Google Scholar. 
The following keywords and varying combinations of these were used: “biopsychosocial,” 
“psychosocial,” “chronic pain,” “pain in sport,” “pain in recovery,” “ultramarathon running,” 
“marathon running,” “ultramarathon runners,” “marathon runners,” “long distance running,” “long 
distance runners,” “endurance sports,” “endurance running,” “endurance runners,” “Comrades 
Marathon,” “recovery”, “recovery modalities,” “fear avoidance beliefs,” “self-efficacy,” “pain 
catastrophizing,” “fear avoidance questionnaire,” “athlete fear avoidance questionnaire,”  
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“long distance running,” “endurance sports,” “endurance running,” “pain catastrophizing 
questionnaire,” and “self-efficacy questionnaire.” 
2.2.  ENDURANCE RUNNING AS A SPORT 
The popularity of endurance running is increasing globally (9), with a surge in new races organised 
each year (20). It is believed the first marathon was run in 490 B.C. where a soldier Pheidippides ran 
from Marathon to Athens in Greece announcing victory on the battlefield (34). Subsequently, the 
number of participants competing in recreational and competitive endurance running has continued 
to experience massive growth (20, 21). The popularity of running may have to do with the increased 
awareness of the importance of daily exercise, physical fitness and the many health benefits 
associated with the sport (35). Physical fitness can be defined as the characteristics that people have 
or that they develop relating to their capacity to perform physical activity (34). The fascination in 
testing the body’s physical fitness and abilities by long endurance events may explain the considerable 
increase in both male and female runners attempting ultramarathons (35). 
Endurance running has numerous physical and psychological benefits. Unfortunately, with the volume 
of training required to participate in an ultramarathon; fatigue, exercise-induced muscle damage 
(EIMD) and delayed-onset muscle soreness (DOMS) are common (14, 18). The next sections will 
provide a brief overview of the positive effects of endurance running and the potential negative effects 
of endurance running with training and following competition. The final section will discuss 
ultramarathon events in South Africa.  
2.2.1. POSITIVE EFFECTS ASSOCIATED WITH ENDURANCE RUNNING 
Endurance running can result in tissue, organ and mechanical adaptations (35). There are numerous 
benefits associated with running. Some of these benefits include improved fitness, weight loss, 
general well-being, reduction in cardiovascular risk factors and enjoyment (9, 35). Additionally, 
running can be performed in many locations with little to no equipment (35). It is easily accessible 
enabling many people to participate in the sport (9, 20, 35).  Metabolic, cardiovascular, 
musculoskeletal adaptations and psychological benefits associated with endurance running will now 
be discussed briefly. A more comprehensive review of the benefits of endurance running is beyond 
the scope of this review. For additional information on the benefits of endurance running, please refer 
to Hawley and Spargo (36). 
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Endurance running largely depends on the aerobic metabolic system (34, 36). This system produces 
energy via oxidative phosphorylation in the mitochondria of active muscle. Glucose and oxygen enter 
the Krebs cycle, in the mitochondria, to create adenosine triphosphate (ATP) or energy. The training 
required to compete in an ultramarathon improves the function of the metabolic system and the 
muscles oxidative capacity (36). These changes allow a runner to experience less fatigue by using 
energy more economically. Additionally, blood distribution to the active muscles improves with the 
increase in the capillary network of the muscle, thereby improving the gas exchange between the 
muscle and capillary network (34, 36).  
Furthermore, endurance running improves the ability of haemoglobin to offload oxygen, increase the 
number of mitochondrial proteins and the number of Krebs cycles, and consequently increases ATP 
production (34, 36). In addition, regular endurance training improves the body’s ability to metabolise 
carbohydrate and fat, sparing glycogen stores, enabling endurance runners to burn less energy (34).  
With regular endurance running the efficiency of the cardiovascular system improves (34). There is an 
increase of blood flow through the heart transporting oxygen to active muscles. Additionally, blood 
volume of the body increases, which enlarges the ventricles’ preload and improving oxygen perfusion 
to muscles. This encourages a greater stroke volume, increasing cardiac output with each heart 
contraction. Subsequently, the load on the cardiovascular system is reduced decreasing the runner’s 
heart rate and blood pressure at rest and during training (34, 37).  
The repetitive mechanical loading involved with ultramarathon training can positively remodel the 
skeletal muscle resulting in greater strength (38). Exposing the body to resistance training and 
repeated mechanical loading can cause muscle adaptations. These long-term adaptations can result 
in muscle hypertrophy resulting in increased running speed and power, imperative to any endurance 
athlete (34, 38). However, training for an ultramarathon alone is not enough to cause muscle 
hypertrophy, in fact excessive exposure to repetitive forces or inadequate recovery time may cause 
overuse injuries in runners (34). 
In addition to physical benefits, studies have shown psychological benefits when participating in a 
marathon (39). To investigate the perceived benefits of running a marathon, 402 endurance runners 
completed a survey within two weeks of competing in a marathon (39). The survey found that 
competitive runners had a greater positive attitude towards running and importance to life.  
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Additionally, recreational runners had a greater general perceived benefit of the sport. The survey 
showed that female runners also had an improved self-image and life fulfilment, when compared to 
male runners.  
 
Studies have concluded that regular running decreases symptoms associated with clinical depression 
and anxiety (39, 40) and improves cognitive function and memory through the increased release of 
the neurotransmitter catecholamine, associated with the brains learning ability (40). Physical exercise, 
in the form of running, has also been associated as a buffer against aging of the brain. Brain scans 
performed on physically active elderly subjects showed a lower rate of brain shrinkage and cognitive 
decline then their inactive counterparts (38-40). Running has also been linked to improved alertness 
during the day and improved circadian rhythms, faster sleep onset, a deeper sleep and a decrease in 
insomnia (36, 38, 40). 
 
2.2.2. POTENTIAL NEGATIVE EFFECTS OF ENDURANCE RUNNING  
 
To become an endurance runner, athletes need to push their bodies to the limit to increase training 
loads and to maximise running performance (35, 40, 41). This requires a balance between the positive 
effects of training and the negative effects of training (40-47). The negative effect of endurance 
running will now be briefly discussed in terms of fatigue, EIMD, DOMS, running related injuries and 
overtraining. For a more comprehensive review of the potential negative effects of endurance running 
please refer to Hyldahl and Hubal (48), as further discussion is beyond the scope of this review.  
 
Fatigue is defined as an increase in perceived effort to produce a specific force output to the eventual 
inability to exert that force output (42). This acutely impairs exercise performance. Muscle fatigue, a 
“loss of maximum force-generating capacity” (35 p9) in ultramarathon runners, is most closely linked 
to the intensity and duration of the race. The type of muscle involved, the type of muscle activation 
and contraction also play a role in muscle fatigue (35).  
 
Muscle fatigue can be subdivided into peripheral and central fatigue (44). Peripheral fatigue is 
characterized by chemicals affecting the peripheral nervous system (PNS) or the muscles. This can 
impact muscle strength and power due to the disruption of the muscle’s excitation-contraction 
coupling. Central fatigue or perceived exertion, is caused by fatigue of the brain. Central fatigue is 
believed to contribute to muscle fatigue in endurance running and can last for several days after an 
ultramarathon. Fatigue, like muscle soreness, is subjectively driven by fear, anxiety and anger (44). 
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Exercise-induced muscle damage, due to unaccustomed intensity or duration that the runner is not 
used to, can lead to muscle damage and pain (35). Thus, an important indicator of EIMD is muscle 
soreness. Eccentric loading, or active muscle lengthening under resistance, is a primary factor 
exacerbating muscle damage. The lengthening of the muscle fibrils results in structural changes 
leading to symptoms of EIMD. This can lead to muscle soreness or DOMS, muscle swelling, an increase 
in muscle protein (creatine kinase) in the blood, a loss in muscle strength and motor control deficit in 
the days following training or a race (27, 45). These symptoms can change the kinematics during 
running which in turn can negatively influence performance.  
The pain associated with EIMD during the recovery period is delayed, appearing 12 hours after training 
and subsiding within seven to 10 days (46).  
 
The integrated model of muscle damage has been described as having four phases (27, 45). These 
phases include initial events, autogenic processes, the phagocytic stage and finally the regenerative 
phase. Initially, after the muscle is damaged, there is an acute inflammatory response, metabolic 
changes and a significant reduction in homeostasis of the damaged tissue. After leukocytes, pro- and 
anti-inflammatory cytokines leak into the damaged muscle, the damaged fibres are removed. The 
regenerative phase promotes muscle repair and growth. Reduced muscle function and DOMS are 
typical features of EIMD (27, 45, 46). 
 
A symptom of EIMD, DOMS, is a result of inflammation and damage to non-contractile tissues causing 
pain when the muscle is activated or stretched. Unlike temporary muscle soreness felt at the end of 
exercise believed to be the result of an accumulation of metabolic waste (45), DOMS can be felt hours 
after exercise lasting days. Symptoms of DOMS include muscle soreness and stiffness, swelling and 
reduced function. Although the symptoms of DOMS are similar to EIMD, DOMS does not result in 
changes in muscle structure or changes in creatine kinase levels (34, 45).  
 
Pain is, therefore, commonly experienced among endurance runners (27, 47). The pain experienced 
after an ultramarathon can be intense enough to delay return to training, prolong recovery time 
between races and reduce participation in daily activities (22). Most interestingly, current studies have 
shown that pain, like thirst or hunger, is an emotional response to reinstate homeostasis and promote 
recovery in the body (46). Assessing muscle soreness is most commonly done using a questionnaire in 
which runners are asked to rate their perceived muscle soreness on a fixed ordinal scale, the visual 
analogue scale (VAS) (45).  
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It is difficult to determine the precise incidence and prevalence of running injuries as most research 
relies on retrospective self-reporting questionnaires. This can result in poor recall of information 
regarding the injuries (34). However, Fredericson and Misra (49) reported a yearly incidence of 
running-related injuries to be around two-thirds of the running population, with an increase to 90% 
when training for a marathon. Research in Switzerland found experienced marathon runners to be 
less likely to be affected by a running-related injury during their training when compared to their 
novice counterparts (49).  
Running mileage (greater than 40 miles or 64 km a week), change in running volume or intensity and 
history of previous injury are the main predisposing factors to running-related injuries (34, 49). A 
review of research regarding running related injuries found an incidence of 26% to 92% of injuries in 
runners, with 80% of injuries occurring at or below the knee joint (50). Common running-related 
injuries include; patellofemoral pain syndrome, tendinopathies, lower back pain, shin splints, and 
stress fractures (50). 
 
Over the past few decades, training loads in most sports have greatly increased to improve 
performance. Consequentially, overtraining syndrome and overreaching are also on the rise (41). 
Overreaching is considered a build-up of training load that results in performance decrements (41, 
51). Overreaching can be subdivided into non-functional and functional overreaching. Functional 
overreaching is a normal process of training and competition, whereas non-functional overreaching 
can result in physical and psychological dysfunction. This can take days to weeks to recover (51). 
However, if overreaching is not addressed with sufficient recovery, overtraining syndrome may occur.  
 
Overtraining syndrome is believed to be due to an imbalance between training and recovery leading 
to systemic inflammation effecting the central nervous system (CNS) (41). Overtraining syndrome has 
been associated with increased risk of injury, disturbed sleep, poor performance, irritability and 
emotional disturbances such as increased anxiety, stress and fear, hormonal changes and central 
fatigue. Insufficient physical recovery coupled with overtraining can result in maladaptation and 
reduced performance (41, 51). With 15% to 50% of endurance runners suffering with non-functional 
overreaching in a season, sufficient recovery is imperative to support increased training loads and 
competition (34). 
 
2.2.3. ENDURANCE RUNNING EVENTS IN SOUTH AFRICA  
 
11 
South Africa is known for two of the world’s most iconic ultramarathon races held every year (3, 20). 
The Two Oceans Marathon (±11 000 runners per year) is a 56 km ultramarathon race which takes 
place in Cape Town and the Comrades Marathon (±20 000 runners per year) takes place between 
Durban and Pietermaritzburg (14). The 2017 Comrades Marathon was an 86.73 km ultramarathon 
held on Sunday 4 June. The race attracts both international and South African participants, with 
differing demographics, socioeconomic classes, psychological groups and levels of competitiveness.  
The first Comrades Marathon took place in 1921 with 34 runners (14). Currently, this race is run by 
around 17 000 athletes, with almost 14 000 completing the race (3, 20). Both the young and old (20 
to 76 years old for 2017), as well as both males and females (4:1 male to female ratio for 2017) (20) 
participate.   
The Comrades Marathon alternates each year between the ‘up’ (Durban to Pietermaritzburg) or 
‘down’ run (Pietermaritzburg to Durban) held in the province of Kwa-Zulu Natal (3, 20). The Comrades 
Marathon has a cut off time of 12 hours with six cut off points along the route. Medals are presented 
to finishers based on their finishing times. The medals are categorised accordingly; Wally Hayward 
medal (sub 6 hours), Silver medal (sub 7 hours 30 minutes), Bill Rowan medal (sub 9 hours), Bronze 
medal (sub 11 hours) and Vic Clapham Copper medal (sub 12 hours). 
To qualify for the Comrades Marathon, participants need to complete a standard marathon (42.2 km) 
in less than five hours in the year leading up to the race.  Many participants use the Two Oceans 
Marathon to qualify for Comrades Marathon (3, 20). Other qualifying races include the Sanlam 
Marathon, Winelands Marathon and Voet van Afrika Marathon in the Western Cape, the Vaal River 
City Marathon, Old Mutual Soweto Marathon and the SABS Jacaranda City Challenge in Gauteng, the 
One City Marathon, NFB Tony Viljoen Masters Marathon and the Legends Ultramarathon in the 
Eastern Cape and the Bluff Athletic and Sani Stagger Marathon in KwaZulu Natal (20).  
The nature of an ultramarathon physically and mentally challenges the human body; hence, recovery 
is vital (41). Recovery allows for the repair of tissues, restoration of function and retrieval of 
psychological wellbeing ensuring optimal performance (7, 41). To return to competition (47), quick 
and effective recovery is imperative, and any factors delaying return to competition need to be 
identified and addressed.   
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2.3.  RECOVERY IN ENDURANCE RUNNING 
Recovery in sport is defined by Kellman and Kallus (19, p96); as an “…inter-individual and intra-
individual multi-level (psychological, physiological, social) process in time for the re-establishment of 
performance abilities”. Adequate recovery is fundamental to improving performance (41) and an 
important factor in determining when an athlete may return to competition (42). There is a large 
variability in recovery time among athletes but the recovery period should be adequate enough that 
an athlete may return to sport without an increased risk of injury (42).  
Inadequate recovery time will prevent necessary adaptation from occurring and possibly result in 
symptoms of overtraining due to extreme exposure to training loads (41, 42). Because endurance 
runners require excessive training volumes, it is imperative that the balance between training and 
recovery is coherent, particularly in those participating in ultramarathons (5, 20, 41).  
The next section will include an overview of the physiological factors affecting recovery in endurance 
running, an overview of recovery modalities used by endurance runners and markers of recovery in 
endurance running. 
2.3.1. PHYSIOLOGICAL FACTORS AFFECTING RECOVERY IN ENDURANCE RUNNING 
Ultramarathons are demanding events that deplete energy reserves and can trigger fatigue, EIMD, 
DOMS, injury and overtraining (49, 50). As discussed, the causes of EIMD and injury are associated 
with multiple physiological systems (7, 41). Muscle damage can lead to inflammation and oedema 
(swelling), a reduction in lactate clearance rates and ultimately pain (45, 48). Muscle fatigue, EIMD 
and DOMS can result in muscle soreness, decreased muscle strength, reduced range of motion and up 
to 40% to 50% reduced functional capacity immediately after an ultramarathon (34, 45-47). These 
physical changes may be due to the body having to absorb forces up to three times the body mass of 
the runner.  These forces are exacerbated when running on uneven surfaces or downhill. Eccentric 
loading of a muscle, which occurs during downhill running, is a primary cause of EIMD and DOMS 
which may exacerbate muscle damage symptoms (34, 45-48).  
The muscles damaged by eccentric loading have a reduction in stored glycogen due to the 
inflammatory and muscle cells competing for available glucose. The glycogen stores in the muscle can 
take up to ten days to recover, meaning that any training during this time will further decrease 
glycogen stores resulting in fatigue. Therefore, it is important that pre-training muscle glycogen levels 
13 
 
are restored (34, 36). Excessive eccentric loading of the muscles also affects the force output of the 
muscle due to the decrease in muscle pre-activation (34, 45). This is believed to be associated with 
the change in the contractile properties of the muscle due to the decrease in the pH level from the 
accumulation of lactic acid. The build-up of lactate and hydrogen ions in the active muscle is related 
to muscle fatigue. Because of this, it is imperative that all these resources are restored during the 
recovery process (36, 44). 
 
These physiological factors can result in a longer recovery period and extended time away from 
training and races (34, 41). The success of recovery is closely associated with returning the athlete to 
pre-race performance levels in the shortest amount of time with the lowest risk of injuries (41). This 
includes attaining the body’s homeostatic equilibrium, restoring energy resources (blood glucose 
levels and muscle glycogen stores) and returning the athlete to sport (19, 41).  
 
Recovery should be a carefully planned process to ensure rapid and ideal return to endurance running, 
while encouraging adaptation to training and preventing overtraining (19, 41, 44, 45). Therefore, the 
use of recovery modalities is central to enabling endurance runners to return to training and 
competition sooner. A brief overview of recovery modalities used by endurance runners will now be 
discussed. 
 
2.3.2. AN OVERVIEW OF RECOVERY MODALITIES USED BY ENDURANCE RUNNERS  
 
Recovery modalities are techniques used to accelerate the recovery process after competition or 
training (19, 34). Recovery modalities can be described as active or passive. Active recovery includes 
low intensity aerobic exercise, stretching, massage, cryotherapy, compression garments or water 
immersion. In contrast, passive recovery includes sedentary rest such as meditation where no physical 
activity is performed (19, 34, 42). Nutritional recovery is crucial in replenishing glycogen stores in the 
muscle and blood glucose levels. This can be obtained by consuming carbohydrates, proteins and 
vitamins (19, 34). Research into the effectiveness of these modalities is limited. Besides active and 
passive recovery, there is widespread use of nonsteroidal anti-inflammatory drugs (NSAIDs) among 
endurance runners (5) suggesting that runners experience some sort of pain sensation during 
recovery. Research shows that 59% of ultramarathon athletes use NSAIDs during training and 61% 
during recovery from a race and a large percentage (71%) during the event (5). Please refer to Jeffreys 
(43) for additional information regarding recovery modalities used in elite sport.  
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2.3.3. MARKERS OF RECOVERY IN ENDURANCE RUNNING 
 
There are a vast range of cardiovascular, physiological, neuromuscular and perceptual markers to 
monitor recovery in athletes following performance. Biomarkers for endurance runners can include 
monitoring proteins, metabolites and electrolytes. With continuous advances in technology, 
biochemical, genetic and haematological testing have been shown to be powerful sources in 
identifying the balance between training and recovery in endurance runners (52).  
However, the majority of these markers are too impractical, costly or invasive to be used by 
recreational and even some competitive endurance runners.  Yet, there is a need to closely assess 
recovery with markers that can be routinely used at rest causing as little additional fatigue, without 
disturbing the recovery process and evaluation of competition readiness (44, 52). 
 
Exercise-induced muscle damage is common among endurance runners following competition (35). 
The damage to the muscles, occurring at a cellular level, is demonstrated by several markers of 
function. These include; pain, tenderness, inflammation, loss of strength, muscle stiffness and 
biochemical markers including; creatine kinase, lactate dehydrogenase, and glutamic oxaloacetic 
transaminase (35, 53). Delayed-onset muscle soreness, peaking after 24 to 48 hours, is one of the main 
variables when assessing EIMD (53). It is therefore common in research to measure DOMS to assess 
recovery following an endurance event. To quantify DOMS, a simple numerical measurement tool has 
been used, the Visual Analogue Scale (VAS). The VAS consists of a 10 cm line whose end points are 
labelled with “no pain” and “unbearable pain.” As pain is a multidimensional construct including 
affective, sensory and evaluative aspects, a study (53) compared the VAS, a unidimensional pain 
instrument, to a multidimensional pain instrument. Results of the study found no significant 
differences between the pain intensity ratings of the two pain instruments (correlation coefficient of 
r = 1.00). Therefore, to date, the VAS remains the most common perceptual method of assessing 
DOMS following an ultramarathon event (53).  
 
Nevertheless, as Kellman and Klaus (19) described, recovery is a multilevel process that incorporates 
physical, psychological and social elements, recovery is not complete when the physiological 
parameters are met. Additionally, psychosocial factors serve an important indicator for successful 
recovery (19, 41). 
 
2.4.  PSYCHOSOCIAL FACTORS AND RECOVERY IN ENDURANCE RUNNING 
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Recent work suggests that physical and psychological recovery do not occur simultaneously (41, 54). 
This suggests that athletes might appear physically ready to return to sporting performance, but not 
psychologically ready. Even after athletes have recovered physically meeting pre-injury or pre-
competition levels in strength, range of motion and flexibility, some athletes still take extended 
recovery time, are hesitant to return to their sport or never return to their previous level of 
performance (41, 54-56). With physical factors in recovery all being met, it appears that this delay in 
return to sport may be associated with psychosocial factors (41, 54).  
This section will introduce psychosocial factors with a brief overview then discuss the introduction of 
psychosocial factors in sport followed by the biopsychosocial model and recovery in sport and the role 
psychosocial factors play in pain recovery in endurance runners. 
 
2.4.1. PSYCHOSOCIAL FACTORS 
 
Psychosocial factors are defined as a combination of psychological and social constructs affecting an 
individual (57). Psychological factors refer to individualised thought or behavioural processes which 
influence an individual’s mental state. Social factors are concerned with social processes or social 
structures surrounding an individual. How an individual understands these social factors may be 
determined by their psychological state (57). There is an increased recognition of the interaction 
between psychosocial factors and human biology. Furthermore, psychosocial factors have been 
shown to play an integral part in disease processes and rehabilitation. In fact, psychology has a 
biochemical basis emerging into the field currently known as "Health Psychology” (58). 
 
2.4.2. THE INTRODUCTION OF PSYCHOSOCIAL FACTORS IN SPORT  
 
When considering an athletes injury, factors of a biological, psychological and social nature need to 
be acknowledged. The belief that psychosocial factors play an integral role in injury risk among 
athletes was first identified in the 1960s (58). Since then it has been accepted that psychosocial 
factors, which become major stresses in an athlete’s life, can negatively impact an athlete’s 
performance by increasing the prevalence and duration of sports-related injuries. Fear, anxiety, stress 
are all traits that have been shown to delay recovery from an injury (14, 58).  
 
Recently, Nicolas (14) explored the relationship between the perception of stress and anxiety in 
runners following an ultramarathon event. More specifically, he wanted to investigate the association 
between perceived stress and recovery in the athlete’s physical, emotional and social life. He believed 
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that the ability to monitor an athlete’s perceived stress prior to a race and recovery following a race 
may aid in preventing the development of the overtraining syndrome. Thus, 14 male participants 
competing in a 24-hour ultramarathon were recruited for a longitudinal study. The athletes’ 
psychological states were measured at 1, 3, 6, 9, 12, 15, 21 and 30 days following the race (14).  
 
 
High levels of perceived stress before and during the ultramarathon race were recorded among 
participants, with those scoring higher in stress and anxiety levels pre- and post-race also having a 
poorer perceived recovery following the race (14). Additionally, a time frame of two weeks was 
required for both stress and performance to return to pre-race levels. Sport-related stress levels took 
at least six days to decrease, while general stress reduced significantly after 15 days. Furthermore, 
total wellbeing (as measured through self-efficacy, general wellbeing, sleep, social relaxation) took at 
least 15 days to return to baseline (14, 23).  
 
This study recognised the key role the psychosocial factors; stress and anxiety, play during recovery. 
In addition, Nicolas (14) suggested a period of at least 10 days for psychosocial factors to recover. As 
stress and anxiety were only measured once prior to the ultramarathon, these results might reflect a 
false representation of the runners’ general psychological state. This study acknowledged that 
recovery is an individualised process with each athlete’s recovery process being influenced by a 
complex network of biological, physical, psychological and social factors (14).  
 
With evidence that recovery from a sports-related injury is a complex process involving biological, 
psychological and social factors (14, 34), it would be interesting to determine if these factors impacted 
recovery following competition, such as an ultramarathon race. To better understand the psychosocial 
factors involved in sporting recovery, Wiese-Bjornstal (17) described elements associated with 
recovery from sport. These elements were adapted from the biopsychosocial model. This model will 
be discussed in greater detail in Section 2.4.3.  
 
In 2010, Wiese-Bjornstal (17), recognised that recovery in sport was a multilevel process. He 
determined that athletes processed the pain they felt, after heavy training, competition or injury, 
differently. Recovery was therefore subdivided into three interrelated elements namely; cognitive, 
affective and behaviour. Cognition involves the assessment the athlete makes of their own pain for 
example if an athlete interprets pain as severe, and pain is regarded as an indication of recovery, it is 
logical for an athlete to have negative cognitions about the pain experience. Affective factors can be 
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described as the emotional experience of the athlete, including emotions such as fear, depression, 
anxiety, stress and low self-efficacy (17). Negative cognitions of pain experienced during recovery 
which arise when the athlete experiences symptoms of EIMD or DOMS may then give rise to negative 
emotions including fear.  
Finally, based on the cognitions and affective factors, behaviours arise such as avoiding the actions 
and activities that will contribute or increase to their symptoms. Arguably, the most extreme 
manifestation of these factors, which leads to a delay in recovery or loss of training time and decreased 
performance, occurs during competition (58). Therefore, the runner’s personality traits, currents life 
events, social situation, response to stress and available coping resources are examples of factors that 
may predispose the runner to a delay in return to performance following an ultramarathon (58, 59). 
To achieve successful recovery from competition (after an ultramarathon race), these three factors 
need to be understood (55, 59). The biopsychosocial model will be used to better understand the role 
psychosocial factors play in recovery from an ultramarathon race. 
2.4.3. THE BIOPSYCHOSOCIAL MODEL AND RECOVERY IN SPORT 
The biopsychosocial model, defined as the systemic interaction between biological (physical), 
psychological (behaviour) and social (cultural) factors, was first applied to the sporting population in 
2001 (10), when researchers argued that returning an athlete to sport is a complex process involving 
many factors (11). The psychological factors were found to have a linking relationship with biological 
and social factors which in turn affect an athlete’s performance (12). It was suggested that exploring 
the different aspects of the model would indicate how soon athletes can return to sport after a 
competition (recovery) or after an injury (10-12). If, for example, the athlete is anxious about returning 
to sport, has poor self-belief or confidence, receives ineffective social support from team-mates or 
mentors or has a fear of pain or re-injury, this will hinder their return to training (1, 10, 12). It can thus 
be argued that psychological and social factors play an equally vital role in return to sport and pain 
recovery (10-12).  
However, previous research has only been applied the biopsychosocial model in an athletic population 
that is returning to sport following an injury (1, 9-12).  This model has yet to be implemented in a 
population of athletes recovering from competition and wanting to return to pre-race level of 
performance and training. This gap in knowledge has led to an interest in the effects of psychosocial 
factors on return to performance and recovery. 
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2.4.4. THE ROLE PSYCHOSOCIAL FACTORS PLAY IN RECOVERY IN ENDURANCE RUNNING 
Research into the psychosocial factors affecting an athlete’s return to sport suggests that athletes 
commonly experience difficulties in one or more areas of autonomy (self-authorised behaviour), 
competency (self-efficacy) and relatedness or sense of belonging in the social world (1, 9, 10).  Issues 
of self-confidence, expectations of the outcome and personal motivation found in social-cognitive 
theory (35) hold relevance in understanding the transition from training to competition to recovery 
and back to training. Social-cognitive theory highlights how personal beliefs (self-efficacy), outcome 
expectations (regarding performance or recovery) and perceived environmental impairments (fear, 
anxiety and stress) or facilitators (support) can affect a person’s wellbeing and motivation (35). 
Depending on where one is situated on the motivation and self-efficacy continuum will determine 
one’s willingness to recover and return to training (35, 60).  
Once an endurance runner has completed an event, there is a high possibility that muscle soreness 
(pain) will result either from EIMD or DOMS (28, 61). This pain sensation is understood to arise from 
nociception due to tissue micro trauma and inflammation. Although athletes are perceived as healthy, 
it has been shown that even healthy participants can experience catastrophic thoughts regarding the 
pain experienced and focus their attention on the most undesirable consequences of their actions. 
Furthermore, athletes have been shown to develop a fear of the pain experienced resulting in 
behaviour to avoid any movements that may evoke the pain (59). Research shows that fear of pain 
and catastrophic thoughts about pain are psychosocial factors that may have a detrimental effect on 
recovery (59). However, the association of fear and catastrophizing and return to sport has been 
primarily researched in athletes following ACL reconstruction (29-31, 33). 
Results of a systematic review (62) on return to sport following ACL reconstruction showed that fear 
was the primary factor for not returning to sport for 19% of the population, despite high rates of 
successful outcome of knee function. Additionally, a study by Kvist et al. (63), found that 43% of 
participants following ACL reconstruction did not return to sport at the same level as prior to injury. 
The participants not returning to their pre-injury level of performance scored high in fear of pain and 
re-injury (63). The association between fear of pain and function during the recovery period in athletes 
19 
 
returning to sport following ACL reconstruction was further investigated by Chmielewski et al. (33). 
Results from the study showed pain as a primary indicator of function across recovery timeframes. As 
fear of pain decreased, knee function increased and ultimately led to return to competition. 
 
 In a study investigating the emotional responses to injury of 30 male athletes over four recovery 
stages, it was found that 13% of the athletes experienced fear during the rehabilitation phase, with 
an increase to 40% reporting fear upon returning to sport (64). It is suggested that these fears can 
remain for years, even after return to sport (65) and be heightened among those with a history of 
injury (66, 67). Athletes who interpret participation in sport as threatening might try to avoid returning 
to peak performance as a way of managing their fear (68). Thus, the fear of pain, rather than pain 
itself, might prevent participation or return to sporting performance (66, 67, 69). 
 
The results from the studies above all support the potential effect of the fear avoidance model (FAM) 
on athletes following ACL reconstruction and perhaps these psychosocial factors may also be 
applicable to recovery in endurance runners following an ultramarathon. The FAM was developed to 
better describe how fear may impact an individual’s recovery (7). The model describes the relationship 
between pain, catastrophizing, fear, avoidance and disability in individuals (7). The FAM will be 
discussed in greater detail in Section 2.6.1. The next section will discuss the role that pain plays in 
endurance running.  
 
2.5.  THE ROLE OF PAIN IN ENDURANCE RUNNING  
 
Pain is regarded as an unavoidable part of sports participation (28, 59). It can be healthy when the 
cause is understood (for example, competition, overtraining, DOMS, injury) and the appropriate 
behavioural response takes place, for example, confrontation, recovery, taper activity, seek medical 
help (28, 59, 70). However, pain becomes unhelpful when its cause no longer exists, or the athlete 
adopts an endurance behavioural response which contributes to the development of chronicity (4). 
To better understand the development of chronicity, the transition from acute to chronic pain will be 
discussed, followed by a description of the two responses to pain using the Avoidance-Endurance 
Model and ending this section with the role chronic pain plays in endurance running. 
 
2.5.1. THE DEVELOPMENT OF ACUTE TO CHRONIC PAIN  
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The mechanisms of chronic pain development are still being understood (2). To appreciate chronic 
pain, the mechanisms of acute pain must first be addressed. Acute pain is related to actual or potential 
tissue damage involving an acute nociceptive response (70). Acute pain resolves once the wound or 
injury is healed.  
An increase in pain felt at the injury site, known as primary hyperalgesia, is believed to be mediated 
by the PNS. However, an increase in pain external to the injury site is mediated by hypersensitivity of 
the CNS and is known as secondary hyperalgesia (70, 71). The inflammatory stage of an injury is 
associated with both primary and secondary hyperalgesia that is sustained by nociceptive activation 
and an acute inflammatory process (70-72). Interestingly, research shows that 20-30% of acute pain 
injuries continue along the path to chronic pain (71). 
 
Chronic pain is defined as persistent, unhelpful pain lasting more than three months; outlasting the 
typical healing time (2, 4). Multiple changes have been recorded in the nervous system of people 
suffering from chronic pain. Some of these changes include structural and functional changes in both 
the spinal cord and the cortex resulting in amplification of nociception. This pathophysiological state 
can result in widespread hyperalgesia, allodynia, lowered firing thresholds of peripheral receptors and 
lowered thresholds in the CNS, known as central sensitisation (4, 70-72). Areas in the brain involved 
in generating the sensation of pain increase in activity, while other areas can become activated (70-
72). Magnetic Resonance Imaging (MRI) studies evaluating chronic pain also show increased activity 
in the brain not associated with acute pain, such as the dorsolateral prefrontal cortex, parietal cortex 
and brain stem (4). These neuroplastic changes in the CNS and PNS can explain the transition of acute 
to chronic pain (71). In addition to CNS sensitisation, chronic pain has been found to prevent the 
descending pain inhibitory pathways activated during exercise (4, 71).  
 
In normal circumstances, exercise activates the downward inhibitory pathways that release an opioid-
mediated analgesic effect. This is responsible for decreasing transmission of nociception during 
exercise by the release of β-endorphins from the pituitary gland. This results in activation of the μ-
opioid receptors peripherally and centrally (4). Thus, exercise results in an increased production of 
endogenous opioids from the nuclei of the brainstem. However, blockage of these receptors at a 
central level, as occurs in chronic pain, results in a reduction of analgesia during exercise or training 
(71, 73) and an increased awareness of pain (71, 72). The combination of lowered pain thresholds, 
increased responsiveness to nociception in the PNS and CNS and loss of descending inhibition of 
people with chronic pain, has multiple effects on the functioning of the individual (71-73). Two polar 
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coping reactions to an individual’s pain experience have been proposed. These reactions will now be 
discussed using the Avoidance-Endurance Model (74). 
 
 
2.5.2. THE AVOIDANCE-ENDURANCE MODEL  
 
The Avoidance-Endurance Model (74) is used to describe these two possible responses to pain, namely 
avoidance and confrontation. Both these patterns can increase the risk of failing to recover from an 
episode of acute pain and lead to the development of chronic pain or in the case of an athlete, impede 
return to optimal performance (74).  
 
The first response, the fear avoidance response pattern, is based on cognitions that pain is an indicator 
of danger or tissue damage and evokes avoidance behaviour of activities that could elicit pain, feelings 
of helplessness and depression (74). This decrease in physical activity may increase the risk of chronic 
pain development (7, 75). Endurance runners experiencing EIMD or DOMS following an event might 
interpret muscle soreness (pain) as an indicator of danger, thus changing their interpretation of pain 
and resulting in a change of behaviour (74, 75).  
 
Carson and Polman (75) identified two avoidance coping strategies in these athletes during recovery, 
namely behavioural avoidance coping and cognitive avoidance coping. Behavioural avoidance coping 
is described as the conscious decision of an athlete to remove oneself from a perceived threatening 
environment, while cognitive avoidance coping is defined as the response of the athlete to either deny 
or mentally distract oneself from the seriousness of an injury and its consequences related to 
returning to sport (75, 76). 
 
The second response in the Avoidance-Endurance Model is the endurance-response pattern, which is 
primarily associated with pain-persistent behaviour involving pushing through pain to complete a set 
goal (68, 76, 77). This distractive behaviour also increases the risk of developing chronic pain by the 
overloading of tissue structures. While studies suggest that the fear avoidance response can increase 
stress levels, the endurance response has a short-term stress-decreasing effect although in the long-
term is maladaptive and possibly contributes to overtraining (59, 78, 79).  
 
The Avoidance-Endurance Model was explored in a study (79) of 30 healthy adults with lower back 
pain (LBP). It was hypothesised that maladaptive fear avoidance response and endurance-response 
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related to pain would have an impact on pain-induced stress levels. Furthermore, fear avoidance 
response would be positively associated with stress, while endurance response would be negatively 
associated with stress. Participants were asked their typical response to pain prior to being exposed 
to an experimental pain stimulus (cold pressor test).  
Stress levels were recorded by comparing the change in salivary cortisol levels (stress hormone) before 
and after the stimulus. The cortisol levels served to measure physiological stress. Affective, cognitive 
and behavioural responses were assessed using the Avoidance-Endurance Questionnaire. A positive 
correlation was found with those scoring high in fear avoidance response having increased stress 
levels (79).  
It could be argued that the results of the above study were a consequence of the participants being 
made aware of the imminent pain stimulus prior to entering the laboratory. However, those in the 
endurance response group had lower baseline cortisol levels, supporting the belief that the 
anticipation of pain in people with this coping strategy results in less stress being experienced. These 
results suggest that diversion of attention from the anticipated pain stimulus might enable one to 
successfully manage a painful situation (79). However, these results should be interpreted with 
caution because, due to a small sample size, there is a lack of data measuring the anticipation of stress. 
The findings of this study are similar to findings of the Nicolas study (14), discussed in Section 2.4.2., 
on pre-race stress levels and recovery following a 24-hour ultramarathon race. If the 24-hour 
ultramarathon race in the Nicolas study (14) could be perceived as the “pain stimulus” and the pre-
race stress and anxiety levels as the “baseline cortisol levels,” it is then suggestive that athletes scoring 
higher in stress and anxiety levels prior to an ultramarathon, and who (knowingly or unknowingly) 
possess fear avoidance beliefs, might not have the coping strategies to deal with their pain following 
the race. This could lead to heightened levels of fear resulting in increased levels of pain experienced. 
This reduction in pain tolerance in an endurance runner would delay recovery and return to pre-race 
performance levels (5, 14, 24). 
Furthermore, higher stress levels and decreased beliefs in one’s own abilities or lower self-efficacy 
have been found to affect performance and perception of injury risk (fear) in 196 collegiate athletes 
suffering from a range of sport related injuries (55). This is the first study of its kind to investigate the 
effect of psychosocial factors on athletes over a wide range of sports, demonstrating a good 
generalisation. Although this study established a relationship between fear (of reinjury) and its effect 
on returning to pre-injury performance levels, it must be noted that the study was carried out under 
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laboratory conditions that do not produce the same extent of stress and anxiety as competitive sports 
(55).  
In sport, however, fear must not always be regarded as a negative emotion as it allows an athlete to 
evaluate potential danger. Yet, if fear becomes irrational and inappropriate, affecting the ability of the 
athlete to return to sport, then it may become unhealthy (80). Both avoidance and confrontational 
responses to pain may be appropriate at certain points in sporting recovery, however, both may 
progress into dysfunctional behaviour becoming negatively associated with an athlete’s engagement 
in physical activity (81).  
2.5.3. THE EFFECT OF CHRONIC PAIN ON ENDURANCE RUNNERS 
As the pain experience is individualised, the interpretation is unique (2). Increased pain demands 
attention and so can interrupt daily activities (72). Unwarranted attention to pain has been associated 
with increased pain-related fear. Acute injury results in pain and, to prevent further injury and 
encourage the necessary care, a certain amount of pain-related fear occurs. This fear is adaptive with 
withdrawal from activity to allow for healing, the next natural progression. However, when the pain 
experienced can no longer be explained by tissue damage, fear leading to avoidance of activities 
becomes dysfunctional and unhelpful (2, 7, 63). 
When an individual’s life is continuously interrupted by pain they may disengage from their daily 
routine activities (2, 7). For an endurance runner this would mean avoiding return to training and 
competition. Such detachment from routine meaningful activity can give rise to catastrophizing 
thoughts. Pain catastrophizers have difficulty in casting their attention away from painful cues and 
develop pain in anticipation of an activity as they ruminate on and magnify their symptoms. This can 
lead to avoidance of an activity to evade pain (72). Additionally, catastrophic thoughts can further 
encourage this avoidance behaviour and increase descending facilitation, prolonging the central 
sensitisation process (4). 
Although the development of chronic pain among endurance runners is unlikely, unhelpful cognitive 
and affective factors which change behaviour might affect their ability to return to pre-race 
performance levels. Endurance runners showing signs of avoidant behaviour and pain-related fear, 
might not go on to develop chronic pain, but could fall into the Avoidance-Endurance Model. Although 
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this might not develop into disability among these runners, it might affect recovery and return to 
performance following a strenuous ultramarathon race (7, 70, 82).  
Psychosocial factors have been identified as playing an important role in an individual’s pain 
experience (83). Pain is an accepted consequence of sporting participation; however, it can emerge as 
a barrier to recovery when it becomes a cause of fear, avoidance behaviour, pain catastrophizing and 
anxiety. Failing to appropriately interpret pain may result in delayed recovery and return to sporting 
performance after competition (64). The next section will discuss the role of these psychosocial factors 
namely; fear avoidance, pain catastrophizing and self-efficacy, play in endurance running. 
2.6.  FEAR AVOIDANCE, PAIN CATASTROPHIZING AND SELF-EFFICACY AND 
ENDURANCE RUNNERS 
Building upon the knowledge of pain in endurance runners, it can be said that pain has intrinsic 
threatening components with the threat value varying across different contexts and individuals. 
Protective behaviour, because of pain-related fear, might be beneficial in the short term, but can result 
in fear avoidance beliefs and pain catastrophizing in the long term (7, 82). The Fear Avoidance Model 
(FAM), attempts to explain the development of disability, stress and disuse as a result of avoidance 
beliefs motivated by fear. The FAM attempts to explain this transition by exploring the interrelating 
psychosocial factors of fear avoidance beliefs, catastrophic thinking and self-efficacy beliefs (7, 70, 82). 
2.6.1. THE FEAR AVOIDANCE MODEL 
Initially, the FAM served as a cognitive-behavioural platform to explain the development of chronic 
pain in acute LBP sufferers. This biopsychosocial model introduces psychological and social factors 
that contribute to the development of chronic pain. It was used to explain why chronic LBP (CLBP), 
and its related disability, develops in only a small number of individuals suffering acute LBP (72, 84). 
The social-cognitive theory (35) is used to explain the interpretation of pain by individuals and how 
this can result in one of two behavioural outcomes. If acute pain is perceived as non-threatening, 
individuals will continue in their activities and the pain will not interfere in their participation 
(confrontation). This is evident in sport where athletes will continue to participate in training or 
complete a race, despite being in pain. However, if acute pain is perceived as threatening, as seen in 
the fear avoidance response pattern, (correctly so in the case of a severe injury, or incorrectly so in 
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the case of a mild injury), it can result in catastrophic thoughts. These catastrophic interpretations can 
lead to cognitive avoidance behaviours relating to fear.   
This avoidance behaviour can be amplified by further unhelpful cognitive beliefs such as decreased 
self confidence in one’s own abilities, namely low self-efficacy (56, 78). These fears and behaviours 
might be plausible and adaptive in the acute pain phase during tissue healing or recovering from EIMD. 
However, if these behaviours continue and become maladaptive, they can lead to long-standing pain 
beyond normal tissue-healing time, disability and disuse (84).  
Fear is described as an emotional response to a situation or perceived threat (cognition) (7, 79). Fear 
can serve as a protective mechanism to adjust a person’s behaviour. The ability to escape this threat 
reduces one’s fear for a short period but has been reported to increase fear in the long term. In 
contrast, anxiety views the threat as undefinable and without clear focus. It encourages preventative 
behaviour, as well as avoidance. Thus, fear avoidance behaviour is believed to decrease anxiety and 
fear in the short term but can have detrimental effects in the long term (7, 71, 79-81, 84, 85). In 
patients with acute LBP, pain-related fear was linked to decreased participation in activities, increased 
sick leave and work loss, and poor performance in daily tasks (79). This avoidance behaviour in the 
acute phase of recovery from injury gives rise to the belief that pain-related fear can contribute to the 
development of chronic pain and disability. (71, 79-81, 86).  
Avoidance behaviour leads those with fear avoidance beliefs to evade activities or perceived threats 
to prevent an increase in the existing pain (71, 80, 81, 85). Supporting evidence confirms that, in the 
population with pain-related fear, there are slower walking speeds, weakened muscles and reduced 
functional performance. Furthermore, poor performance is closely related to fear avoidance beliefs. 
This is detected in individuals with CLBP who will avoid a perceived threatening situation or perform 
it at a suboptimal level using safety behaviours (62). Finally, fear avoidance can affect the experience 
of pain and increase suffering. This can progress into a continuation of pain behaviours. Avoidance 
behaviour then develops in anticipation of pain, resulting in further anxiety, fear, pain and disability 
(62).  
This avoidance behaviour in endurance runners recovering from an ultramarathon would be 
unhelpful. The normal pain felt after an ultramarathon, due to the physical demands of the race, may 
be misinterpreted because of pre-existing fear avoidance beliefs. This could result in delayed recovery 
or even return to suboptimal performance to avoid any perceived threatening activity (training) that 
could cause (further) pain.  
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Although the FAM was designed to describe the transition from acute to chronic pain in the general 
population, it is not appropriate to evaluate fear avoidance behaviour in the sporting population as 
the model is not specific enough to athletes (7, 79). Thus, interest in sports participation and return 
to sport led to the development of the Athlete Fear Avoidance Model (7).  
 
2.6.2. THE ATHLETE FEAR AVOIDANCE MODEL AND ENDURANCE RUNNERS  
 
Due to the nature of sport, athletes experience pain and injury regularly (7). It is therefore 
understandable that avoidance behaviour in sport is not uncommon. Pain-related fear was first 
identified as contributing to athlete recovery when it was noted that the duration of rehabilitation 
was inconsistent with the athlete’s initial injury (7, 55). This then led to the development of the Athlete 
Fear Avoidance Model which explains the transition where behaviour and experience develop into an 
exaggerated perception of pain (72, 84). This heightened perception of pain can result in chronic pain 
and disability in athletes (7).  
 
A vast amount of research has explored the FAM for the general population. Questionnaires 
developed in this area have shown good reliability and validity in the general population, however 
there is a gap in research assessing fear avoidance in the sporting population. The questionnaires 
available are not specific enough for the athletic population who understandably tolerate pain 
differently (7, 79). Pain among athletes can be interpreted as an “ally” suggesting that the athlete is 
working hard and reaching their training goals. Therefore, in sport, pain is an accepted part of their 
training and performance, and athletes learn to not focus on pain but rather on the sport (79).  
 
Endurance runners train at moderate to high intensities of physical activity over a long distance. Thus, 
pain is a well-accepted component of ultramarathons (23). Hoffman (28) explored pain perception of 
21 ultramarathon runners after competing in the 2005 Western States 100-mile (161 km) marathon. 
The study examined whether the perception of pain is affected or altered when competing in this 
marathon.  
 
Hoffman (28) hypothesised that only the fastest or most well-trained athletes would experience 
exercise-induced hypoalgesia or a reduction in pain intensity. This hypothesis was based on the notion 
that physical activity levels at a sufficient intensity reduce pain experienced, an opioid analgesic effect 
(87). This is commonly known as the “runner’s high” (11). “Runner’s high” is associated with 
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conditioned pain modulation. This conditioning in runners reduces excitability in the CNS, increases 
levels of endogenous opioids and serotonin and increases brainstem inhibition (88).  
This allows endurance runners, exercising at a certain intensity, to tolerate pain better and continue 
participating in an ultramarathon (86). 
 
Hoffman (28) used pressure pain threshold tests to the finger, before and after the race, with 
participants rating their overall pain and pain relating to the pain threshold test. This data was used 
to assess the functioning of their conditioned pain modulation. Results showed that the runners with 
the quickest finishing times rated their pain on the pressure pain threshold test lower after the race 
than before the race, suggesting a change in pain threshold. Remarkably, only the faster runners 
experienced this exercise-induced hypoalgesia, or “runners high” (28).  
 
When examining the demographics, the faster runners were younger in age and had undergone large 
amounts of long distance training prior to the race. The excessive amounts of training could have 
modulated the runner’s ability to deal with pain. The more pain the runner experienced in training, 
and could successfully recover from, the lower the threat value of pain (fear). This decrease in the 
threat value of pain may have better equipped the runners to cope with the pain felt and dissociate 
from the pain experienced to perform better (run faster). In addition, marathon runners who are 
regularly exposed to injury and pain during training may develop higher levels of self-efficacy in the 
pursuit of their goal, while tolerating the pain and discomfort. Higher self-efficacy beliefs may permit 
runners to perform better (run faster) in an ultramarathon race due to previous experience in training 
of achieving personal running goals (11). The small sample size limited Hoffman’s (28) ability to detect 
small changes of pain perception among participants, and the metrics were geared to recognise large 
differences between the subjects’ results. Despite these limitations, the data supports the view that 
physical activity at a moderate to high intensity results in physiological adaptations in the CNS which 
may prevent development of fear avoidance beliefs (28).  
 
Sport participation involves continuous strain on the body, which can result in pain. Athletes will 
continue to compete in training and competition despite pain (endurance response) because of social 
expectations, personal expectations or poor coping strategies (59). Research has identified how 
external factors (media, coaches, peers) can influence the attitude an athlete has towards pain, the 
role psychosocial determinants play in the behavioural response to pain in the sporting population is 
still being understood (59). The lack of research into the role of the FAM in the athletic population 
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encouraged Dover (7) to develop and validate an Athlete Fear Avoidance Questionnaire specifically 
for the athletic population. 
The Athlete Fear Avoidance Questionnaire addresses all key areas in fear avoidance; sport injuries, 
psychology and athletic experience. The goal of the questionnaire is to allow early identification of 
fear avoidance traits and assist in the development of an effective recovery programme and earlier 
return to performance (7, 81).  Along with fear avoidance beliefs, pain catastrophizing may be an 
important predictor of pain during recovery and in return to performance (29). Understanding the 
components of catastrophizing that influence pain may provide information useful for returning an 
athlete to peak performance as soon as possible. This can be done by identifying areas to target 
through intervention (16, 29).  
2.6.3. PAIN CATASTROPHIZING AND ENDURANCE RUNNERS 
The term “pain catastrophizing” was coined in 1962 by Albert Ellis as the process where individuals 
focus on the most negative consequences of actions (84). Catastrophizing thoughts heighten pain-
related fear and thus attention to the painful stimulus increases. The predisposition of an individual 
to catastrophize pain can result in extended and even inadequate recovery following an injury (79). 
Pain catastrophizing has been correlated with the development of chronic pain and movement 
dysfunction (79, 81). Furthermore, pain catastrophizing exaggerates the perceived threat value of pain 
and one’s inability to cope with pain by intensifying the pain experience. In addition to the relationship 
between catastrophizing and intensified pain, catastrophizing can be related to disability, specifically 
in CLBP (81).  
Initially, pain catastrophizing was identified using non-standardised interviews. However, the 
interpretation of these interviews was subjective to the assessor and served as a weak measuring tool 
(89). Additional research focused on self-reporting tools to assess catastrophizing such as The Coping 
Strategies Questionnaire (90). This questionnaire was then further developed by Sullivan et al (91) into 
the Pain Catastrophizing Scale.  
The Pain Catastrophizing Scale was the first of its kind to assess other factors of catastrophizing, 
namely helplessness, rumination and magnification. This scale has successfully been used across 
healthy, pain-free individuals (92), chronic-pain individuals (86), across a range of ages (93), in diverse 
cultures (94), and the sporting population (95). 
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The Pain Catastrophizing Scale was first introduced into the sports community by Sullivan (59), who 
wanted to examine the reliability of the scale among athletes. Volunteers included 237 healthy 
students (19.4 years ±3.6) 97 of whom (41 males, 56 females) were engaging in competitive sport five 
times a week. The 140 sedentary students and the sports group completed a sports questionnaire and 
the Pain Catastrophizing Scale. Results showed that in both the sedentary and sporting group’s pain 
catastrophizing consists of three factors: magnification, rumination and helplessness. In other words, 
participants scoring high on the Pain Catastrophizing Scale tended to amplify the threat value of pain 
(magnification), excessively focus on pain itself (rumination) and view themselves as incapable of 
controlling pain intensity (helplessness). The results suggest that the scale is internally consistent 
across sedentary and the sporting population. Furthermore, the Pain Catastrophizing Scale is a useful 
tool in athletes who experience pain due to sporting participation (59).  
However, when comparing the reliability of magnification across the two groups the reliability 
coefficients were low. This low internal reliability of the magnification scale between sedentary and 
the sporting population is further supported in previous work (91). These results may be owing to the 
small number of items representing magnification and low degree of repetition. Furthermore, those 
who participate in one form of magnification (remembering other painful experiences), may not 
participate in other forms, for instance expecting a poor outcome (59, 91). This might affect the 
reliability value for magnification in the scale (91). 
With the understanding that each athlete manages pain differently and that the way athletes manage 
pain can influence recovery and return to performance, Sullivan et al (59) examined the value of the 
Pain Catastrophizing Scale in pain prediction in the athletic population.  Fifty- four sedentary (27 male) 
and 54 athletes (26 male) attending university participated in the study. It was hypothesised that pain 
catastrophizing would be a valuable predictor of pain in the sporting population, like the general 
population, and that pain intensity recorded by athletes could be influenced by pain catastrophizing. 
Pain was induced by a cold pressor and pain catastrophizing was assessed prior using the Pain 
Catastrophizing Scale. Participants then submerged their arms in ice water for 1 minute before rating 
their pain on a scale from 0 to 10 (59). 
The results showed that athletes reported less pain than their sedentary counterparts. Additionally, 
the Pain Catastrophizing Scale was found to be a valuable predictor of pain intensity in the athletic 
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population. In other words, those athletes scoring high on the Pain Catastrophizing Scale also scored 
high on the pain scale following the cold presser test.  
However, catastrophizing alone could not explain the difference in pain intensity ratings between the 
athletic and sedentary population. Hence, this study suggested that catastrophizing plays a key role in 
pain prediction among the athletic population but did not identify the reason for the lack of difference 
in the perception of pain between sedentary and athletic populations (59, 97, 98). 
Further analyses show that the magnification component of the Pain Catastrophizing Scale did not 
correlate with pain ratings in this study comparing athletes and non-athletes (59). This might in part 
be related to the nature of the pain produced. The procedure of submerging an athlete’s arm in ice 
water to elicit a pain response is an intervention often used in recovery and therefore might not be 
experienced as threatening by the athletic population. Fear and stress play a role in pain magnification 
among athletes. Therefore, the experimentally controlled condition in which pain was induced in this 
study might not evoke the same fear and stress as an athlete experiences in training or competition 
and consequently, might not induce the same behavioural response. Future studies should use a more 
threatening pain stimulus which is not associated with treatment. This might better assess the 
psychosocial factors or possible pre-existing fear avoidance beliefs associated with the tolerance of 
pain in athletes (11,12).  
Even though this study exposed catastrophizing as a factor related to pain experience, it is not the 
only relevant psychosocial factor. In addition to fear avoidance beliefs and pain catastrophizing, self-
efficacy, goal planning, threat value and hopefulness may also be vital predictors of pain among 
endurance runners and have a role in recovery (95, 96). 
2.6.4. SELF-EFFICACY BELIEFS AND ENDURANCE RUNNERS 
Self-efficacy was first described by Bandura (66) as the self-belief one has in one’s own abilities to 
complete a task. Therefore, it does not assess one’s skill but self-confidence in one’s own skill (99). 
Bandura proposed that self-efficacy beliefs will impact not only the activity pursued but also the effort 
put into completing the activity (66). He continues to describe the four main sources related to self-
efficacy: what one believes one can accomplish based on past performance; how one sees oneself 
imitating others; the social persuasion and reinforcement one receives from others; and the physical 
function one views oneself to have (95). 
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It has been accepted that high self-efficacy among athletes is imperative to successful rehabilitation 
following an injury (64, 78, 79). Thomee and colleagues (100), who described self-efficacy as the self-
assessment of a person’s capability to carry out a task, found a relationship between low optimism, 
negative mood and increased pain during recovery following an ACL reconstruction. They proposed 
that the athlete’s sense of control of the recovery process and how the athlete felt in relation to the 
knee’s ability to perform were the primary predictors of self-efficacy (100).  
One hundred and sixteen athletes (mean age 31.2 years), of whom 45 had ACL deficiencies (49% 
female) and 71 had ACL reconstruction (34% female), were included in the study. Participants were 
recruited by an experienced orthopaedic surgeon within one month of injury or assigned surgery. All 
participants completed a Knee Self-Efficacy Scale (K-SES), which had been previously validated (56), at 
one month visit and 12 months post injury or reconstruction (100). The most important determinant 
of self-efficacy, in the above-mentioned athletes, was how they felt about their knee function 
following recovery, rather than the objective physical findings. Athletes scoring higher on the K-SES 
prior to rehabilitation returned to sport and pre-injury performance sooner.  
These results suggest that a strong correlation exists between high ratings of self-efficacy before 
reconstruction and a positive recovery outcome. However, it must not be ignored that the participants 
in the study were young athletes who were physically active prior to the ACL reconstruction. This could 
have resulted in favourable factors influencing a higher score of self-efficacy. Although an ACL injury 
has great personal impact for an athlete, these findings can in no way be generalised across all 
recoveries that follow sport injuries. Injury-related bias can be reduced in future studies by 
investigating recovery in other injuries that have the same prevalence and severity in an athlete’s 
sporting career, for instance grade three ankle sprain. Yet, within the athletic population this study 
amplified the key role self-efficacy plays in a positive recovery outcome (100). 
The finding that higher self-efficacy scores result in improved recovery following ACL reconstruction 
has also been supported in further studies. Pre-operative self-efficacy scores predicted athletes’ 
outcomes in terms of return to play, symptoms of the knee, and muscle function (16, 29, 56). It can 
be recognised that high levels of self-efficacy preoperatively relate to a better outcome following an 
ACL injury (16, 29). These studies shed light on the fact that if those with low self-efficacy could be 
identified early in training, recovery might be optimised to allow them to return to sport sooner (16, 
29, 56).  
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As previously discussed, endurance runners experience not only pain but also strong emotions of fear, 
depression and fatigue before, during and after an ultramarathon competition. Investigation into 
these aftermath emotions suggests that intense, prolonged exercise, such as an ultramarathon, can 
result in increased emotional disturbance. However, there are endurance runners that can tolerate 
and cope well with these emotions as a result of high self-efficacy beliefs and thus improve their 
running performance (5, 6, 9, 61).  
 
The role of self-efficacy beliefs and catastrophizing as pain mediators was investigated by Johnson (11) 
in 26 marathon runners. The effects of self-efficacy and coping strategies were explored with regard 
to pain tolerance using the Cognitive Coping Strategies Inventory, and the Visual Analogue Scale. The 
study revealed marathon runners had a 40% increase in pain tolerance and pain threshold compared 
to non-marathon runners. Pain tolerance by marathon runners seems to be improved by an increased 
level of pain-specific self-efficacy but it is not influenced by general cognitive coping strategies (55, 56, 
101). This evidence further supports the argument that psychosocial factors play a role in pain 
tolerance among marathon runners, with higher levels of self-efficacy permitting marathon runners 
to tolerate pain better during and after a race (recovery) (56, 101). 
 
Since research supports the early identification of low self-efficacy in injured athletes returning to 
sport, the obvious next step is to understand the relationship self-efficacy plays in competition and 
returning to performance. Self-confidence in an athlete’s own skills has been recognised as crucial for 
successful sporting performance (99, 100), therefore, an instrument to determine where an athlete 
lies on the self-efficacy spectrum would be beneficial. 
 
As the construct of self-efficacy is specific to the situation presented, a wide variety of questionnaires 
have been developed to assess self-efficacy in different areas (21, 102). The Pain Self-Efficacy 
Questionnaire (21), the Physical Self-Efficacy Questionnaire (103) and K-SES (56), to name a few, have 
all been validated in their areas. Given the numerous situations where self-efficacy might be a 
concern, it is unrealistic to develop countless scales and, therefore, the development of scales for 
general areas is desirable (23). 
 
However, a higher correlation has been found between self-efficacy and pain when using a task-
specific questionnaire than when using a general questionnaire. Furthermore, the use of self-report 
questionnaires has been shown to be more valid when compared to objective measures (99).  
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For example, the measure of tennis players’ self-belief that they can win a competition is more 
valuable than the number of successful serves when measuring self-efficacy in performance (99). 
 
Therefore, with the understanding of the imperative role fear avoidance beliefs, pain catastrophizing 
and self-efficacy beliefs plays in sports performance and pain recovery, it is important that these 
factors are explored and if necessary addressed during training, before they hinder or slow return to 
performance (80, 104). Therefore, the timing of assessment of fear avoidance beliefs, pain 
catastrophizing and self-efficacy is crucial. 
 
Based on this research measuring fear avoidance beliefs, pain catastrophizing and self-efficacy in 
athletes prior to competition, such as an ultramarathon, it would be beneficial to identify possible 
factors that could result in prolonged recovery from pain and delayed return to performance. 
Detecting these psychosocial factors during training could reduce time away from sport following a 
competition and reduce recovery time (7, 80). 
 
2.7. SUMMARY OF LITERATURE REVIEW  
 
Running is a popular sport worldwide with participation in marathons increasing annually (9, 20). 
There are many documented benefits of running including; metabolic, cardiovascular, musculoskeletal 
and psychological (9, 20, 35, 36). However, with the volume of training and intensity required to 
participate in endurance running, particularly an ultramarathon, there are many negative potential 
effects (40-45). The primary potential negative consequences include; fatigue, EIMD, DOMS, 
overtraining and injuries (40-47). Although these negative effects are a normal physiological process 
of recovery following a marathon, they can result in delayed return to performance and training (40, 
41). 
 
Recovery is a fundamental part of endurance running. It allows for physical adaptations to improve 
performance (41) and is an important indicator of when a runner may return to training and racing 
(42). Recovery has both physical and psychosocial elements and both elements need to be addressed 
for recovery to be successful (19). Despite a great deal of research around physical recovery, there is 
a lack of research into the psychosocial factors affecting recovery (41, 54). Literature has recognised 
the role stress, fear avoidance beliefs, pain catastrophizing and self-efficacy beliefs play in recovery 
(14, 16, 29, 58, 105). These psychosocial factors have been found to delay return to sport, prevent 
return to pre-race performance and increase levels of stress and anxiety in athletes (14, 58).  
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Yet, with previous research recognising the role psychosocial factors play following an injury, no 
studies have investigated the role psychosocial factors play in recovery following competition (14, 16, 
58), such as an ultramarathon race.  
 
Literature identifies fear avoidance beliefs, pain catastrophizing and self-efficacy beliefs as imperative 
psychosocial factors in returning an athlete to sport post injury. However, these psychosocial may not 
solely be a consequence of an injury but may be a pre-existing factor in athletes (7, 80). If these 
psychosocial factors play a role in delay of recovery following an injury, it is possible that they may 
play a role in return to competition following a race. Therefore, the aim of this study is to determine 
the relationship between fear avoidance beliefs, pain catastrophizing and self-efficacy beliefs and 
recovery following an ultramarathon race. Potentially early recognition of these possible pre-existing 
psychosocial factors in marathon runners may prevent delay in return to training and earlier return to 
pre-race performance levels (14, 17).  
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CHAPTER 3: DO PSYCHOSOCIAL FACTORS PREDICT PAIN AFTER 
PARTICIPATION IN AN ULTRAMARATHON RACE?  
3.1.  INTRODUCTION 
The popularity of endurance sport is increasing globally (9), with endurance running being undertaken 
by a wide range of competitive and recreational athletes (20). Ultramarathon races impose severe 
physical and emotional stress on endurance runners (14-20). Recovery is, therefore, an essential part 
of endurance running to promote positive adaptations from training and reduce the negative effects 
of training such as exercise-induced muscle damage (EIMD), delayed-onset muscle soreness (DOMS) 
and fatigue (41). The recovery process is multidimensional involving physical, psychological, social and 
emotional aspects. These aspects of recovery do not occur simultaneously (41, 54). 
Endurance runners are embedded in a culture that accepts the “no pain, no gain” expression in 
competition and training (89).  Pain is therefore an inevitable part of participating in an ultramarathon 
(28, 59). However, pain can become obstructive when its cause cannot be explained. If pain is 
misinterpreted during recovery an endurance runner may adopt unhelpful behaviour which may 
develop into chronicity (4). The Fear Avoidance Model has been used to better understand how this 
unhelpful behaviour, driven by fear of pain, can develop into disability and disuse. This model explores 
the relationship between psychosocial factors of fear avoidance beliefs, catastrophic thinking and self-
efficacy beliefs (7, 70, 82). These psychosocial factors may play a significant role in the pain recovery 
process (105).  
Despite the increasing popularity of endurance running and the importance of recovery in endurance 
running, there is a lack of information from reputable sources about psychosocial factors and their 
effect on pain recovery in this population (21, 61). The aim of this study was to determine whether 
there is an association between fear avoidance beliefs, pain catastrophizing and self-efficacy beliefs 
and athletic pain recovery in a cohort of ultramarathon runners competing in the 2017 86.73 km 
Comrades Marathon road race.  
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3.2.  METHODS 
3.2.1. STUDY DESIGN 
This study used a descriptive, longitudinal cohort design.  The rationale behind the study design was 
to establish if there was any association between the baseline pain psychosocial questionnaire scores 
(Pain Catastrophizing Scale, Athlete Fear Avoidance Questionnaire, Pain Self-Efficacy Questionnaire) 
and pain recovery following the race. The study consisted of two parts. In the first part, participants 
completed questionnaires regarding their training history and pain psychosocial questionnaires to 
establish a baseline. In the second part of the study, daily pain scores of each participant were 
observed for 10 days following the race to record recovery. Pain was used as a marker for recovery 
following the ultramarathon (see Section 2.3.3., page 14). 
3.2.2. INCLUSION CRITERIA 
Healthy ultramarathon runners between the ages of 20 and 60 who had qualified for and were 
intending to compete in the 2017 Comrades Marathon were included in this study.  
 3.2.3. EXCLUSION CRITERIA 
Participants were excluded if they failed to complete written informed consent (Appendix 1); reported 
any signs of illness within the two-week period prior to the race; or reported any relevant medical or 
surgical procedure that would prevent participation in the race. Participants with a diagnosed history 
of chronic pain, complex regional pain syndrome or other chronic pain conditions or who did not 
complete the race were also excluded. The information evening and the information sheet (Appendix 
2) were used to inform any potential participants diagnosed with a chronic pain condition that they
would be excluded from the study. 
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3.2.4. SAMPLE SIZE DETERMINATION 
To determine whether psychosocial factors predict pain during recovery, a multiple regression analysis 
was conducted to determine sample size using the Daniel Soper statistical calculator (106). The 
dependent variable used was pain, and the predictor (or independent variables) used were 
catastrophic thinking, fear avoidance beliefs and self-efficacy. The minimum sample size required 
based on an effect size of 0.15; a power of 0.8; an alpha level of 0.05 and three (3) predictors was 76. 
A conservative effect size estimate of 0.15 was selected based on the levels of fear avoidance beliefs 
exhibited by athletes with and without ankle injuries (106). To allow for loss to follow-up, a minimum 
sample of 80 participants was required for this study.  
3.2.5. PARTICIPANT RECRUITMENT 
All participants were runners recruited from Randburg Harriers Running Club and Wanderers Sports 
Club, the largest (570 members) and second largest (553 members) running clubs in Johannesburg at 
the time of this study respectively. A convenience sampling method was utilised, as these clubs were 
selected due to their proximity to the researcher’s work and the size of the clubs.  
Participants were recruited using advertisements at the running clubs and Randburg Medicross, where 
the researcher works. Recruitment by advertisement started in April 2017 where participants were 
made aware of the study and informed of an information session that was going to be held by the 
researcher at the running clubs.  Additionally, the researcher contacted the secretaries of the 
Randburg Harriers Running Club and Wanderers Sports Club with information regarding the study and 
the information evening that was going to be held two weeks prior to the 2017 Comrades Marathon. 
Members who showed interest in the study, required more information or wanted to participate but 
could not attend the information evening contacted the researcher directly on the email provided by 
the club secretaries. The information sessions were held at the running clubs two weeks prior to the 
Comrades Marathon to inform the potential volunteers about the study. At the information session, 
the consent forms and information sheets were handed out and completed.  
The participants were invited to participate in the study with the broad outline of general recovery 
after the Comrades Marathon and their view of pain, without explicitly telling the participants that 
psychosocial factors and their possible association to pain recovery was the focus of the study. This 
was to avoid response bias and subject bias of participants. 
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3.2.6. MEASUREMENT INSTRUMENTS 
 
3.2.6.1. INFORMED CONSENT FORM 
 
The informed consent form, completed prior to participation, included a description of the significance 
and procedure of the study, information regarding ethical approval, the possible risks and benefits of 
the study and the right to withdraw at any stage. Participants were informed that all personal 
information and data would remain confidential. 
 
3.2.6.2. MEDICAL AND SPORTS HISTORY QUESTIONNAIRE  
 
The Medical and Sports History Questionnaire (Appendix 3), handed out at the information evenings, 
was either collected and returned at the information evenings or returned within 48 hours of the 
information evenings via email. This Medical and Sports History Questionnaire was based on the 
questionnaire that was successfully used in the 2000, 2001, 2006, 2007, and 2014 Two Oceans 
Marathon and Ironman research studies (35). The questionnaire was developed and validated in a 
previous study (35) by two experts in endurance exercise. The validators commented on the 
importance and relevance of the questions and whether the questions were concise, easily 
understood and clear. In addition, the validators gave input regarding areas not covered in the 
questionnaire and an updated version was created which was again consolidated by the two experts. 
Before the questionnaire was used in the above-mentioned study (35), the final version of the training 
questionnaire was validated across the panel of experts who concurred that all objectives of the 
questionnaire regarding medical and sports history in endurance athletes were met (35). 
 
The questionnaire was used to obtain information regarding the participant’s; demographics, training 
history, competition history, medical history and injury history. Past injuries were recorded as any 
injury experienced during the participants running career. These current injuries would have been 
present at the time the Medical and Sports History Questionnaire were completed, two weeks prior 
to the Comrades Marathon. Details of the current injuries reported included anatomical area, 
structure, injury severity on a scale of 1 to 4, how the injury had been treated to date (rest, surgery 
physiotherapy, exercises and medication) and the specific year or month the participant first became 
aware of the injury.  
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The injury severity scale was graded 1 to 4 with grade 1 representing: “I only experience symptoms 
after exercise,” grade 2: “I experience symptoms during exercise, but it does not interfere with 
exercise,” grade 3: “I experience symptoms during exercise that may interfere with my 
training/competition,” and grade 4: “I am so painful that I may not be able to train or compete.”   
 
Previously used pain-relieving medication after completion of a running race was recorded with no 
specific timeframe of use. Over the counter pain-relieving medication were listed with an option of 
participants adding additional medication used in a section under “other.”   
 
3.2.6.3. THE PSYCHOSOCIAL QUESTIONNAIRES 
 
The three psychosocial questionnaires utilised in this study have been widely used and validated in 
pain management and research (7, 70, 73, 81). The Pain Catastrophizing Scale (Appendix 4) was used 
to explore whether a correlation exists between inconsistent pain recovery and catastrophizing 
thoughts. The Athlete Fear Avoidance Questionnaire (Appendix 5) was used to assess the athlete’s 
fears and thoughts about returning to performance and pain-related fear. The Pain Self-Efficacy 
Questionnaire (Appendix 6) was used to assess the participant’s confidence in their ability to cope 
with pain. All questionnaires were made available in Afrikaans and isiZulu. The three baseline 
psychosocial questionnaires will now be discussed in greater detail.  
 
3.2.6.4. THE PAIN CATASTROPHIZING SCALE 
 
The Pain Catastrophizing Scale is used to assess the components of catastrophizing: rumination (four 
items), helplessness (three items) and magnification (six items). The questionnaire consists of a five-
point scale of 13 items measuring different thought processes of individuals that might be 
experiencing pain. The points range from a score of zero to four where zero represents “no worry at 
all” and four represents “worrying all the time” or increased levels of catastrophizing (79). The cut-off 
score for the questionnaire is 30 (indicating unhelpful pain catastrophizing). The cut-off scores for 
rumination, helplessness and magnification are 11, five and 13 respectively (95, 96). Research suggests 
the scale is the only one of its kind to successfully identify the level of catastrophizing in the general 
population. It has also been successfully used and tested in the South African context (94). The Pain 
Catastrophizing Scale was translated into English, Afrikaans and Xhosa to adapt the scale across South 
African cultures. The adapted scale showed excellent test-retest reliability (0.90, 0.91, 0.89 for English, 
Afrikaans, Xhosa) and internal consistency across all three languages.  
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This scale is therefore a valid and reliable tool to assess catastrophizing within the South African 
context. Additionally, the scale has been effectively used in the sporting population (59). 
3.2.6.5. THE ATHLETE FEAR AVOIDANCE QUESTIONNAIRE 
The Athlete Fear Avoidance Questionnaire consists of 10 items where five represents strong 
agreement to the question and one represents strong disagreement (7). Content validity was 
established through a cross-sectional study in which the questionnaire was validated by a board of 
eight experts. Their expertise was in the field of sport, fear avoidance, psychology and sport therapy. 
Concurrent validity was established in a sample of 99 athletes attending university across a variety of 
sports. The 99 athletes completed the Athlete Fear Avoidance Questionnaire, the Fear Avoidance 
Beliefs Questionnaire and the Pain Catastrophizing Scale. Results showed significant associations 
between these questionnaires. This ensures the questionnaire is measuring fear in athletes and no 
other confounding variables. A Cronbach α of 0.805 supports high internal consistency of the 
questionnaire (7).  
Currently, the Athlete Fear Avoidance Questionnaire is the only questionnaire of its kind to specifically 
detect fear avoidance beliefs that could hinder return to performance in the athletic population. It can 
be used to detect possible psychosocial barriers to recovery and rehabilitation in athletes (7). Although 
the questionnaire is complex, with evidence of good internal validity and consistency, the sex and age 
of athletes were not considered and might obscure the results (7). Further testing in this area across 
a range of ages and between male and female athletes is therefore needed. 
3.2.6.6. THE PAIN SELF-EFFICACY QUESTIONNAIRE 
The Pain Self-Efficacy Questionnaire was developed in the 1980s to assess the self-confidence one has 
in completing a task despite pain. It consists of 10 items. The total score ranges from 10 to 60, with a 
cut-off score of 30. Those scoring below this mark are scored as having low self-efficacy (12). A study 
investigated the validity and reliability of the Pain Self-Efficacy Questionnaire and Pain Catastrophizing 
Scale in 103 participants aged between 18 and 60 years. The participants’ diagnoses ranged from 
fibromyalgia to CLBP. Data was gathered at the initial assessment and three months later. The Pain 
Catastrophizing Scale showed high reliability (0.93) and validity (0.87). The Pain Self-Efficacy 
Questionnaire also demonstrated high validity (0.67-0.84) and reliability (0.92) (21). 
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The use of the Pain Self-Efficacy Questionnaire within the South African context has yet to be 
validated, however, the Coping Self-Efficacy Scale (CSE) was validated across a multicultural sample in 
South Africa (n=2214). The cross-sectional survey design indicated good alpha reliability coefficient of 
0.87. Furthermore, substantial correlations were reported between the CSE and other self-efficacy 
measures, concluding that the English version of the CSE had good reliability and validity within the 
South African context (104). 
The most acceptable assessment tool to assess self-efficacy and pain (recovery) in the sporting 
population is the Pain Self-Efficacy Questionnaire (38, 83) because recovery from sport is most 
effectively measured by subjective pain intensity ratings (83). There is a lack of research assessing self-
efficacy after competition, during recovery and when returning to performance. Although he K-SES is 
the only questionnaire of its kind to assess self-efficacy in the sporting population, it has only been 
validated in athletes with an ACL injury (56).  To assess performance in athletes, task-specific self-
efficacy measures correlate most strongly when compared with general self-efficacy assessment 
measures (56, 103). This suggests that to measure, for example, recovery in sport, a specific self-
efficacy questionnaire must be used. 
3.2.6.7. THE PAIN LOG BOOK 
The Pain Logbook (Appendix 7) is a 10-day brief pain inventory (BPI) logbook (101) commencing on 
the evening of the Comrades. It was filled out before bed every night to allow for standardization. This 
logbook was used to generate a Pain Severity Score out of 10. Research shows that the BPI is valid and 
reliable in different populations, including athletes, with a good test-retest reliability (94). The Pain 
Severity Score is generated from four questions which explore the severity of the participant’s pain 
(93). These four questions measure pain variability over time: pain at its “worst,” “least”, “average” 
and “now” (current pain).  Numerical scores ranging from zero to 10, zero representing “no pain”, five 
representing “moderate pain” and 10 representing “worst pain you can possibly imagine.” The mean 
of the four scores gives the Pain Severity Score (93, 94). This gave an average of the participant’s pain 
severity over 24-hours. In this study, the Pain Severity Score and the BPI were used to monitor pain 
during recovery from the Comrades Marathon.  
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3.2.7. STUDY PROCEDURE 
Ethical approval (Appendix 8) was obtained from the Human Research Ethics Committee of the UCT 
Faculty of Health Science prior to recruitment (HREC REF: 045/2017). The 2017 Comrades Marathon 
was to be held on Sunday, 4 June 2017. Therefore, participants were recruited from April 2017, prior 
to the 2017 Comrades Marathon, via advertisements at the running clubs, at Randburg Medicross and 
through word of mouth. In addition, the secretaries of Randburg Harriers Running Club and Wanderers 
Sports Club were contacted by the researcher. These advertisements were then forwarded by the 
secretary to the email addresses of all members of the participating running clubs who were running 
the 2017 Comrades Marathon. The researcher’s email address was provided by the secretary for 
runners who required further information, would like to participate in the study or were unable to 
attend the information evening. Information evenings were held two weeks prior to the 2017 
Comrades Marathon, towards the middle of May, at the running clubs, to allow the researcher to 
present and explain the current study to all potential participants. Recruitment was on a voluntary 
basis.  
3.2.7.1. DATA COLLECTION 
The data collection procedure is illustrated in Figure 1. Consent forms and information forms were 
handed out on the information evening to all interested participants. Those who signed the informed 
consent received a Medical and Sports History Questionnaire to complete and hand in that night or to 
return via email within 48 hours. Those who were unable to attend the information evening received 
the informed consent forms and Medical and Sports History Questionnaire by email. These 
participants had previously contacted the researcher via email after receiving information from their 
club secretary regarding the study. The psychosocial questionnaires and the pain logbook were 
handed out in hard copy at the information evening or sent as a downloadable electronic copy via 
email to the participants once consent was obtained. All psychosocial questionnaires were made 
available in English, Afrikaans and isiZulu. These forms had already been translated into English, 
Afrikaans and isiZulu, but interestingly, all participants requested the English questionnaire, so there 
were no transcultural issues raised in the analysis of the data. 
Participants were asked to complete the psychosocial questionnaires (Pain Catastrophizing Scale; 
Athlete Fear Avoidance Questionnaire and Pain Self-Efficacy Questionnaire) 48 hours prior to the race 
as the pre-race baseline measures.  
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Research suggests that measuring baseline levels of fear of pain and catastrophizing 48 hours prior to 
an event is a good indicator for the development of disability and prediction of peak pain (69). 
Furthermore, measuring fear of pain prior to an injury has shown the greatest construct for predicting 
future pain intensity (69). 
3.2.7.2. PAIN LOGBOOK COMPLETION 
The pain logbook was commenced on the night of the race (Day 1) and completed for nine days 
following the race, giving a total of 10 entries. SMSs and phone calls were used on the day of the 
Comrades Marathon and for nine days following the race to remind participants to complete the pain 
logbook before bed. Participants were asked to record any pain-relieving medication and dosage that 
they were taking from a comprehensive list attached to the pain logbook (Appendix 7). The list only 
provided the brand name and generic name of all the pain-relieving medication available in South 
Africa. No additional information of the pain-relieving medication was provided, for example dosage, 
interactions and contraindications. This was to ensure that the study did not interfere with the 
participants’ usual practice of over the counter medication use post-race. Any information, regarding 
pain-relieving medication, given prior to the study, could have affected the participants’ rating of their 
pain or changed how they typically took pain-relieving medication during the recovery post-race. 
However, as a precaution, the harmful effects of non-steroidal anti-inflammatory drugs (NSAIDs) were 
discussed as part of the presentation at the information evening.  
The official race time of each participant was recorded from the race website by the researcher after 
the race. Finishing times were then categorised according to the medal times which are listed in 
Section 2.2.3 (page 11). All completed data were collected from the running clubs, directly from 
individual participants or were emailed to the researcher. The data were captured manually and 
stored under password protection with a copy on an external hard drive. The external hard drive was 
kept at the Randburg Medicross physiotherapy practice in a locked safe. All hard copies of the 
questionnaires and pain logbooks were filed and kept with the external hard drive in the safe at the 
Randburg Medicross. Only the researcher and owner of the practice had access to the key. The 
electronic data was only accessible to the primary researcher and student researcher and will be kept 
until 2023. 
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Figure 1: Summary of the data collection procedure from completion of the baseline psychosocial 
questionnaires until completion of the pain logbook 
 
3.2.8. STATISTICAL ANALYSES 
 
Data were captured into Excel. Statistical analyses were performed using Statistica software (Data 
analysis software system, version 13, www.statsoft.com). The Kolmogorov-Smirnov test was used to 
assess normality of pain as the primary outcome measure. As the pain data from day 1 had normal 
distribution, means and standard deviations were used to summarise the demographic and training 
history of the participants.  
 
Participants’ scores on the Pain Catastrophizing Scale, Athlete Fear Avoidance Questionnaire and Pain 
Self-Efficacy Questionnaire were summarised (mean and standard deviation). Cut off scores for the 
Pain Catastrophizing Scale and Pain Self-Efficacy Questionnaire were used to categorize participants 
into two groups for each questionnaire.  
-14 Days
•Information evening held at Randburg Harriers Running Club and Wanderers 
Sports Club
•Completion of informed consent and Medical and Sports History Questionnaires                                                 
-2 Days
•Baseline Psychosocial Questionnaires filled out
Race Day
• 4 June 2017 Comrades Marathon
•86.73 km “up” run from Durban to Pietermaritzburg
Evening of          
Race and post 
9 days
•Start to complete Pain logbook. Logbooks completed the same time every evening.
•Running times recorded from the race website by the researcher
•Completed data collected from the club, from the participant directly or emailed to 
researcher
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As no information regarding the cut off score for the Athlete Fear Avoidance Questionnaire was found 
the author of the questionnaire was contacted directly via email. The author of the instrument 
recommended that the scores be analysed as continuous data to avoid generating subgroups, 
therefore no cut off scores were created for the Athlete Fear Avoidance Questionnaire (107). 
 
Using the cut-off score for the Pain Catastrophizing Scale (31), participants were categorized as having 
catastrophizing thoughts or not catastrophizing.  In addition, participants were categorized according 
to the subgroups of catastrophizing for rumination, magnification and helplessness. In addition, for 
the Pain Self-Efficacy Questionnaire, participants were categorized as having high or low self-efficacy 
based on the cut point of 40 (86, 87). As the group sizes for both catastrophizing (n=9) and non-
catastrophizing (n=68) and high self-efficacy (n=75) and low self-efficacy (n=2) were skewed, non-
parametric analysis (Friedman’s test) was used to explore relationships between catastrophizing and 
pain, and self-efficacy and pain during the recovery period.  
 
Changes in pain severity scores over time were summarised using a box and whisker plot. Although 
the data on day 1 were normally distributed, the data were not normally distributed each day after 
that. Therefore, non-parametric analyses were performed using the Friedman’s test.  To explore 
relationships between pain catastrophizing and self-efficacy with pain, Friedman’s test was conducted 
to compare recovery in catastrophizers versus non-catastrophizers and comparing participants with 
low self-efficacy vs. high self-efficacy.  
 
To explore relationships between fear avoidance beliefs and pain, Spearman’s correlation analyses 
were conducted to determine if there was a relationship between pain on each day of recovery and 
the scores on the AFAQ. In addition, Pearson’s correlations were conducted to explore relationships 
between scores on the Pain Catastrophizing Scale, Athlete Fear Avoidance Questionnaire and Pain 
Self-Efficacy Questionnaire and pain on days 1 to 10. Significance was accepted as p˂0.05. 
 
Finishing times of participants captured from the Comrades website by the researcher were entered 
into Excel. Data was categorised according to the five medal times (listed in section 2.2.3., pg 11) that 
participants in the study achieved. Due to the small numbers in some of the categories and the non-
parametric nature of the data, a Spearmans rank order correlation was performed to determine if 
there was a difference in scores on the Pain Catastrophizing Scale, Athlete Fear Avoidance 
Questionnaire and Pain Self-Efficacy Questionnaire according to finishing categories.  
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3.2.9. ETHICAL CONSIDERATIONS 
 
The study proposal was submitted to the University of Cape Town, Faculty of Health Sciences Human 
Research Ethics Committee. Ethical approval was obtained prior to study commencement (UCT HREC 
REF: 045/2017). The study was carried out in accordance with the Declaration of Helsinki (108). To 
protect justice, all participants were selected without bias or prejudice. Those wanting to participate 
and meeting the inclusion/exclusion criteria were required to complete an informed consent. The 
consent form included all relevant information regarding the procedure of the study, any possible risks 
and benefits and confidentiality of the results. The opportunity to withdraw from the study without 
any consequences was also outlined. In addition, consent was discussed in detail at the information 
evening held at the running clubs where participants were given the opportunity to ask questions and 
interact with the researcher. Participants were not compensated for their participation in the study. 
 
The researcher did not have any affiliation to the clubs and did not give or receive any monetary 
compensation. There were no potential conflicts of interest in this study. 
 
3.2.9.1. RISKS OF THE STUDY TO PARTICIPANTS 
 
There were no risks associated with filling out the questionnaires or completing the pain logbook. 
There might have been risks associated with participating in the Comrades Marathon, due to the 
distance of the race and strenuous component of the sport. However, all participants had qualified 
for the race by previously completing a marathon and were entered to participate in the Comrades 
Marathon before recruitment into the current study. The detailed medical history section of the 
questionnaire, as well as any flu-like symptoms two weeks prior to the race were grounds for exclusion 
from the study. Dealing with participants’ safety was always a key concern and focus in the current 
study.  
 
3.2.9.2. BENEFITS OF THE STUDY TO PARTICIPANTS 
 
On completion of the dissertation, the included participants will receive their individual psychosocial 
questionnaire results. The research results will be presented at the running clubs to those who indicate 
an interest in receiving this information. This might improve participants understanding of the 
development of chronic pain and how it could affect their running recovery. This will be completed 
after submission of this dissertation.  
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3.3.  RESULTS 
3.3.1. DESCRIPTIVE CHARACTERISTICS 
Of the 83 participants who were recruited for this study, data from 77 participants were included for 
analysis (Figure 2). Six participants were excluded from the study, with three not finishing the 
Comrades Marathon, two being lost to follow up after not handing in their pain logbooks and not 
responding to the reminder emails and one withdrawing from the study prior to participating in the 
Comrades Marathon due to other commitments. The majority of the runners were male (n=45) with 
an average age of 41 years (±9), height 172 cm (±8.2), weight 65 kg (±9.6). The group were 
predominantly English speaking (n=57) with the majority of participants running for Randburg Harriers 
running club (n=26) (Table 1).  
 Figure 2: Flowchart showing participant recruitment process 
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*Participants (n=42) reported more than 1 injury, therefore total injuries n=54.
** Current use of pain- relieving medication taken chronically
***Participants reported the use of more than 1 medication
Table 1: Descriptive characteristics of participants (n=77). Data are expressed as number 
and percentage (%) or mean ± standard deviation (SD) 
Number (%)  or mean ± SD 
Language 
English 57 (74%) 
Afrikaans 15 (19,5%) 
Setswana 2(2.6%) 
isiZulu 1(1.3%) 
isiXhosa 1(1.3%) 
Venda 1(1.3%) 
Running Club 
Randburg 26(33.8%) 
Wanderers 22(28.6%) 
Born2run 12(15.6%) 
Jeppe 6(7.8%) 
Pirates 5(6.4%) 
Florida 3(3.9%) 
Fourways 3(3.9%) 
Previous ultramarathons completed 
Two Oceans Marathon 53(68.8%) 
Comrades Marathon 60(78%) 
No previous ultramarathons completed 13(10%) 
The number of Comrades Races completed per participant who 
previously completed a Comrades Marathon 
5.3± 6 
Comrades Personal Best (PB) race time 583 minutes ±90.8 
2017 Comrades Race Time 623 minutes ±80.9 
% Time of 2017 Comrades Marathon race vs PB 95(12%) 
Participants reporting a previous running-related injury 66(85.7%) 
Number of participants with current injuries at baseline* 42(54.5%) 
Number of current injuries 54 
Grade of current injury(s) 
Grade 1 6 
Grade 2 23 
Grade 3 20 
Grade 4 5 
Previously used pain-relieving medication after a race 54 
Type of  pain-alleviating medication previously used after a race (or in 
combination) to treat an injury or pain** 
NSAIDS 39 
Anti- inflammatory gel 18 
Paracetomal 10 
Codeine 3 
Cortisone injection 1 
Currently taking chronic medication for pain management** 5(6.5%) 
Type of chronic medication currently used for pain management (or in 
combination)** 
NSAIDS 3 
Cortisone 1 
Paracetomal 1 
Antiretroviral Therapy 1 
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3.3.2. COMPLETION AND INJURY HISTORY 
The majority, 78% (n=60), of the participants had completed a Comrade’s Marathon race previously, 
with 69% (n=53) finishing a Two Oceans (56 km) ultramarathon (Table 1). Thirteen percent (n=10) of 
participants were novices to the ultramarathon distance. The average finishing time of the participants 
was 623 minutes (10hrs 23min), with the average personal best finishing time of those participants 
who had previously completed a Comrades Marathon was 583 minutes (9hrs 43min). Participants ran 
the 2017 Comrades Marathon at an average of 95% of their speed when compared to the participants 
previous Comrades Marathon personal best times.   
Seventy percent (n=54) of the participants recorded that they had previously used pain-relieving 
medication after a race with oral NSAIDs being the most popular choice (n=32). Of the 77 runners, 
85.7% (n=66) documented a history of injury, with 54.5% (n=42) reporting a current injury. Of the 42 
with injuries, 14% reported suffering with a grade 1 injury (n=6), 55% grade 2 (n=23), 48% grade 3 
(n=20) and 12 % grade 4 (n=5). Only 6% (n=5) of the runners reported current use of chronic pain-
relieving medication (Table 1).  
3.3.3. FINISHING TIMES FOR 2017 COMRADES MARATHON 
Two participants received Silver medals, 14 participants received Bill Rowan medals, 31 participants 
received Bronze medals and 30 participants received Copper medals. 
3.3.4. BASELINE QUESTIONNAIRES: PAIN CATASTROPHIZING, FEAR AVOIDANCE BELIEFS 
AND SELF-EFFICACY  
Baseline descriptive scores for the Pain Catastrophizing Scale are presented in Table 2. The baseline 
Pain Catastrophizing Scale revealed that the participants generally had low pain catastrophizing scores 
(15 ±10.2). In addition, the runners scored low on rumination and helplessness (5.9±4 and 5.7±5 
respectively) with magnification being scored the lowest (3.4±2.4).  
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Table 2: Baseline scores of the sample (n=77): Pain Catastrophizing Scale, Athlete Fear 
Avoidance Questionnaire and Pain Self-Efficacy Questionnaire  
Baseline Questionnaire Mean Score (SD) 
Pain Catastrophizing Scale (PCS) – Total (x/52) 14.99 (10.15) 
PCS - Rumination (x/16) 5.88 (3.96) 
PCS - Magnification (x/12) 3.39 (2.37) 
PCS – Helplessness (x/24) 5.70 (4.91) 
  
Athlete Fear Avoidance Questionnaire (x/50) 20.12 (5.96) 
  
Pain Self-Efficacy Questionnaire (x/60) 53.36 (8.13) 
(x/x) represents the mean score of each questionnaire or sub-section 
 
At a cut off score of 30 (67), only 12% of the participants (n=9) were categorised as having unhelpful 
pain catastrophizing thoughts (Appendix 9). In the sample of 77, 17% (n=13) scored high in rumination, 
33% (n=25) scored high in magnification and 12% (n=9) scored high in helplessness. Interestingly, 8 of 
the 9 participants scoring high on magnification also scored above the cut-point of 30 for the total 
instrument, indicating catastrophic thinking about pain. The two participants scoring highest in 
magnification on the Pain Catastrophizing Scale were novice runners with a history of only completing 
one Comrades Marathon race previously (in 2016). 
 
Baseline descriptive scores for the Athlete Fear Avoidance Questionnaire are presented in Table 2. 
Sixty-one participants scored low on the Athlete Fear Avoidance Questionnaire (mean of 20 out of a 
total score of 50), suggesting that this sample group had low fear avoidance beliefs. 
 
Baseline descriptive scores for the Pain Self-Efficacy Questionnaire (Table 2) generally showed a high 
self-efficacy score (mean of 53.4±8.1 out of 60). Only 2 of the 77 runners scored below the cut-point 
(below 40) on the questionnaire (Appendix 10). Both these runners were novice runners with history 
of only three completed Comrades Marathons between them (Appendix 14). The participant with the 
lowest Pain Self-Efficacy Questionnaire score (25 out of 60) had only completed one Comrades 
Marathon which was in 2016. As the Comrades Marathon alternates between an “up” to “down” race 
each year, the 2017 Comrades Marathon would have been this runner’s first “up” race. The age of the 
above mentioned participants, 29 and 31 years (Appendix 14), fall below the mean age (41y±9) of the 
sample.   
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3.3.5. PAIN SEVERITY SCORES AND RECOVERY 
 
As shown in Figure 3, 50% of the participants scored moderate pain ratings (93) on the Pain Severity 
Scale the evening following completion of the Comrades (Day 1). It took up to five days from the day 
of Comrades Marathon for 75% of the runners to score a rating of 1 or lower. Seven days into recovery, 
75% of the runners reported no pain.  
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Figure 3: Median Pain Severity Scale scores for 10 days of Recovery following the Comrades 
Marathon (n=77) 
 
3.3.6. ASSOCIATIONS BETWEEN PAIN SEVERITY SCORES AND PAIN CATASTROPHIZING, 
FEAR AVOIDANCE AND SELF-EFFICACY   
 
When comparing catastrophizers (PCS≥30; n=9) to non-catastrophizers (PCS<30, n=68) there were no 
significant differences between groups in Pain Severity Scores over the 10-day recovery period (Figure 
4). Pearson correlations (Figure 5) showed a weak positive correlation between Pain Severity Score on 
Day 1 and Pain Catastrophizing Scale (χ2=0.27; p<0.05). There was no correlation between Pain 
Severity Score and Pain Catastrophizing Scale on any of the other days of recovery (Appendix 11).  
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Figure 4: Change in pain scores over time in runners who had high scores on the Pain Catastrophizing Scale (PCS≥30; n=9) vs. those who scored 
low on the Pain Catastrophizing Scale (PCS<30; n=68) 
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Figure 5: Correlation between the Pain Severity Score (PSS) on Day 1 (race day) and the 
Pain Catastrophizing Scale (χ2=0.27; p<0.05) 
There were no correlations between Athlete Fear Avoidance Questionnaire scores and Pain Severity 
Scores on days one to 10 as seen in Table 3.  
Table 3: Pearson correlations between Athlete Fear Avoidance Questionnaire (AFAQ) that 
showed no correlation to Pain Severity Scores (PSS) over the 10 days of recovery 
p-value r-value
PSS Day 1 and AFAQ 0.502 0.07 
PSS Day 2 and AFAQ 0.551 0.07 
PSS Day 3 and AFAQ 0.630 0.06 
PSS Day 4 and AFAQ 0.086 0.2 
PSS Day 5 and AFAQ 0.107 0.19 
PSS Day 6 and AFAQ 0.185 0.15 
PSS Day 7 and AFAQ 0.158 0.16 
PSS Day 8 and AFAQ 0.197 0.15 
PSS Day 9 and AFAQ 0.193 0.12 
PSS Day 10 and AFAQ 0.381 0.10 
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When comparing the low self-efficacy group (<40, n=2) and high self-efficacy group (≥40, n=75) there 
were no significant differences in pain severity scores between the two groups over the 10-day 
recovery period (Figure 6).   
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Low Pain Self-Efficacy Group (<40)
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Figure 6: Change in pain scores over time in runners who had high scores on the Pain Self-Efficacy Questionnaire (≥40; n=75) vs. those who 
scored low on the Pain Self-Efficacy Questionnaire (<40; n=2) 
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3.3.7. ANALYSES OF COMRADES FINISHING TIMES OF PARTICIPANTS  
 
The two participants in the low self-efficacy group fell in the Bronze medal category, while the nine 
participants in the high catastrophizing group fell into either the Bill Rowan Medal, Bronze medal and 
Copper medal group (Figure 4). Interestingly, the two participants who received silver medals scored 
high in the Pain Self-Efficacy Questionnaire (59 and 60), low in the Pain Catastrophizing Scale (5 and 
14) and low on the Athlete Fear Avoidance Questionnaire (19 and 28), having one Athlete Fear 
Avoidance Questionnaire score higher than the mean (20) of the sample. There were no differences 
in the Pain Catastrophizing Scale, Athlete Fear Avoidance Questionnaire or Pain Self-Efficacy 
Questionnaire scores for participants completing the race in the different categories (Table 4).  There 
were no correlations found between finishing times and pain during recovery. 
 
Table 4: Spearman’s correlation matrix between finishing categories that showed no 
correlation to Pain Catastrophizing Scale (p=0.79), Athlete Fear Avoidance Questionnaire 
(p=0.68) and Pain Self-Efficacy Questionnaire (p=0.14). Data are expressed as mean and 
standard deviation (SD) 
Finishing category Number of 
runners (n=77) 
Pain 
Catastrophizing 
Scale  
p=0.79 
Athlete Fear 
Avoidance 
Questionnaire 
p=0.68 
Pain Self-Efficacy 
Questionnaire 
p=0.14 
Silver (6-7.5hrs) 2 9.5 (6.36) 23.5 (6.36) 59.5 (0.71) 
Bill Rowan (<9hrs) 14 13.21 (8.27) 20.21 (7.15) 54.57 (6.79) 
Bronze (<11hrs) 31 13.74 (9.69) 18.94 (4.46) 54.03 (8.97) 
Copper (<12hrs) 30 17.47 (11.36) 21.07 (6.71) 51.7 (7.92) 
 
3.3.8. SUMMARY OF RESULTS 
 
The sample of this study comprised of 77 participants (aged 41 years ±9), 45 being male and mainly 
English speaking. Majority of participants (78%) had completed a Comrades Marathon race previously 
with 13% being novices to the ultramarathon distance. The average 2017 Comrades Marathon 
finishing time for participants was just over 10 hours.  Seventy-percent of participants had previously 
used pain-relieving medication after a race while the majority of participants (86%) documented a 
history of injury, with 55% reporting a current injury. Only 6% reported to be currently using chronic 
pain-relieving medication.  
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The baseline psychosocial questionnaires revealed that majority of the participants demonstrated low 
fear avoidance beliefs (79%), low pain catastrophizing beliefs (88%) and high self-efficacy beliefs 
(97%). It took five days from the day of the 2017 Comrades Marathon for 75% of participants to score 
a pain rating of one or lower in the pain logbook and seven days for 75% of participants to report no 
pain. There were no correlations between psychosocial factors and pain recovery in this sample of 
Comrades runners. There was also no correlation between finishing times and pain during recovery. 
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3.4.  DISCUSSION 
 
This study investigated associations between pain catastrophizing, fear avoidance beliefs and self-
efficacy beliefs and pain during recovery in ultramarathon runners competing in the 2017 Comrades 
Marathon. No correlations were found in the 10 days of recovery between pain and pain 
catastrophizing, pain and fear avoidance beliefs, and pain and self-efficacy beliefs in the sample of 
runners who successfully completed the race. The findings will be discussed in more detail and will 
conclude with a section on study limitations. 
 
3.4.1. PARTICIPANTS 
 
Data from 77 participants were included for analysis in this study. This was just above the minimum 
sample size of 76 required for a statistical power of 95%. The baseline questionnaires completed in 
the two weeks leading up to the Comrades Marathon were made available in English, Afrikaans and 
isiZulu as a hard copy and electronic copy. This allowed participants to have easy access to the forms 
and complete them in their home language, if preferred.  However, participants who were recruited 
via email and who did not attend the information evening at the running clubs were at a disadvantage 
as there was no direct communication. Although participants were instructed to complete the 
baseline psychosocial questionnaires 48 hours prior to the race, this was impossible to control. If the 
baseline psychosocial questionnaires were not completed two days preceding the race, a time when 
the enormity of the race was more real, the scores on the baseline psychosocial questionnaires may 
have been affected. To control the timing of questionnaire completion, future studies should look at 
recruiting participants during registration, held a few days prior to the race. 
 
When comparing the demographics of the sample of the dissertation to the population of Comrades 
runners competing in the 2017 marathon they matched for average age with 41 years and 42 years 
respectively (20). There were more male to female runners (4:1) competing in the population of 
Comrades Marathon when compared to the sample (3:1) (Appendix 12). The number of previous 
Comrade Marathon races completed per participant was higher in the sample (5.3) in comparison to 
the population (4.95) (3, 20). The average finishing time of the population was faster at  09:50:05 (3, 
20) in comparision to the sample whose average finishing time was 10:23:00 (Table 1). 
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The study design and strategy of recruiting participants both at the information evening and by email 
from the club secretaries makes it impossible to determine the response rate for the study. The loss 
to follow up of three of the participants (two lost to follow up and one withdrawal) may have been 
because of the length of the baseline questionnaires. Future studies might target a specific 
psychosocial factor, while keeping questionnaires short. However, due to the nature of this study 
being the first of its kind, it was necessary to include a range of psychosocial factors.  
Although participants were recruited from the two largest running clubs in Johannesburg, the sample 
was based on geographical convenience to the researcher. This limits variability in the sample as 
majority of participants were English speaking (n=57) and male (n=45).  
Participants with limited access to email and internet would also be at a disadvantage in participating 
in the study. This reduces the generalisability of the results. Recommendations are discussed under 
study limitations in this section. 
The majority (78%) of the participants had previously completed a Comrades Marathon. The mean 
number of Comrades Marathons completed per participant was five (Table 1). Novice runners have 
been classified as completing less than three marathons (34).  Therefore, according to this definition, 
the participants in this sample were mainly experienced. Only 13% of the sample were novices to the 
ultramarathon distance. The fact that most participants were classed as experienced runners may 
have influenced the psychosocial baseline scores. Knowledge of what to expect during and after the 
race may have played a role in the low fear avoidance and pain catastrophizing scores reported prior 
to the race (20, 29). This will be discussed in further detail. 
When analysing running pace, the participants ran the 2017 Comrades Marathon at 95% when 
compared to their recorded personal best times. This means the participants completed the 2017 
Comrades Marathon at a 5% slower pace than their personal best times. However, as the data only 
recorded personal best times of previously completed Comrades Marathons, those runners who were 
novices to the ultramarathon distance were excluded from this data analysis. Future studies should 
compare Comrades Marathon pace to qualifying marathon pace. This would ensure Comrades novices 
were included in the comparison.  
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Research suggests a yearly incidence of running-related injuries to be around two-thirds of the running 
population, with an increase to 90% when training for a marathon (49). Although there were a high 
number of past injuries recorded among the participants (86%), the number of participants reporting 
a current injury was significantly lower (55%) than the literature. The higher number of previous 
injuries reported by this sample may have predisposed the participants to the current injury reported 
(34, 49). It was impossible to determine if the current injuries had any influence on the pain severity 
score reported during recovery due to missing data. 
In addition, the current study did not record any issues (injuries, illnesses) experienced by the 
participants during the Comrades Marathon that may have affected their performance and 
subsequent pain recovery. Therefore, future longitudinal studies might determine if current injuries, 
based on definition of a current injury and grading of injury severity, have any effect on performance 
and pain recovery following the race.  
Furthermore, a more detailed definition of a “past” and “current” injury may need to be defined in 
the Medical and Injury History Questionnaire to avoid misinterpretation. 
An increasing number of endurance runners are using pain-alleviating medication during training and 
recovery (5), despite the known negative side effects. Across all sports, but especially in ultramarathon 
events, pain-alleviating medications are the most commonly used medication not only to treat pain 
but also as a prophylactic intervention in the anticipation of pain. Non-steroidal anti-inflammatory 
drugs (NSAIDS) are used as a prophylactic not only during the ultramarathon event but also to enhance 
recovery (5). In the current study, 70% of the participants reported using pain-alleviating medication 
after a race, with 64% using oral NSAIDs and 33% using anti-inflammatory gel, both with similar 
absorption rates (5). This may suggest that the sample of Comrades Marathon runners associate 
recovery with a painful experience and use pain-alleviating medication to not only treat actual pain 
but potential pain that might be experienced.  
3.4.2. PAIN CATASTROPHIZING 
With only 12% of the sample scoring above the cut point on the Pain Catastrophizing Scale (PCS), it is 
apparent that the majority of this sample population did not have catastrophic thoughts about pain 
prior to competing in the race. Research shows a strong correlation between low catastrophic 
thoughts and a better toleration of pain (109). Athletes are believed to tolerate increased levels of 
pain during a race or competition. This is thought to be due to good cognitive coping strategies.  
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As discussed in Section 2, this resilience to pain is believed to be related to several factors including: 
experience (learnt over time), greater intensity of performance (release of endorphins and opioid 
mechanism) and motivation to succeed (for example, beat a personal best time, win a medal). With 
78% of the sample having previously completed the Comrades Marathon race, experience might have 
played a key role in the low pain catastrophizing scores (15 ±10.2) of this sample (20, 29). Furthermore, 
all the participants of this sample completed the race which may suggest that there was a high 
motivation to succeed. 
Yet, research shows that athletes suffering from an injury have higher catastrophic thinking related to 
greater emotional distress (anxiety, depression) than the general population (97, 105). This is believed 
to be associated with perceived external (coach, media) or internal (athlete identity) pressures (105) 
which may affect the ability of a runner to complete a race (97).  
As injuries can bring about harmful psychological responses, especially in competitive athletes (97), it 
might be beneficial for future studies to explore the effect of psychosocial factors on pain recovery in 
endurance runners who do not finish the race. Future studies should compare a population of long 
distance runners, who are matched with injury and severity (if any) and separate them according to 
PCS scores. Those above the cut off score of 30 on the PCS are high and those below 30 are low. Future 
research needs to investigate if there is any correlation between injured runners scoring above 30 on 
the PCS (having catastrophizing beliefs) who do not complete the ultramarathon race and a prolonged 
recovery time.  
Examining the three components of catastrophizing: rumination, magnification and helplessness, 
might have relevance to athletes who are in pain (29) and might give greater insight into potential 
targets of intervention. Neither rumination (where athletes cannot stop thinking about pain) nor 
helplessness (where athletes believe nothing will decrease their pain intensity) (109), appeared to 
have any significance in the findings of this study. However, a correlation was found between 
participants who scored high in magnification also scoring above the cut point of 30 on the PCS. This 
suggests that these participants magnify the distress they feel during a painful experience (29) or 
worry that something serious might occur (109). These participants might be recalling a high number 
of previous painful experiences or injuries (16, 105).  
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As discussed in Section 2, the psychological response to a sports injury involves emotional, cognitive 
and behavioural factors, all of which can directly impact physical and psychosocial recovery (17). 
Likewise, the biopsychosocial model of sports recovery suggests cognitive and affective factors can 
influence return to competition outcomes, with indirect relation mediated by pain (65). This suggests 
that psychological implications of (past) injuries could result in runners recollecting the high number 
of physically painful experiences associated with injuries and possibly result in a higher pain 
catastrophizing score.  
 
The ability of a runner to complete a race and recover efficiently, despite pain from an injury, EIMD or 
DOMS, may be explained using the biopsychosocial model (17), as discussed in Section 2. Out of the 
two potential pathways; namely the endurance reaction and avoidance cycle (74, 77), endurance 
runners often fit into the endurance model in response to pain during recovery.  This pain persistent 
coping strategy encourages pain experienced during recovery to be viewed as temporary (17).  
 
Long training sessions prior to the Comrades Marathon as well as the ability to recover from races 
timeously to qualify for Comrades, may reduce the threat value of a runner’s pain as a result of learnt 
past experiences.  In other words, the behavioural and cognitive efforts of an endurance runner to 
manage the demands of recovery may have been a result of adaptive responses learnt from the 
familiarity of previous recovery sessions (17, 29). So, even if an endurance runner scores high on the 
PCS prior to a marathon, the coping response during recovery may distract from the pain experienced 
(29). This may enable the runner to confront their pain, lower the threat value of the pain and possibly 
return to running sooner (17, 74, 77).   
 
Additionally, these cognitive coping strategies may be motivated by self-confidence and self-
determination (29), thereby higher self-efficacy beliefs in runners could contribute to evading the 
avoidance cycle. The avoidance cycle would prevent endurance runners from returning to training or 
effectively adapting to their pain during recovery. The effects self-efficacy may have on recovery, 
following the Comrades Marathon, will be discussed in detail later in section 3.4.4. (pg 68). 
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As mentioned, past experiences may have played a role in the low pain catastrophizing scores of this 
sample. This may suggest why two out of the nine participants with high pain catastrophizing scores 
scored high in magnification. With both participants categorized as novices to the Comrades 
Marathon, competing in the unknown, with a lack of previous knowledge regarding the outcome, 
catastrophizing thoughts in these two runners could have been amplified before the race started, 
possibly explaining the higher magnification score in the PCS. 
 
With only two out of the nine participants with high pain catastrophizing scores scoring high in 
magnification, the low internal reliability of the magnification scale, as mentioned in Section 2, must 
be recognised. The low number of runners in this study scoring high in magnification (2), may be owing 
to the small number of items representing magnification with low degree of repetition, participants 
who engage in one form of magnification (remembering painful experiences), may not engage in other 
forms (expecting a poor result). Future studies, which choose to explore the relationship between pain 
catastrophizing and recovery from pain in the sporting population and utilise the total score of the 
PCS, must be aware that this may mask the distinctive role of each of its components; namely 
rumination, helplessness and magnification. 
 
3.4.3. FEAR AVOIDANCE  
 
Seventy-nine percent of the participants in this study scored a low mean score on the Athlete Fear 
Avoidance Questionnaire (AFAQ) suggesting this sample had low fear avoidance beliefs prior to the 
Comrades Marathon. Fear avoidance may serve as a psychological barrier during pain recovery 
resulting in athletes scoring high on the AFAQ (7). The results from this study, however, suggest the 
opposite. 
 
There are multiple possible explanations why a large proportion of this sample scored low on the 
AFAQ, although over half (55%) reported a current injury. The physical and physiological differences 
between ultramarathon runners and recreational runners has been appreciated in research, however, 
the psychological differences between these two groups may help to explain the results from the 
AFAQ.   It is acknowledged that endurance runners push their bodies’ abilities past what might be 
regarded as the ordinary limits during training and competition (14). To qualify for the Comrades 
Marathon, the participants in this study had to complete a standard marathon (42. 2 km) in under five 
hours (3). The successful completion of a race, particularly completing within a set time, involves both 
mental and physical capabilities (14).  
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Research has found ultramarathon runners to have high levels of stability and low levels of anxiety 
(12, 110). As previously mentioned, anxiety has been closely linked with fear. Therefore, the 
psychological profile that defines an ultramarathon runner may already predispose them to low levels 
of fear (10-12).  
Additionally, ultramarathon runners represent a population that has exceptional capacity to push 
through the physical pain of a race and recover (86). Ultramarathon runners’ resilience towards pain, 
compared to the general population, might explain the low fear avoidance scores of this study. Like 
pain catastrophizing, the cognitive strategies adopted by ultramarathon runners to overcome any 
feelings of anxiety and fear (12) to finish an ultramarathon, may be what separates them from a 
recreational runner.  This attitude may also encourage them to better manage and push through their 
pain to complete their goal (12). Furthermore, their less negative responses to pain perception, lower 
pain perception and increased self-confidence in their own abilities to achieve a goal might have 
predisposed them to become ultramarathon runners in the first place (10-12, 20).  
Therefore, an ultramarathon runner’s psychological profile as well as their ability to cope with fear to 
complete an ultramarathon may have to do with their goal directed behaviour (20, 105, 111). Runners 
are more likely to engage in ultramarathon running if they believe they will be successful (111).  
Self-confidence plays a key role in their ability to push themselves through a painful ultramarathon to 
finish the race and to quickly return to performance following the race (105). Self-efficacy is therefore 
a vital component for success in ultramarathon running.  
3.4.4.  SELF-EFFICACY BELIEFS 
It is known that competing in sport improves physical well-being as well as positive self-beliefs (8, 11, 
98). It is important for endurance runners to be able to cope with pain as well as deal with setbacks 
to complete an ultramarathon. Therefore, a high level of self-efficacy beliefs is crucial to succeed in a 
strenuous event, like the Comrades Marathon (111). Of the 77 participants in this study, only two 
scored below the cut point of 40 on the Pain Self-Efficacy Questionnaire (PSEQ). This represents a high 
level of self-efficacy among the sample of endurance runners (21).  
A high level of self-efficacy beliefs in marathon runners have been shown to effect pain tolerance, 
affective states, reactions to stress and stamina (66, 111). Endurance runners cognitively interpret 
their physical state to form self-efficacy judgements about whether they can complete a marathon.  
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In preparation for the Comrades Marathon, participants would have spent considerable time and 
effort in increasing running intensity, duration and distance (20).  
To qualify for a Comrades Marathon and to successfully complete the race, participants would have 
to persevere through challenges and learn to cope with pain to reach goals set in training. Essentially, 
this training would result in improvements in running endurance and tolerance to pain (35, 111), 
improving both physical and mental skills. Furthermore, self-efficacy beliefs have been inversely 
related to pain perception. In other words, endurance runners with higher self-efficacy beliefs may be 
able to cope with pain experienced during and after a marathon better to pursue their goal. This goal 
may be completing a marathon or earlier return to training after completing a marathon. Endurance 
runners with lower self-efficacy beliefs are more likely to give up when faced with challenges, like 
completing an ultramarathon race (111).  
When investigating the driving force behind why endurance runners compete in marathon and 
ultramarathon events, the appeal to achieve a goal was found as a primary motivator (112). Literature 
specifically investigating self-efficacy in endurance runners has focused mainly on the effects of self-
efficacy on running performance, there is minimal research exploring the influence of self-efficacy 
beliefs on recovery (111).  
In Australia, male Olympic-level endurance runners (111) scoring high in self-efficacy placed higher in 
events, set more difficult goals and ran at a faster pace than runners with lower running self-efficacy. 
A more recent study in 2008 following a sample of endurance runners training for a marathon found 
that improvement in running ability related to increased self-efficacy levels (113). In addition, it was 
also noted that variations in running abilities were related to changes in self-efficacy levels. 
A study exploring the change in self-efficacy over 15 weeks of training for a marathon found that of 
the 39 Caucasian, college runners (11 males), self-efficacy significantly increased from pre-training to 
post-race (111). The students were asked to complete self-efficacy, affect and training volume 
questionnaires weekly during training.  The final set of questionnaires were completed after the 
marathon race. Results showed that self-efficacy beliefs pre-training were quite high with a mean of 
80%; but post-race results showed a significant increase with self-efficacy scores reaching a mean of 
97%. However, finishing times were not recorded, so there was no way to determine if self-efficacy 
had any effect on running performance (111).  
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Future studies might want to replicate this study and explore the effects of self-efficacy on 
performance, in addition, a larger and more cross-cultural sample is needed. The high self-efficacy 
scores prior to training in the above-mentioned study may suggest that individuals who choose to 
partake in marathon races may already have pre-existing high self-efficacy beliefs (11,103,112).  
In addition to the training, completing a challenge successfully in sport, like finishing an ultramarathon 
race, is associated with increased self-efficacy (98, 99). A significant increase in self-efficacy from pre-
race to post-race was also found in the study mentioned above (111). Therefore, these college runners 
had more confidence in their abilities to tackle challenges after the race, such as recovery and 
returning to running. Individuals that choose to participate in ultramarathons are willing to expose 
themselves to pain and stress to follow strict training programmes (20, 111). This is supported by 
marathon and ultramarathon runners having higher self-efficacy scores than the general population 
(98, 102).  
The results of these studies give greater insight into the associations between self-efficacy beliefs and 
endurance runners, an increased level of self-efficacy is imperative for success in ultramarathons.  
Therefore, this sample of marathon runners in the current study, may not be a suitable sample to 
explore the associations between psychosocial factors and pain recovery.  
With 97% of the sample in the current study scoring above the cut-point on the PSEQ, this sample may 
not be appropriate to determine if there is any relation between psychosocial factors and pain during 
recovery in sport. Future studies might explore the effect of psychosocial factors on pain recovery in 
different sporting populations.  
Past performances, such as previously completing a marathon, serve as a strong source of self-efficacy. 
Of the 77 participants in the current study, 60 had previously completed the Comrades Marathon with 
53 completing the Two Oceans Marathon. Only 13% reported that they were novice runners to the 
ultramarathon distance. Successful past performances in running are based on a runner’s own 
mastery experience of completing an ultramarathon (20, 111). Experienced marathon runners who 
can reflect on successful past achievements in running are able to self-appraise their performance, 
which will affect the way they assess future races. Endurance runners, who view their previous races 
as successful, will unknowingly increase their self-efficacy beliefs (98, 103).  
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An average of five Comrade Marathon races were completed per runner of the 60 participants who 
had previously completed the Comrades Marathon prior to 2017, an average of five Comrades 
Marathon races were completed per runner (Table 1). The experience of having successfully 
completed a Comrades Marathon race may have increased the perception that the participant can 
complete another ultramarathon successfully.  
Previous performance and success tend to provide the greatest amount of reliable material upon 
which to base a runner’s pain self-efficacy. Successful previous performances, such as training and 
races (qualifying events), will raise efficacy expectations in the runners.  However, if training sessions, 
races and qualifying events are deemed failures by the runners this lowers efficacy expectation 
(111,114). This may highlight an area that needs further investigation in the future. Runners who do 
not complete the Comrades Marathon would make an interesting sample. This will be discussed 
further under study limitations. 
As mentioned, both participants scoring below the cut off score on the PSEQ were novice runners, 
with the participant scoring the lowest on the PSEQ only having completed one Comrades Marathon 
the year before. As the 2017 Comrades Marathon would have been this runners’ first “up” race, with 
no previous experience upon to make expectation, this may have lowered the runner’s pain self-
efficacy prior to the race. Feelings of anxiety as one races the unfamiliar could potentially lower self-
efficacy beliefs. However, experience cannot be viewed as the only factor potentially effecting self-
efficacy before a race. A multitude of factors exist that can possibly facilitate or hinder the successful 
completion of a race and its influence on self-efficacy beliefs.  
These potential factors include social support at the time of the race and throughout training, 
resources available to the runner during training such as access to qualifying races and the 
circumstances around which training, the race and recovery are completed. This includes family, 
finance and personal health, all of which can encourage or hinder an endurance runners performance 
and recovery (110, 111, 114). 
Closely related to running experience, is the effect age may have on the self-efficacy of endurance 
runners.  The age of the participants scoring below the cut point on the PSEQ fell below the mean age 
(41 years) of the sample, as seen in Section 3.3.1 (Table 1). There is little research on the effects of age 
on self-efficacy in sports; however, older endurance runners may have competed in the sport for a 
longer period and as a result have greater experience in participating in ultramarathons (111).  
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There is no evidence to suggest that age influences self-efficacy beliefs, yet as shown, past running 
experience does improve self-efficacy beliefs (20, 111). Nevertheless, age should be considered in 
future designs measuring self-efficacy in athletes.  
 
In addition to running experience, social support plays a vital role in increasing self-efficacy in 
endurance runners during training, the race and recovery (110, 111, 114).  All the participants of the 
current study were members of running clubs. Verbal persuasion and modelling from peers, coaches 
and friends has been shown to enhance self-efficacy beliefs in runners. Verbal persuasion or 
encouragment from others can positively influence a runner’s behaviour and performance by 
improving the perception they have of themselves (17). The encouragement (or discouragement) from 
fellow running club members, peers or coaches, especially those that are highly respected, can 
influence a runner’s self-confidence (66, 111). Yet, verbal persuasion has a limited influence and can 
only impact a runner’s self-confidence if the feedback is somewhat realistic to the runner (111).  
 
Being a member of a running club exposes runners to others who have successfully completed 
ultramarathons. It is possible that observation of other runners, who have successfully completed the 
Comrades Marathon, may have contributed to increased beliefs that one too can achieve this goal. 
Modelling behaviour has been found to enhance self-efficacy in a wide variety of sports, including 
running (17). The social support, encouragement and modelling of behaviour that a runner receives 
when being part of a running club may serve as a factor to further enhance self-efficacy beliefs prior 
to competing in the Comrades Marathon race.  
 
However, as verbal persuasion, observation and socialiastion were not measured in the current study, 
it must be recognised that any social support, encouragement and modelling behaviour one may 
receive from being part of a running club is only an assumption.  
 
Considering the above research, it is not surprising that participants of this study had high self-efficacy 
scores (mean score of 53.36 out of 60) before running the Comrades Marathon. Although research 
suggests both verbal persuasion and modelling hold a place in increasing self-efficacy, successful past 
performances are still shown to be the most influential source of self-efficacy in endurance runners 
(20, 111). Of the 77 participants, only 13% of the sample were novice to the ultramarathon distance 
and therefore the majority of participants were experienced in completing an ultramarathon race.  
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Consequently, this study was subject to a ceiling effect as a large percentage of the participants scored 
very high on the PSEQ, thereby making it difficult to discriminate among the participants at the top of 
the scale. The ceiling effect may be because of the positive self-image the runners had prior to the 
Comrades. This positive self-image could be owing to the large volume of training and previous 
ultramarathons that the participants had completed to qualify for the Comrades Marathon (98). This 
may have resulted in a higher reported self-efficacy score (only 48 hours prior to Comrades) than if 
the participant were to complete the PSEQ at the beginning of, or mid training.  It would, therefore, 
be beneficial to identify how endurance runners attribute success and failure along with available 
strategies to enhance self-efficacy beliefs in this population.  
 
3.4.5.  PAIN SEVERITY SCORES AND RECOVERY 
 
It is well-known that pain can impede recovery following a sporting event or injury (109). However, 
there is a lack of aligned research exploring recovery following a marathon (42, 105, 109), with large 
variability reported in individual recovery periods (42). The general trend of research suggests the 
discomfort experienced with DOMS reduces within seven to 10 days of a marathon race (46). As 
discussed EIMD, DOMS, fatigue and running training history all play a role in the recovery period (49, 
50), with research reporting a positive correlation between marathon running experience and 
improved pain recovery time (114, 115).  
 
In the current study over three-quarters of the sample (78%) had previously completed a Comrades 
Marathon. This data may explain why 75% of participants reported one out of 10 or less by day five 
on the Pain Severity Scale. Further investigation into pain recovery following an ultramarathon should 
explore a novice group of endurance runners. This may attempt to eliminate the role experience in 
running can play in recovery. 
 
Fear avoidance beliefs and pain catastrophizing have a considerable influence on the pain recovery 
process (105). However, there were no correlations between PCS scores and pain scores or AFAQ 
scores and pain scores over the 10 days of recovery. As mentioned, psychological traits have been 
shown to influence pain perception. Ultramarathon runners do not view pain as a threat but rather 
an “ally” during training (79). As the intensity and volume of training increases, pain-related fear is 
reduced, and pain is interpreted as a sign of accomplishing a set goal (79). Therefore, not only does 
pain tolerance increase with training and experience in running, but the view on the pain experience 
changes (69).  
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These unique traits, either inherent or learnt over time, encourage long distance runners to draw their 
attention away from pain either during an ultramarathon race or during recovery from a race. As 
discussed, goal setting and achievement, training for an ultramarathon and successful past 
performances go hand in hand with increased self-efficacy beliefs (12). Runners with higher self-
efficacy scores can manage their pain better during performance and recovery (104). This may explain 
the Pain Severity Scores over the 10-day recovery, with 75% of participants reporting one out of 10 or 
less by day five.  
Perhaps these findings can be carried over into the general sporting population. Ultramarathon 
runners learn to reduce their awareness and attention to pain during training, improving pain 
tolerance and encouraging quicker recovery and return to performance (12, 20, 28). This behaviour 
can be encouraged in other sports by health professionals, sports physiotherapists and coaches. 
Strategies of increasing pain tolerance by enhancing self-efficacy beliefs will be discussed under 
Section 3.4.5.1. 
The results of this study showed little correlation between finishing times and psychosocial factors, 
and no correlation between finishing times and pain catastrophizing, fear avoidance beliefs and self-
efficacy beliefs. However, research suggests that self-efficacy plays a role in improving and predicting 
performance in runners following a marathon (20, 92, 102). Perhaps the results of the current study 
differed to previous studies because of the sample used. This study is the first of its kind to explore 
psychosocial factors affecting recovery in ultramarathon runners.  
As mentioned, the psychological character traits of ultramarathon runners, namely; better pain 
tolerance, higher self-efficacy beliefs and improved mental coping strategies, may be associated 
factors in the recovery observed in the sample following the 2017 Comrades Marathon (14, 47). The 
perception of these participants that they could compete successfully in the Comrades Marathon 
whether it be from experience, modelling behaviour or verbal persuasion (87, 88, 114, 115), may have 
played a role in the successful completion of the race. However, due to the ceiling effect in the current 
study, future studies should develop a more sensitive instrument to measure self-efficacy in athletes. 
It is evident from existing literature that high self-efficacy beliefs play an important role in a runner’s 
performance and may potentially play a role in an athlete’s ability to recover from a race (111, 114). 
Additionally, runners with high self-efficacy beliefs can tolerate pain better during performance and 
recovery (84). With 75 of the 77 participants of the current study scoring high on the PSEQ prior to 
the Comrades Marathon, self-efficacy may have contributed to their successful recovery.  
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In addition,  75% of participants reporting one out of 10 or less by day five of their recovery. It is 
suggested that self-efficacy beliefs are motivated by four principal sources: positive self-talk, 
instruction and drills, modelling confidence and verbal persuasion (66, 88) which will now be discussed 
in more detail. 
3.4.5.1. IMPROVING SELF-EFFICACY BELIEFS IN ATHLETES 
Gradually exposing athletes to activities which they view as threatening (graded exposure) is 
recognised as an effective strategy to reduce fear avoidance beliefs and pain catastrophizing (99, 104).  
Though graded exposure seems to be effective in reducing fear avoidance beliefs and pain 
catastrophizing, strategies for addressing low self-efficacy among athletes are also necessary. Self-
confidence and high self-efficacy have proven to be crucial factors in competitive, successful 
performance in athletes (66) and may play a role in recovery. 
Positive self-talk is highly effective in promoting self-efficacy in athletes, with national Olympic 
coaches in the USA identifying this strategy as being the most effective and most widely used in 
enhancing self-confidence in their teams (88). Bandura (66) believed that completing a task 
successfully is the most important means of enhancing self-efficacy. By qualifying for the Comrades 
Marathon, runners would have already increased self-efficacy beliefs with successful completion of a 
marathon in order to qualify.  
Furthermore, setting SMART (specific, measurable, attainable, relevant, timely) goals and achieving 
them, such as participating in time trials, improving finishing times, completing longer training runs 
and qualifying for races, may further increase self-efficacy in Comrade runners (10, 114).  
As mentioned, being part of a running club and being surrounded by experienced runners who have 
successfully completed a Comrades Marathon may potentially be associated with modelling 
confidence in novice runners (87). Likewise, research suggests verbal persuasion or encouragement 
from coaches, fellow runners from running clubs and health professionals has been proven to enhance 
self-efficacy in athletes (111). However, the influence of running clubs on improving self-efficacy was 
not investigated in the current study. Therefore, any verbal persuasion or modelling behaviour 
associated with being a member of a runnng club can only be seen as an assumption. Further 
limitations to the current study will now be discussed. 
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3.4.6. STUDY LIMITATIONS 
A primary limitation of this study, which is characteristic of correlational research, is reporting bias.  
In addition, data were collected from only two running clubs in Johannesburg with participants mainly 
being male and English speaking. This convenient and purposive population limits generalisability. A 
wider group of participants are required with a greater variability in demographics. Future studies 
should include a greater number of running clubs representing a greater range of demographics across 
South Africa.  
The Comrades Marathon race alternates each year between an “up” and “down” race. The “up” race 
starts in Durban at an altitude just above sea-level. At 20 km it reaches an altitide of 450 m with a 
steep incline to the 40 km mark reaching an altitude just below 750 m. The “up” race then plateaus 
slightly with rolling hills ranging between 700 m and 750 m above sea level. It reaches its highest point 
of 810 m above sea level at the 70 km point before finishing in Pietermaritzburg with a gradual decline 
to 700 m above sea level. The “down” race is the reverse starting in Pietermaritzburg and ending in 
Durban. The symptoms associated with EIMD and DOMS are significantly exacerbated when running 
downhill compared to uphill (22, 45, 46). The 2017 Comrades Marathon was an “up” race which may 
have influenced the pain experienced during recovery compared to if the race was a “down” race. 
Future studies should explore the effects of psychosocial factors and pain recovery on ultramarathon 
runners competing in a race with a profile that is mainly downhill where the extent of EIMD and DOMS 
is significantly higher. 
As there were no significant correlations found between pain recovery and pain catastrophizing, fear 
avoidance beliefs and self-efficacy beliefs (three independent variables), a multiple regression analysis 
could not be performed.  However, if future studies find correlations between pain recovery and these 
psychosocial factors based on the suggestions above, a multiple regression analysis is recommended.  
Further pain recovery was the only marker used to assess recovery following the Comrades Marathon. 
Pain, however, is poorly correlated with biomechanical and functional markers of recovery (116). 
Future research mightassess different recovery markers, such as fatigue. By exploring different 
recovery markers, additional psychosocial factors influencing recovery may be identified.   
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Despite these limitations, this study provides insight into the importance of self-efficacy in athletes 
and the role it plays in success in running. Therefore, athletes demonstrating lower self-efficacy beliefs 
may benefit from employing strategies which not only address fear and pain catastrophizing but 
increase self-efficacy (81). 
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CHAPTER 4: SUMMARY AND CONCLUSION 
 
There is a wealth of literature that supports the negative impact that psychosocial factors can have on 
an athlete’s performance, coping strategies and recovery from injury (7, 13, 26). Fear avoidance beliefs 
and pain catastrophizing can delay recovery from an injury or sporting event and delay return to sport 
(29, 69). If athletes are not mindful of this, fear avoidance beliefs and pain catastrophizing have the 
potential to contribute to the development of persistent pain and/or reduced performance (7, 9). 
Consequently, the longer the exposure to these negative psychosocial stressors, the greater the 
impact and possible disability and development of chronic pain (7). 
 
Self-efficacy has proven to play a key role in an athlete’s success. Increased self-belief in one’s own 
abilities has shown to improve an athlete’s tolerance to pain. This will allow an endurance runner to 
not only complete an ultramarathon but also better cope with pain afterwards, allowing for a quicker 
return to performance. Past experiences (training, qualifying for an ultramarathon, previously 
completing an ultramarathon), goal setting and achieving, social support from peers and running clubs 
have all been shown to increase self-efficacy belief in endurance runners (67, 99, 101). 
 
Thus, the purpose of this dissertation was to explore potential associations between pain 
catastrophizing, fear avoidance beliefs and self-efficacy beliefs and pain recovery in a cohort of 
ultramarathon runners competing in the 2017 Comrades Marathon. The study applied a quantitative 
approach to investigate the relationship between these three mentioned psychosocial factors and 
pain recovery for 10 days after the Comrades Marathon. Results from this study showed no correlation 
between each of the psychosocial factors and pain over the 10 days of recovery following the 2017 
Comrades Marathon.  
 
The results of this study might be explained by the sample group used. Research has shown that 
ultramarathon runners have a higher tolerance to pain felt during and after a race and better coping 
strategies to deal with stress and fatigue to complete a goal. Higher self-efficacy beliefs are believed 
to be an associated factor to this psychological trait. Running experience, such as previously 
completing a Comrades marathon, qualifying for the Comrades Marathon and successful training, 
plays a vital role in improving self-efficacy among runners.  
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Regardless of the limitations of the current study, high self-efficacy scores, previous experience, higher 
pain tolerance and better coping strategies in ultramarathon runners may be contributing factors to 
the success in recovery from pain. Therefore, health professionals need to be aware that athletes in 
pain are potentially emotionally vulnerable. With fear avoidance beliefs, pain catastrophizing and self-
efficacy beliefs all possibly influencing pain experienced during recovery, it is the role of the 
physiotherapist, sports physician and coach to ensure the athlete is both physically and psychologically 
ready to return to performance (55, 56).  
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CHAPTER 6: APPENDICES 
 
APPENDIX 1: INFORMED CONSENT FORM  
 
Study: Do psychosocial factors predict pain after participation in an ultramarathon race? 
 
Dear Participant,  
 
The University of Cape Town and Masters of philosophy student in sports physiotherapy, Jessica 
Rabbitte, will be conducting a study to investigate the following:  
 
• To predict whether psychosocial factors predict pain in ultramarathon runners after 
competing in the Comrades ultramarathon  
• To assess the effect of psychosocial factors on recovery in runners competing in the 
Comrades ultramarathon. 
 
The study will help us to understand whether there are other underlying factors that contribute to 
pain and essentially recovery in ultramarathon runners and to what extent. The findings of this study 
might allow us to identify and treat these factors early in training to reduce the time taken to 
recover from an endurance sporting event. 
 
Researcher’s Contact information: 
Investigator Contact number Email Address 
Jessica Rabbitte 0829256220 jessrabbitte@gmail.com 
 
Please answer all the following questions by ticking the appropriate block. Once all the questions 
have been answered please print your name and sign the form in the space provided. 
Consent Form 
Have you read the study information sheet? Yes No 
Have you had an opportunity to ask questions and discuss the study? Yes No 
Have you received satisfactory answer to all your questions? Yes No 
Have you received enough information about the study? Yes No 
 
 
89 
 
Do you agree that your participation in the study is voluntary and that 
you are free to withdraw at any stage? 
Yes No 
Do you understand that the study has received ethical clearance from 
the University of Cape Town Ethics Committee 
Yes No 
Do you understand who will have access to your personal data, how the 
data will be stored, and what will happen to the data at the end of the 
research project 
Yes No 
Do you agree to take part in the study? Yes No 
 
Participant: (Please print name): 
Signature: _______________________   Date:    ______________   
 
Witnessed Consent (Please print name): 
Signature: _______________________   Date:   ______________ 
 
 
**The UCT’s Faculty of Health Sciences Human Research Ethics Committee can be contacted on 021 
406 6338 in case you have any ethical concerns or questions about your rights or welfare as a 
participant on this research study 
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APPENDIX 2: INFORMATION SHEET 
Study: Do psychosocial factors predict pain after participation in an ultramarathon race? 
Dear Participant, 
My name is Jessica Rabbitte, I am a qualified physiotherapist completing a Sports Physiotherapy 
master’s degree at the University of Cape Town and I’m currently researching the effects of 
psychosocial factors on pain and recovery in ultramarathon runners.  
Why is this study being done? 
It is important to any sportsperson to become a better athlete. This can be done by improving 
performance and reducing recovery time after a race.  Reduced recovery time means that athletes 
will be able to return earlier to their sport.  A lot of factors can affect returning to sport after a big 
race including stiffness, pain and injuries. However, there is little information on the effects of 
psychosocial factors on recovery. But what are psychosocial factors? Psychosocial factors are the 
psychological and social behaviours that affect a person’s well-being and health. These factors can 
include stress, anxiety, relationships with family and friends, support structures, culture etc.  
Psychosocial factors can also include fear of injuring one’s self or fear of re-injury. 
A lot of research has looked at how “physical factors” can affect an athlete’s recovery but there is 
little information on how these “psychosocial factors” affect sporting recovery. This lack of 
information has motivated me to look at whether these psychosocial factors influence recovery after 
the Comrades marathon. The Comrades marathon has been chosen as it is a physically challenging 
race that requires a good recovery after the race. I am hoping that this study will help us to improve 
recovery in runners after they compete in an ultramarathon race. I am hoping that this study can 
identify any factors other than physical ones that can slow down an athlete’s recovery and return to 
sport. 
Are you eligible to take part in the study? 
In order to compete in this study, you must be already qualified to participate in the Comrades 
Marathon 2017. For your own safety, any flu-like symptoms two weeks prior to the race will result in 
exclusion from the study and you will be encouraged to see a doctor for further assessment in this 
situation.  
What will happen if you wish to take part in the study? 
Should you choose to take part in the study, you will be asked to complete the attached 
questionnaires today: Medical and Sports History questionnaire and sign the informed consent (it 
will take you no longer than 20 minutes). These will need to be handed to the researcher today. The 
scales are also available in Afrikaans and isiZulu from the researcher. 
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You will also receive a second pack of questionnaires (pack two) containing: 
(1) Pain Catastrophizing Scale,
2) The Athlete Fear Avoidance Questionnaire
3) Pain Self-Efficacy Scale
These questionnaires are to assess different psychosocial components of pain. Each questionnaire 
will include questions that you need to answer that will give the researcher a better understanding 
on how you, think, feel and deal with pain when training and competing in sport. There are no right 
or wrong answers for these questionnaires and it is important that these questionnaires are 
answered truthfully. 
After the race I will also need access to your marathon running times which I will get from the 
comrade’s marathon website using your race numbers. These times will remain confidential and the 
information will be used to work out your running performance.  
How long will the study take? 
You will be asked to complete the 3 questionnaires (above) in pack two 48 hours before the 
Comrades race. This will take you approximately 10 minutes. 
Attached to this pack will be a pain logbook. You will be asked to start the logbook the night of the 
Comrades and the next 9 evenings (with a total of 10 entries). It is encouraged that the logbook be 
completed around the same time every night before bed.  
What if you forget? 
An SMS or email will be sent to you 48 hours before the race to remind you to complete the 
questionnaires in pack two. An SMS or email will also be sent to you every day for the 10 days after 
the Comrades to remind you to fill out your pain logbook. If you miss a day of completing the 
logbook please continue to complete the next night’s logbook the following day. This ensures that 
the logbook will be fully completed 9 days after the race. 
What do you do with the completed questionnaires and pain logbook? 
These questionnaires and logbook will be collected from the running club, you directly or handed 
into the researcher at the Richard Feher Physiotherapy practice at Randburg Medicross. 
What are the risks of the study? 
There are no risks associated with filling out these questionnaires or completing the pain logbook. 
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What are the benefits of the study? 
You will receive the results of your individual questionnaires after the study is completed. The 
results of the study will be presented one evening after the study is finished to those who are 
interested. There will be no remuneration for taking part in the study. 
Who will see the information which is collected from the study? 
Only the researcher and research assistants will have access to your personal information. Your 
information and completed questionnaires will be kept in a locked safe at the Randburg Medicross 
physiotherapy practice. The results will be saved on an external hard drive that will be password 
protected and locked in the safe at the practice. Only the researcher and research assistants will have 
access to the safe key. The study will only make use of your answers from the questionnaires. There 
will be no personal details used in the study itself. When the results of the study are presented, all 
information will be anonymous. You will have access to your individual results after the study is 
completed. 
What happens at the end of the study? 
On completion of the study your findings will be made available to you. An evening will be held at 
you running club to discuss the results of the study if you would like to attend. This is not 
compulsory. The study will be published in a peer reviewed journal. However, all your personal 
information will remain confidential.  
What other choices do you have? 
You may wish not to participate in this study. There will be no penalty if you choose not to 
participate. You are also free to pull out of the study at any time without any penalty or explanation 
needed. 
I appreciate your willingness to participate in the study. 
Kind regards, 
Jessica Rabbitte  
BSc Physiotherapy (UCT) 
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Who do I speak to if I have any further questions about the study?  
 
Investigator contact details 
 
Jessica Rabbitte 
Richard Feher Physiotherapy 
and Associates  
Randburg Medicross 
Corner of Malibongwe and 
Rabie Road 
Robindale  
Johannesburg 
0829256220 
jessrabbitte@gmail.com 
 
Supervisor: 
 
A/Prof Romy Parker 
Division of Physiotherapy 
Department of Health and 
Rehabilitation Sciences 
University of Cape Town 
Groote Schuur Hospital 
Anzio Road 
Observatory 
7725 
021 406 6431 
Romy.parker@uct.ac.za 
Supervisor: 
 
Dr Theresa Burgess 
Division of Physiotherapy 
Department of Health and 
Rehabilitation Sciences 
University of Cape Town 
Groote Schuur Hospital 
Anzio Road 
Observatory 
7725 
021 406 6171 
Theresa.burgess@uct.ac.za 
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APPENDIX 3: MEDICAL AND SPORTS HISTORY QUESTIONNAIRE  
 
MEDICAL AND SPORTS HISTORY QUESTIONNAIRE 
 
 
 
Instructions: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Please complete Sections A, B, C, D, E, F 
 
Section A: Personal Details 
Section B: Racing and Training history 
Section C: General Medical History 
Section D: Specific Medical History 
Section E: Specific Medical History- Medications 
Section F: Specific Injury History  
 
Thank you for taking the time to complete this questionnaire, which will take 10 minutes of 
your valuable time to complete. The completion of the questionnaire is voluntary, and all 
the information will be kept confidential. The information collected will only be used for 
research purposes. 
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Section A: Personal Details 
2017 Comrades 
Race Number 
Surname 
First Name 
Language 
Postal Address 
Postal/ Zip Code 
E-mail address Phone (day time) code number 
Date of birth yyyy-mm-dd Cell 
Height cm Gender Male:    Female: 
Weight kg 
Running club Age 
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Section B: Racing and Training History 
What is your predicted time for the 
2017 Comrades Marathon? 
 ____Hrs  ____Min 
Type of Event 
Two Oceans Marathon Comrades Marathon 
Which Races have you participated in?  Yes    No  Yes No  
Year of first event 
How many events have you participated 
in? 
Personal best time _________ hrs:min _________ hrs:min 
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Section C: General medical history 
1.In the past 6 weeks did you suffer from any
symptoms of flu (fever, sore throat, blocked or
runny nose, cough, wheeze, muscle aches and
pains)?
If you answer “yes”, please complete the 
additional questions in Section D. 
 Yes  No 
2.Have you ever in your running career suffered
from an injury?
Yes No 
3.Have you ever in your running career used
medicines to treat injuries or pain in the week
before, during or after a race – including anti-
inflammatory drugs, cortisone (pills, or
injection), or pain killers?
If you answer “yes”, please complete the 
additional questions in Section E. 
Yes No 
4.Please tick in which anatomical area you ever
had surgery performed.
 Head  Finger 
 Neck  Lower back 
 Face  Hip 
 Front chest  Thigh 
 Back chest  Knee 
 Shoulder  Lower leg 
 Upper arm  Achilles 
 Elbow  Ankle 
 Forearm  Foot 
 Wrist  Abdomen 
Other (Specify: _________________________) 
 NO SURGERY TO DATE 
5.Do you currently suffer from any symptoms
of injury in the muscles, tendons, bones,
ligaments or joints?
If you answer “yes”, please complete the 
additional questions in Section F. If “no” 
continue with the rest of the questionnaire 
leaving out Section F. 
Yes No 
 
 
98 
 
6.Neurological Conditions 
Do you currently present with any neurological 
conditions? 
 
 Yes  N0    
(Please Specify: ________________________ 
____________________________________________
_______________________) 
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Section D: Specific Medical History 
1. Flu symptoms in the last 6 weeks
(1a) Please tick which of these flu symptoms 
you suffered from in the last 6 weeks. 
 Fever  Cough  Joint pains 
 Blocked nose  Wheezing 
 Runny nose  Muscle aches 
 Any other flu symptoms  
 (Specify: _____________________________) 
(1b) Please tick which of these flu symptoms 
you suffered from in the last 7 days. 
 Fever  Cough  Joint pains 
 Blocked nose  Wheezing 
 Runny nose  Muscle aches 
 Any other flu symptoms  
 (Specify: _____________________________) 
Section E: Specific Medical History - Medications 
2. Use of medicines to treat an injury or pain before or during participation in Comrades
 (2a) Which of the following medicines have you used in the 
past to treat an injury or pain in the week just before a 
race? 
 Paracetamol (e.g. Panado, Tylenol) 
 Non-steroidal anti-inflammatories 
(e.g. Voltaren, Cataflam) 
 Cortisone (pills) 
 Cortisone injection 
 Codeine 
 Anti-inflammatory 
gels/creams/patches 
 Any other pain killers  (Specify: 
_____________________________) 
(2b) Which of the following medicines have you used in the 
past to treat an injury or pain during a race? 
 Paracetamol (e.g. Panado, Tylenol) 
 Non-steroidal anti-inflammatories 
(e.g. Voltaren, Cataflam) 
 Cortisone (pills) 
 Cortisone injection 
 Codeine 
 Anti-inflammatory 
gels/creams/patches 
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 Any other pain killers  (Specify: 
_____________________________) 
(2c) Which of the following medicines have you used in the 
past to treat an injury or pain after a race? 
 Paracetamol (e.g. Panado, Tylenol) 
 Non-steroidal anti-inflammatories 
(e.g. Voltaren, Cataflam) 
 Cortisone (pills) 
 Cortisone injection 
 Codeine 
 Anti-inflammatory 
gels/creams/patches 
 Any other pain killers  (Specify: 
_____________________________) 
3. Current use of Chronic Medication for Pain or Neuropsychiatric Conditions
(3a) Are you currently taking any chronic medication for 
pain management? 
 Yes N0  
 Oral Cortisone 
 Other (Please Specify: 
________________ 
_________________________________
_________________________________
_________________________________
___________) 
(3b) Are you currently taking any chronic medication for 
neuropsychological conditions? 
 Yes N0  
(Please Specify: 
________________________ 
_________________________________
_________________________________
_________________________________
___________) 
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Section F: Specific Injury History 
1. History of any current injury that you suffer from
Injury 1 
(1a) What was the approximate date when 
you first became aware of the injury? 
 Month   Year 
(1b) Please indicate which side of your 
body is injured. (if applicable) 
 Right  Left 
(1c) Please indicate which anatomical area 
is currently injured 
 Head  Elbow  Hamstring 
 Neck  Forearm 
Quadriceps 
 Face  Wrist  Knee 
 Front chest  Finger  Shin 
 Back chest  Lower back  Achilles 
 Shoulder  Hip  Ankle 
 Upper arm  Thigh  Foot 
Other (Specify:  ________________________) 
(1d) Please indicate the type of structure 
that was injured 
 Muscle  Ligament 
 Tendon  Joint 
 Bone 
Other (Specify:  ________________________) 
(1e) Please indicate the severity of the 
injury. Please only tick one box. 
 I only experience symptoms after exercise - Grade 1 
 I experience symptoms during exercise, but it does 
not    interfere with exercise - Grade 2 
 I experience symptoms during exercise that may 
interfere with my training/competition - Grade 3 
 I am so painful that I may not be able to train or 
compete - Grade 4 
(1f) Please indicate how your injury was 
treated to date. You can tick more than one 
box. 
 Rest  Tablets 
 Stretches  Cortisone injection 
 Physiotherapy  Other injection 
 Surgery  Orthotics 
 Strengthening exercises 
 Equipment change 
Other (Specify:  ________________________) 
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Injury 2 
(2a) What was the approximate date when 
you first became aware of the injury? 
 Month   Year 
(2b) Please indicate which side of your body is 
injured. (if applicable) 
 Right  Left 
(2c) Please indicate which anatomical area is 
currently injured. 
 Head  Elbow  Hamstring 
 Neck  Forearm 
Quadriceps 
 Face  Wrist 
Knee 
 Front chest  Finger  Shin 
 Back chest  Lower back  Achilles 
 Shoulder  Hip  Ankle 
 Upper arm  Thigh  Foot 
Other (Specify:  ________________________) 
(2d) Please indicate the type of structure that 
was injured. 
 Muscle  Ligament 
 Tendon  Joint 
 Bone 
Other (Specify:  ________________________) 
(2e) Please indicate the severity of the injury. 
Please only tick one box. 
 I only experience symptoms after exercise - Grade 
1 
 I experience symptoms during exercise, but it does 
not interfere with exercise  - Grade 2  
 I experience symptoms during exercise that may 
interfere with my training/ competition - Grade 3 
 I am so painful that I may not be able to train or 
compete - Grade 4 
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(2f) Please indicate how your injury was 
treated to date. You can tick more than one 
box. 
 Rest  Tablets 
 Stretches  Cortisone injection 
 Physiotherapy  Other injection 
 Surgery  Orthotics 
 Strengthening exercises 
 Equipment change 
Other (Specify:  ________________________) 
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APPENDIX 4: PAIN CATASTROPHIZING SCALE 
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APPENDIX 5: ATHLETE FEAR AVOIDANCE QUESTIONNAIRE 
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APPENDIX 6: PAIN SELF-EFFICACY QUESTIONNAIRE 
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APPENDIX 7: PAIN LOGBOOK 
Participant Pain Logbook 
Participant race number: ________________________ 
Please complete the following logbook for a total of 10 days. Please start the logbook on the evening 
of completing the Comrades. Continue to complete the logbook for every successive day at the 
same time in the evening (before bed). 
If you have any queries, please contact Jessica Rabbitte using the details below. Thank you for taking 
time to participate in this study and completing the form. 
Jessica Rabbitte 
BSc Physiotherapy (UCT) 
Cell: 0829256220 
Email: jessrabbitte@gmail.com 
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PAIN LOGBOOK DAY 1: (Night of the Comrades) 
Please complete the pain logbook before you go to bed every evening. Write down the time you 
complete the form and mark your pain on the visual analogue scale out of 10. 
Time: ______________ 
Visual Analogue Scale: How bad has your pain been today on average? 
Visual Analogue Scale: What was your pain at its worst today? 
Visual Analogue Scale: What was your pain at its least today? 
Visual Analogue Scale: What was your pain right now 
Medication taken today for pain: 
Time taken: 
Name of medication and 
dosage (eg. Panado, 500mg) 
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PAIN LOGBOOK DAY 2: 
Please complete the pain logbook before you go to bed every evening. Write down the time you 
complete the form and mark your pain on the visual analogue scale out of 10. 
Time: ______________ 
Visual Analogue Scale: How bad has your pain been today on average? 
Visual Analogue Scale: What was your pain at its worst today? 
Visual Analogue Scale: What was your pain at its least today? 
Visual Analogue Scale: What was your pain right now? 
Medication taken today for pain: 
Time taken: 
Name of medication and 
dosage (eg. Panado, 500mg) 
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PAIN LOGBOOK DAY 3: 
Please complete the pain logbook before you go to bed every evening. Write down the time you 
complete the form and mark your pain on the visual analogue scale out of 10. 
Time: ______________ 
Visual Analogue Scale: How bad has your pain been today on average? 
Visual Analogue Scale: What was your pain at its worst today? 
Visual Analogue Scale: What was your pain at its least today? 
Visual Analogue Scale: What was your pain right now? 
Medication taken today for pain: 
Time taken: 
Name of medication and 
dosage (eg. Panado, 500mg) 
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PAIN LOGBOOK DAY 4: 
Please complete the pain logbook before you go to bed every evening. Write down the time you 
complete the form and mark your pain on the visual analogue scale out of 10. 
Time: ______________ 
Visual Analogue Scale: How bad has your pain been today on average? 
Visual Analogue Scale: What was your pain at its worst today? 
Visual Analogue Scale: What was your pain at its least today? 
Visual Analogue Scale: What was your pain right now? 
Medication taken today for pain: 
Time taken: 
Name of medication and 
dosage (eg. Panado, 500mg) 
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PAIN LOGBOOK DAY 5: 
Please complete the pain logbook before you go to bed every evening. Write down the time you 
complete the form and mark your pain on the visual analogue scale out of 10. 
Time: ______________ 
Visual Analogue Scale: How bad has your pain been today on average? 
Visual Analogue Scale: What was your pain at its worst today? 
Visual Analogue Scale: What was your pain at its least today? 
Visual Analogue Scale: What was your pain right now? 
Medication taken today for pain: 
Time taken: 
Name of medication and 
dosage (eg. Panado, 500mg) 
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PAIN LOGBOOK DAY 6: 
Please complete the pain logbook before you go to bed every evening. Write down the time you 
complete the form and mark your pain on the visual analogue scale out of 10. 
Time: ______________ 
Visual Analogue Scale: How bad has your pain been today on average? 
Visual Analogue Scale: What was your pain at its worst today? 
Visual Analogue Scale: What was your pain at its least today? 
Visual Analogue Scale: What was your pain right now? 
Medication taken today for pain: 
Time taken: 
Name of medication and 
dosage (eg. Panado, 500mg) 
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PAIN LOGBOOK DAY 7: 
Please complete the pain logbook before you go to bed every evening. Write down the time you 
complete the form and mark your pain on the visual analogue scale out of 10. 
Time: ______________ 
Visual Analogue Scale: How bad has your pain been today on average? 
Visual Analogue Scale: What was your pain at its worst today? 
Visual Analogue Scale: What was your pain at its least today? 
Visual Analogue Scale: What was your pain right now? 
Medication taken today for pain: 
Time taken: 
Name of medication and 
dosage (eg. Panado, 500mg) 
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PAIN LOGBOOK DAY 8:  
Please complete the pain logbook before you go to bed every evening. Write down the time you 
complete the form and mark your pain on the visual analogue scale out of 10. 
Time: ______________ 
Visual Analogue Scale: How bad has your pain been today on average? 
 
Visual Analogue Scale: What was your pain at its worst today? 
 
 
Visual Analogue Scale: What was your pain at its least today? 
 
 
Visual Analogue Scale: What was your pain right now? 
 
 
 
Medication taken today for pain: 
Time taken:  
Name of medication and 
dosage (eg. Panado, 500mg) 
 
117 
PAIN LOGBOOK DAY 9: 
Please complete the pain logbook before you go to bed every evening. Write down the time you 
complete the form and mark your pain on the visual analogue scale out of 10. 
Time: ______________ 
Visual Analogue Scale: How bad has your pain been today on average? 
Visual Analogue Scale: What was your pain at its worst today? 
Visual Analogue Scale: What was your pain at its least today? 
Visual Analogue Scale: What was your pain right now? 
Medication taken today for pain: 
Time taken: 
Name of medication and 
dosage (eg. Panado, 500mg) 
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PAIN LOGBOOK DAY 10: (Final Form) 
Please complete the pain logbook before you go to bed every evening. Write down the time you 
complete the form and mark your pain on the visual analogue scale out of 10. 
Time: ______________ 
Visual Analogue Scale: How bad has your pain been today on average? 
Visual Analogue Scale: What was your pain at its worst today? 
Visual Analogue Scale: What was your pain at its least today? 
Visual Analogue Scale: What was your pain right now? 
Medication taken today for pain: 
Time taken: 
Name of medication and 
dosage (eg. Panado, 500mg) 
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Pain killer drugs: Checklist 
Dear participant, 
Below is a list of pain medications available in South Africa. Should you use any pain medications 
after the race, please refer to the list to ensure correct recording of the medication that you use.  
Please feel free to record the brand or generic name in your pain diary if you are taking any pain 
medication. 
Non-Narcotic Analgesics 
Generic Brand Name 
Acetaminophen Tylenol 
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) 
Generic Brand Name 
Bromfenac Prolensa, Bromday 
Diclofenac Cataflam, Voltaren, Zipsor 
Diflunisal Dolobid 
Etodolac Lodine, Lodine XL 
Fenoprofen Nalfon 
Flurbiprofen Ansaid 
Ibuprofen 
Advil, Cramp End, Dolgesic, Excedrin IB, Genpril, 
Haltran, Ibren, Ibu, Ibuprin, Ibuprohm, Ibu-Tab, 
Medipren, Midol IB, Motrin, Nuprin, Pamprin-IB, 
Q-Profen, Rufen, Trendar
Indomethacin Indocin, Indocin SR, Tivorbex 
Ketoprofen Actron, Orudis, Oruvail 
Ketorolac Toradol, Sprix 
Meclofenamate Meclomen 
Mefenamic Acid Ponstel 
120 
Meloxicam Mobic, Vivlodex 
Nabumetone Relafen 
Naproxen 
Aleve, Anaprox, 
Anaprox DS, EC-Naprosyn, Naprelan, Naprosyn 
Nepafenac Nevanac 
Oxaprozin Daypro 
Phenylbutazone Cotylbutazone 
Piroxicam Feldene 
Sulindac Clinoril 
Tolmetin Tolectin, Tolectin DS 
COX-2 Inhibitors 
Generic Brand Name 
Celecoxib Celebrex, Arcoxia, Rayzon 
Narcotic Pain Medications (Painkillers) 
Generic Brand Name 
Buprenorphine Buprenex, Butrans transdermal patch 
Butorphanol Stadol 
Codeine 
Hydrocodone 
Hydromorphone 
Dilaudid, Dilaudid-5, Dilaudid-HP, Hydrostat IR, 
Exalgo ER 
Levorphanol Levo-Dromoran 
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Meperidine Demerol 
Methadone Dolophine, Methadose 
Morphine 
Astramorph PF, AVINZA, Duramorph, Kadian, 
M S Contin, MSIR, Oramorph SR, Rescudose, 
Roxanol 
Nalbuphine Nubain 
Oxycodone OxyContin, Roxicodone, Oxecta 
Oxymorphone Numorphan 
Pentazocine Talwin 
Propoxyphene Cotanal-65, Darvon 
Tapentadol Nucynta 
Central Analgesics 
Generic Brand Name 
Tramadol Ultram 
Tramadol and Acetaminophen Ultracet 
Combinations 
Generic Brand Name 
Butalbital, Acetaminophen, and Caffeine Femcet, Fioricet, Esgic, Esgic-Plus 
Butalbital, Aspirin, and Caffeine Fiorinal 
Butalbital, acetaminophen, caffeine, and 
codeine Fioricet with Codeine 
Hydrocodone and Ibuprofen Hydrostal IR, Vicoprofen 
Morphine/Naltrexone Embeda 
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Oxycodone/Naltrexone Troxyca ER 
Pentazocine/Naloxone Talwin NX 
Narcotic Analgesics and Acetaminophen 
Acetaminophen and Codeine 
Capital with Codeine, Margesic #3, Phenaphen 
with Codeine, Tylenol with Codeine 
Dihydrocodeine, Acetaminophen, and 
Caffeine DHCplus 
Hydrocodone and Acetaminophen 
Allay, Anexsia 5/500, Anexsia 7.5/650, Dolacet, 
Dolagesic, Duocet, Hycomed, Hydrocet, 
Hydrogesic, HY-PHEN, Lorcet 10/650, Lorcet-HD, 
Lortab, Panacet 5/500, Panlor, Stagesic, T-Gesic, 
Ugesic, Vicodin, Zydone 
Oxycodone and Acetaminophen 
Endocet, Percocet, Roxicet, Roxilox, Tylox; 
Xartemis XR 
Pentazocine and Acetaminophen Talacen 
Propoxyphene and Acetaminophen 
Darvocet-N 50, 
Darvocet-N 100, E-Lor, Propacet 100 
Narcotic Analgesics and Aspirin 
Aspirin, Caffeine, and Dihydrocodeine Synalgos-DC 
Aspirin and Codeine Empirin with Codeine 
Hydrocodone and Aspirin Damason-P, Lortab ASA, Panasal 5/500 
Oxycodone and Aspirin Endodan, Percodan, Percodan-Demi, Roxiprin 
Pentazocine and Aspirin Talwin Compound 
Propoxyphene, Aspirin, and Caffeine 
Darvon Compound-65, PC-Cap, Propoxyphene 
Compound-65 
Topical Analgesics 
Generic Brand Name 
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Capsaicin 
ArthriCare, ARTH-RX, Axsain, Capsagel, Dura-
Patch, Methacin, Qutenza, Zotrix, Zotrix-HP 
Topical Anesthetics 
Generic Brand Name 
Benzocaine Americaine, Endocaine, Lagol 
Benzocaine / Menthol Benzocol, Butyl Aminobenzoate, Dermoplast 
Dibucaine 
Cinchocaine, Nupercainal Cream, Nupercainal 
Oinment 
Lidocaine LidaMantle, Lidoderm, Lignocainem, Xylocaine 
Lidocaine/ Prilocaine EMLA 
  Adapted from:  http://www.emedexpert.com/lists/pain-meds.shtml 
 https://www.sapj.co.za/index.php/SAPJ/article/viewFile/1005/1161 
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APPENDIX 8: ETHICAL APPROVAL LETTER (HREC Ref: 045/2017) 
125 
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APPENDIX 9: BASELINE MEASURES: FREQUENCY TABLE OF CATASTROPHIZERS 
VS. NON-CATASTROPHIZERS  
Table 5: Baseline measures: frequency table of catastrophisers (cut off score of 30 out of 
52) 
Category 
Frequency table: Catastrophising Yes/no (Background information in Results final) 
Count 
Cumulative 
Count 
Percent (%) 
Cumulative 
Percent (%) 
No 68 68 88.31 88.31 
Yes 9 77 11.69 100 
Missing 0 77 0 100 
Table 6: Baseline measures: frequency table of rumination (cut off score of 11) 
Category 
Frequency table: Rumination yes/no (Background information in Results final) 
Count 
Cumulative 
Count 
Percent (%) 
Cumulative 
Percent (%) 
No 64 64 83.12 83.12 
Yes 13 77 16.88 100 
Missing 0 77 0 100 
Table 7: Baseline measures: frequency table of magnification (cut off score of 5) 
Category 
Frequency table: Magnification Yes/No (Background information in Results final) 
Count 
Cumulative 
Count 
Percent (%) 
Cumulative 
Percent (%) 
No 52 52 67.53 67.53 
Yes 25 77 32.47 100 
Missing 0 77 0 100 
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Table 8: Baseline measures: frequency table of helplessness (cut off score of 13) 
Category 
Frequency table: Helplessness Yes/no (Background information in Results final) 
Count 
Cumulative 
Count 
Percent (%) 
Cumulative 
Percent (%) 
No 68 68 88.31 88.31 
Yes 9 77 11.69 100 
Missing 0 77 0 100 
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APPENDIX 10: BASELINE MEASURES: FREQUENCY TABLE OF HIGH SELF-
EFFICACY BELIEFS VS. LOW SELF-EFFICACY BELIEFS  
Table 9: Baseline measures: frequency table of self-efficacy (cut off score of 40) 
Category 
Frequency table: PSEQ High/low (Background information in Results final) 
Count 
Cumulative 
Count 
Percent (%) 
Cumulative 
Percent (%) 
Low 2 2 2.60 2.60 
High 75 77 97.40 100 
Missing 0 77 0 100 
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APPENDIX 11: PAIN SEVERITY SCORES OVER 10 DAYS OF RECOVERY BETWEEN 
CATASTROPHIZERS VS NON- CATASTROPHIZERS  
Table 10: Mann- Whitney U Test showing Pain Severity Scores (PSS) over 10 days of recovery 
between catastrophizers (n=9) and non- catastrophizers (n=68) 
10 Days of Recovery z-value p-value
Day 1- Pain Severity Score (PSS) -0.10 0.92 
Day 2 PSS -0.44 0.66 
Day 3- PSS 0.11 0.91 
Day 4- PSS -0.47 0.64 
Day 5- PSS 0.67 0.50 
Day 6- PSS 1.29 0.20 
Day 7- PSS 0.72 0.47 
Day 8- PSS 0.55 0.58 
Day 9- PSS 0.16 0.87 
Day 10- PSS 0.56 0.57 
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APPENDIX 12: DATA CAPTURED FROM MEDICAL AND SPORTS HISTORY QUESTIONNAIRE, PAIN CATASTROPHIZING 
QUESTIONNAIRE, ATHLETE FEAR AVOIDANCE QUESTIONNAIRE, PAIN SELF-EFFICACY QUESTIONNAIRE AND PAIN 
LOGBOOK  
Table 11: Excel spreadsheet: data captured from Medical and Sports History Questionnaire, PCQ, AFAQ, PSEQ and pain logbook for 
comrades runners (n=77) over 10 days of recovery   
 
Participant Language DOB Gender Height (cm) Weight (kg) Running Club Age Predicted time (min)
1 afrikaans 23/12/1975 female 172 59 klerksdorp marathon club 41 630
2 english 10/04/1958 female 157 56 pirates running club 59 690
3 english 24/05/1968 female 150 48 fitness from africa 49 710
4 english 19/09/1976 female 160 60 pinelands ac 40 658
5 english 10/08/1987 male 72 born2run 30 525
6 english 17/02/1988 female 165 64 randburg harriers 29 630
7 english 12/05/1974 female 163 64 born2run 43 690
8 english 18/08/1963 female 159 56 jeppe 53 675
9 english male 187 80 florida 53 600
10 afrikaans 26/07/1977 male 184 76 mpha centurion 39 570
11 english 27/07/1980 male 184 82 wanderers AC 36 445
12 english 18/08/1976 male 180 68 wanderers AC 40 530
13 venda/english male 158 60 wanderers AC 34 450
14 english 3/6/1984 male 168 57 jeppe 32 510
15 english 22/07/1991 male 185 75 wanderers AC 25 630
16 english 10/03/1966 male 185 83 randburg harriers 51 600
17 english 22/11/1969 male 176 71 randburg harriers 47 530
18 afrikaans 29/08/1984 female 176 59 wanderers AC 32 659
19 afrikaans 24/05/1979 male 179 90 magnolia running club 38 705
20 english 24/04/1954 female 170 60 born2run 63 690
21 english 24/07/1987 male 173 77 faku chiefs 29 645
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Participant Language DOB Gender Height (cm) Weight (kg) Running Club Age Predicted time (min)
22 english 10/11/1966 female 167 53 pinetown and districts athletics club50 540
23 english 25/09/1958 female 173 60 born2run 58 630
24 english 29/08/1975 male old eds 41 588
25 english 23/05/1956 male 177 87 jeppe 61 690
26 english 15/08/1964 male 173 89 pirates running club 52 659
27 isizula 09/08/1982 male 170 65 wanderers AC 35 520
28 english 06/05/1972 male 177 73 florida 45 659
29 afrikaans 14/05/1979 male 177 72 fourways road runners 38 440
30 english male 183 75 pirates running club 35 440
31 english male 169 78 panorama running club 34 630
32 isixhosa 21/05/1978 female 64 team vitality 39 600
33 english 26/04/1972 male 164 70 jeppe 45 630
34 english 29/12/1981 male 175 66 randburg harriers 35 630
35 english 09/10/1983 female 172 62 born2run 33 560
36 english 06/05/1966 female 170 57 jeppe 51 640
37 english 27/05/1971 male 176 66 fourways road runners 46 385
38 english 26/12/1985 male 181 71 wanderers AC 31 525
39 afrikaans 07/09/1979 female 166 64 pretoria marathon club 37 710
40 english 04/01/1974 male 170 63 pretoria marathon club 41 539
41 english 05/07/1979 female 163 67 roodepoort 38 710
42 afrikaans 05/06/1984 female 168 60 pentagon pistols 32 705
43 english 13/08/1967 male 175 66 panorama running club 49 630
44 english 11/12/1968 female howick athletic club 48 680
45 english 04/11/1985 male 77 born2run 31 570
46 english male 177 69 48 540
47 english 20/02/1988 male 165 65 faku chiefs 29 600
48 afrikaans 09/10/1981 female 170 68 randburg harriers 35 600
49 english 15/04/1986 male 175 67 wanderers AC 31 510
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Participant Language DOB Gender Height (cm) Weight (kg) Running Club Age Predicted time (min)
50 english male 176 68 wanderers AC 675
51 afrikaans 10/02/1966 male 183 80 acrw 51 650
52 afrikaans 17/10/1985 female 176 57 germiston callies harriers 31 690
53 english female 169 54 rand road warriors 39 504
54 english 19/11/1982 female 175 61 randburg harriers 34 580
55 english 28/07/1971 male 172 70 vitality ac 45 650
56 english 03/02/1988 female 166 54 howick athletic club 29 590
57 afrikaans 27/02/1975 female 173 62 wanderers AC 42 630
58 english 16/02/1971 female 167 57 born2run 46 665
59 english 31/05/1976 female 163 62 born2run 40 690
60 setswana male 168 56 randburg harriers 36 430
61 english 14/03/1988 male 177 80 nedbank 29 660
62 english 13/03/1973 male 187 80 randburg harriers 44 599
63 english 04/07/1977 male 195 77 born2run 39 630
64 afrikaans 21/09/1986 male 188 83 randburg harriers 30 615
65 english 23/10/1974 female 152 48 randburg harriers 42 660
66 english 02/03/1957 male 176 71 alberton 60 630
67 english 03/03/1982 female 176 58 randburg harriers 35 482
68 setswana 04/05/1985 male 172 70 team butterfly athletics club 32 660
69 english 03/08/1988 male 173 71 westville athletic club 28 680
70 afrikaans 24/01/1985 male 168 55 kumba irone 31 550
71 english 15/12/1971 female 153 60 florida 44 730
72 afrikaans 12/08/1983 female 176 59 randburg harriers 32 600
73 english 03/03/1969 male 168 57 alpha centurion runners and walkers46 700
74 english 17/01/1964 male 172 71 team vitality 52 540
75 afrikaans 04/05/1981 male 180 72 benoni northerns athletics club 35 720
76 english 1966 female 169 55 jeppe 49 600
77 english female wanderers AC 47 620
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Participant
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
Two oceans #2o Yr of first 2o 20PB (min) Comrades #Com Yr of first Com Com PB (min)
yes 1 2015 379 yes 6 2000 648
yes 6 1988 329 yes 24 1988 557
yes 3 2014 390 yes 2 2015 714
yes 4 2014 390 yes 2 2015 672
yes 2 2016 288 yes 1 2016 593
yes 1 2016 410 no
yes 2 2014 350 yes 2 2014 640
yes 2 2015 660 yes 2 2015 681
yes 26 1992 295 yes 2 2014 616
no no
yes 4 2013 264 yes 6 2011 471
yes 8 2008 284 yes 3 2010 523
yes 1 2016 434 yes 1 2016 471
yes 3 2013 278 yes 3 2013 478
no
yes 4 2014 330 yes 3 2014 570
yes 1 2013 333 yes 3 2011 535
yes 1 2015 360 no
yes 2 2015 405 yes 4 2012 692
yes 1 2016 403 no
yes 1 2015 340 yes 1 2016 643
yes 1 2016 354 yes 2 2015 536
yes 1 1998 322 yes 15 1989 558
yes 2 2016 348 yes 9 2008 577
134 
  
Participant Two oceans #2o Yr of first 2o 20PB (min) Comrades #Com Yr of first Com Com PB (min)
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
yes 11 2001 369 yes 11 1999 633
yes 4 2012 402 yes 3 2014 696
yes 1 2016 285 yes 1 2015 549
no yes 4 2010 659
yes 2 2012 283 yes 2 2014 518
yes 1 2011 302 yes 1 2013 453
no yes 2 2015 593
yes 2 2016 370 no
yes 6 1998 231 yes 18 1997 418
yes 2 2016 369 no
yes 4 2011 325 yes 4 2014 595
yes 25 1990 287 yes 27 1988 491
yes 3 226 yes 9 2008 377
yes 1 2013 304 yes 1 2016 592
no yes 1 2016 646
yes 2 2013 360 yes 17 2000 432
no no
no no
no yes 1 2016 718
no yes 1 2016 695
yes 2 2008 325 yes 2 2015 595
no no
yes 1 2015 350 yes 1 2016 644
no yes 1 2016 626
yes 1 2014 410 no
yes 13 1988 307 yes 24 1988 496
 
 
135 
 
   
    
Participant
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
yes 3 1998 322 yes 4 1998 563
no no
yes 1 2016 350 yes 5 2011 567
no yes 1 2016 527
yes 3 2011 338 yes 6 2010 640
yes 1 2017 340 yes 2 2015 589
yes 4 2006 347 yes 5 2006 588
no no
yes 2 2016 401 yes 1 2016 708
yes 8 2010 237 yes 7 2010 446
yes 2 2010 346 no
yes 1 2014 365 yes 3 2014 592
no no
yes 1 2016 331 yes 2 2012 625
no yes 5 2012 574
yes 15 2001 316 yes 17 2000 610
no yes 5 2011 482
no yes 4 2013 647
no yes 1 2016 649
no no
no yes 1 2016 706
yes 1 2015 350 yes 4 2013 653
no yes 3 2014 716
yes 3 2012 240 yes 5 2012 501
no no
yes 5 2001 308 yes 19 1998 584
no yes 1 2016 588
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Pace of Com PB (km/hour)Com time 2017 (min) Pace of Com time 2017 (km/hour)% time of 2017 race vs PBHx meds after a race
7.28 634 7.19 101 yes
6.25 690 7.57 83 yes
8.14 719 8.17 100 no
7.45 688 7.56 99 no
6.05 492 5.4 112 no
650 7.3 yes
7.23 647 7.28 99 yes
7.51 625 7.12 105 no
7.06 601 6.56 108 yes
574 6.37 yes
5.26 477 5.3 99 yes
6.02 536 6.11 99 no
5.26 514 5.56 95 no
5.31 532 6.08 87 yes
625 7.12 99 no
6.34 623 7.11 89 no
6.1 705 8.08 75 yes
671 7.44 104 no
7.59 694 8 107 yes
698 8.03 95 yes
7.25 613 7.04 103 yes
6.11 551 6.21 98 yes
6.26 654 7.32 86 yes
6.39 712 8.13 79 yes
Windows User:
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Pace of Com PB (km/hour)Com time 2017 (min) Pace of Com time 2017 (km/hour)% time of 2017 race vs PBHx meds after a race
7.18 710 8.11 89 yes
8.01 716 8.15 98 no
6.2 529 6.06 102 no
7.36 711 8.12 91 yes
5.58 505 5.49 102 yes
5.13 400 4.37 117 no
6.5 655 7.33 89 yes
714 8.14 82 yes
4.49 703 8.06 56 yes
698 8.03 yes
6.52 583 6.43 101 no
4.17 693 7.59 55 yes
4.21 392 4.31 98 yes
6.5 529 6.06 107 no
7.27 708 8.1 90 no
4.59 529 6.06 76 yes
709 8.1 yes 
710 8.11 no
8.17 712 8.13 100 yes
8.01 668 7.42 108 yes
6.52 583 6.43 101 no
569 6.34 yes 
7.26 613 7.04 103 no
7.13 663 7.39 96 yes
492 5.4 yes 
5.43 714 8.14 67 yes
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6.29 648 7.28 86 yes
692 7.59 yes
6.32 525 6.03 105 yes
6.05 546 6.18 98 no
7.23 589 6.47 112 yes
6.47 588 6.47 100 yes
6.47 604 6.58 98 yes 
702 8.06 yes
8.1 713 8.13 100 yes
5.09 502 5.47 93 yes
638 7.21 yes
6.5 600 6.55 99 no
640 7.23 yes
7.12 649 7.29 98 yes
6.37 656 7.34 87 yes
7.02 636 7.2 98 yes
5.33 491 5.4 99 yes
7.28 700 8.04 91 no
7.29 667 7.41 98 yes
544 6.16 no
8.08 705 8.08 100 yes
7.32 569 6.34 115 yes
8.15 714 8.14 100 yes
5.47 533 6.09 90 yes 
716 8.15 no
6.54 638 7.21 91 yes
6.47 635 7.19 90 yes
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Recovery pain meds Hx of injury Hx of ortho surgery Current injury 1 Grade Current injury 2 Grade
NSAIDS yes no yes 2
NSAIDS yes yes yes 4
no no no
yes yes no
yes no yes 2
NSAIDS yes yes no
paracetomal yes yes yes 3
no no no
NSAIDS, paracetomal yes yes no
NSAIDS no no no
NSAIDS, cortisone injection, myprodolyes no yes 1 yes 2
yes no no
yes no yes 2 yes 1
codeine yes no yes 3
yes no yes 2
yes yes no
anti-inflammatory gel, paracetomolyes yes yes 2
yes no yes 2
anti-inflammatory gel yes no no
anti-inflammatory gel yes no no
NSAIDS yes no no
NSAIDS, anti- inflammatory gel yes no no
ibuprofen yes no yes 3
NSAIDS yes yes yes 3
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Recovery pain meds Hx of injury Hx of ortho surgery Current injury 1 Grade Current injury 2 Grade
bezemax yes no yes 3 yes 3
yes yes yes 3 yes 3
no no no
paracetomal yes yes no
NSAIDS yes yes no
yes yes yes 4
myprodal yes yes yes 2
NSAIDS, norflex yes no yes 3
NSAIDS yes no no
NSAIDS, paracetomal, anti-inflammatory gelyes no yes 2 yes 3
yes no no
NSAIDS, anti- inflammatory gel yes yes yes 4 no
NSAIDS yes no yes 3 yes 3
yes no yes 2
yes no yes 2 yes 3
NSAIDS yes no yes 2 yes 3
NSAIDS, mypaid yes no no
no yes no
arnica ice no no no
NSAIDS yes yes yes 2 yes 3
no no no
NSAIDS no no yes 2
yes no yes 4
NSAIDS, anti- inflammatory gel yes no yes 2
myprodal, anti- inflammatory gel yes no yes 2 yes 1
ibuprofen yes no no
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voltaren yes no yes 1
cataflam yes no yes 2
myprodal yes no yes 2 yes 3
yes no yes 2
NSAIDS, anti- inflammatory gel, paracetamolyes no yes 2
codeine yes no yes 3
paracetomal yes no no
NSAIDS, anti- inflammatory gel yes no no
NSAIDS, anti- inflammatory gel yes no no
anti- inflammatory gel yes no no
codeine, anti- inflammatroy gel, NSAIDS, mypaidyes no yes 4 yes 3
no no no
NSAIDS no no no
paracetomal, anti- inflammatory gelyes no no
NSAIDS, paracetomal yes no yes 3
mypaid yes no no
NSAIDS yes no no
no no no
NSAIDS yes no no
yes no yes 1
paracetomal, anti- inflammatory gelyes yes yes 2
NSAIDS yes no yes 1
myprodal yes yes no
myprodal yes yes yes 2
no no no
NSAIDS, anti- inflammatory gel yes yes yes 2
cataflam yes yes yes 3
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pain/ neuro meds Meds 1 Meds 2 PCS - Total PCS - rumin PCS - magnif PCS - help AFAQ PSEQ
yes NSAIDS 10 4 3 3 12 60
yes NSAIDS 21 11 4 6 24 60
no 24 11 9 4 25 60
no 20 5 5 10 14 59
no 13 3 4 6 13 60
no 3 1 1 1 23 48
yes cortisone injparacetomal 21 11 4 6 24 60
no 4 1 1 2 21 42
no 10 4 2 4 21 60
no 13 4 3 6 26 55
no 14 5 4 5 28 60
no 21 11 4 6 24 60
no 4 1 1 2 21 60
no 16 4 5 7 18 48
no 16 6 4 6 26 60
no 9 5 2 2 21 53
no 12 5 4 3 23 45
no 23 5 5 12 16 50
no 10 4 2 4 14 45
no 7 3 2 2 11 55
no 18 10 0 8 11 25
no 8 4 3 1 12 60
no 4 1 1 2 14 60
no 30 9 7 14 23 48
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pain/ neuro meds Meds 1 Meds 2 PCS - Total PCS - rumin PCS - magnif PCS - help AFAQ PSEQ
no 10 4 4 2 17 50
no 4 1 1 2 14 60
no 14 5 2 7 14 54
no 16 5 3 8 22 45
no 24 12 5 7 26 42
no 14 5 4 5 28 60
no 16 4 3 9 18 55
yes ART 19 6 8 5 16 41
no 16 6 1 9 36 45
no 15 5 2 8 33 40
no 8 3 2 3 21 60
no 2 0 0 2 22 60
no 5 3 0 2 19 59
no 18 9 5 4 26 45
no 49 16 11 22 26 45
no 6 4 2 0 25 45
no 17 7 5 5 27 60
no 35 13 5 17 22 60
2 1 0 1 10 57
no 16 4 3 9 16 55
no 17 7 5 5 22 35
no 5 2 1 2 12 59
no 0 0 0 0 18 43
no 4 0 2 2 16 47
no 7 3 3 1 8 53
no 7 4 1 2 17 60
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pain/ neuro meds Meds 1 Meds 2 PCS - Total PCS - rumin PCS - magnif PCS - help AFAQ PSEQ
no 7 4 0 3 19 59
no 35 13 5 17 21 60
no 9 5 2 2 21 60
no 18 8 6 4 18 58
no 7 5 1 1 16 60
no 32 13 5 14 23 43
no 3 0 2 1 15 60
no 20 9 3 8 26 40
no 38 12 8 18 34 45
no 31 14 7 10 32 60
no 18 8 6 4 26 55
no 7 4 1 2 17 60
no 23 9 8 6 18 59
no 28 9 5 14 13 40
yes catafast 22 8 7 7 24 58
no 4 1 2 1 21 51
no 4 2 1 1 10 57
no 5 2 1 2 12 59
no 20 9 3 8 26 40
no 7 5 1 1 15 60
no 20 9 3 8 27 40
no 35 13 5 17 21 60
no 9 5 2 2 22 60
no 4 0 2 2 17 60
no 18 8 6 4 20 60
no 35 13 5 17 22 59
no 18 8 6 4 17 58
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Day 1 - average VASD y 1 - worst VASDay 1 - least VASDay 1 - now VasDay - Pain Severity Score (PSS)Day 1 - medicationDay 2 - average VASD y 2 - worst VASDay 2 - least VASDay 2 - now VAS Day 2 PSS Day 2 - meds
4 8 0 4 4 n/a 3 4 1 1 2.25 n/a
6 8 1 5 5 ibuprofen 7 8 5 7 6.75 ibuprofen
7 8 0 7 5.5 panado 6 7 0 7 5 n/a
7 8 5 7 6.75 arnica 7 7 7 7 7 arnica
6 6 2 5 4.75 n/a 4 4 2 2 3
4 7 0 4 3.75 n/a 4 6 0 1 2.75 n/a
6 8 1 5 5 n/a 7 8 5 7 6.75 n/a
1 1 0 1 0.75 n/a 0 0 0 0 0 n/a
5 6 0 5 4 voltaren, neurofen3 4 1 4 3 voltaren, neurofen
6 8 0 8 5.5 n/a 7 8 7 7 7.25 n/a
7 8 0 5 5 myprodol 2 3 1 1 1.75 n/a
6 8 0 5 4.75 aspirin 1 1 1 1 1 aspirin
1 2 0 1 1 n/a 1 1 0 0 0.5 n/a
6 9 1 7 5.75 myprodol 6 8 5 7 6.5 n/a
6 7 4 6 5.75 myprodol 6 7 2 5 5 myprodol
7 9 0 6 5.5 n/a 4 4 4 4 4 n/a
9 10 9 9 9.25 n/a 7 9 7 7 7.5 n/a
7 8 5 7 6.75 n/a 7 7 7 7 7 n/a
4 8 0 4 4 n/a 3 4 1 1 2.25 n/a
7 9 2 8 6.5 myprodol 6 8 3 7 6 myprodol
7 9 5 0 5.25 besemax 5 6 3 3 4.25 n/a
5 8 0 4 4.25 n/a 3 5 0 2 2.5 n/a
7 7 1 5 5 ibuprofen 4 6 2 5 4.25 ibuprofen
6 8 6 5 6.25 arcoxia 5 5 3 3 4 n/a
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Day 1 - average VASD y 1 - worst VASDay 1 - least VASDay 1 - now VasDay - Pain Severity Score (PSS)Day 1 - medicationDay 2 - average VASD y 2 - worst VASDay 2 - least VASDay 2 - now VASDay 2 PSS Day 2 - meds
5 7 1 6 4.75 n/a 2 4 2 3 2.75 n/a
1 2 0 1 1 n/a 1 1 0 0 0.5 n/a
7 8 0 5 5 n/a 2 3 1 1 1.75 n/a
9 9 0 9 6.75 paracetomal 5 7 1 6 4.75 paracetomal
8 9 4 6 6.75 disprin 4 5 1 1 2.75 n/a
7 8 0 4 4.75 n/a 2 3 0 0 1.25 n/a
6 9 1 7 5.75 myprodol 6 8 5 7 6.5 n/a
10 10 5 10 8.75 norflex 9 10 4 8 7.75 n/a
7 8 4 8 6.75 adcodol 7 8 3 7 6.25 mypaid
7 7 4 8 6.5 n/a 7 7 3 7 6 n/a
5 8 0 4 4.25 n/a 3 5 0 2 2.5 n/a
1 1 0 1 0.75 n/a 0 0 0 0 0 n/a
9 9 0 9 6.75 myprodol 6 8 6 6 6.5 myprodol
9 9 1 9 7 n/a 5 7 1 6 4.75 n/a
7 8 1 6 5.5 disprin 1 5 1 3 2.5 n/a
8 8 0 8 6 n/a 5 7 1 6 4.75 n/a
4 8 0 6 4.5 spasmed 6 8 4 6 6 n/a
5 7 4 0 4 n/a 4 5 2 0 2.75 n/a
7 7 3 5 5.5 n/a 5 5 2 2 3.5 n/a
6 9 1 7 5.75 n/a 6 8 5 7 6.5 n/a
8 9 4 6 6.75 n/a 4 5 1 1 2.75 n/a
5 5 2 3 3.75 n/a 3 4 3 3 3.25 n/a
0 0 0 0 0 n/a 6 7 0 5 4.5 ibuprofen
5 7 2 5 4.75 diclofenak 8 9 5 8 7.5 dicloflam
5 7 2 6 5 mybulen 4 6 1 5 4 n/a
5 7 3 5 5 ibuprofen 4 6 4 4 4.5 ibuprofen
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 Day 1 - average VASD y 1 - worst VASDay 1 - least VASDay 1 - now VasDay - Pain Severity Score (PSS)Day 1 - medicationDay 2 - average VASD y 2 - worst VASDay 2 - least VASDay 2 - now VASDay 2 PSS Day 2 - meds
1 2 1 1 1.25 n/a 2 3 0 0 1.25 n/a
4 8 0 6 4.5 cataflam 6 8 4 6 6 n/a
5 7 0 3 3.75 myprodol 3 5 0 1 2.25 n/a
8 9 3 8 7 neurofen 7 8 2 2 4.75 n/a
8 1 5 6 5 voltaren 4 4 4 0 3 n/a
6 7 0 4 4.25 cataflam 3 4 2 2 2.75 cataflam
4 5 3 3 3.75 paracetomal 0 0 0 0 0 n/a
3 7 0 1 2.75 catafast 2 3 0 1 1.5 n/a
6 8 5 9 7 cataflam 8 8 6 8 7.5 cataflam
6 8 6 6 6.5 n/a 5 6 5 4 5 panado
3 4 0 2 2.25 n/a 7 10 3 7 6.75 myprodol
5 6 1 5 4.25 n/a 3 5 1 3 3 n/a
9 10 0 9 7 ibupain 7 7 4 6 6 ibupain
3 5 0 3 2.75 norflex 2 3 1 1 1.75 norflex
7 9 0 5 5.25 n/a 3 4 1 2 2.5 n/a
3 5 1 2 2.75 n/a 2 2 1 1 1.5 n/a
7 8 4 8 6.75 adcodol 7 8 3 7 6.25 mypaid
5 5 2 3 3.75 n/a 3 4 3 3 3.25 n/a
3 7 0 2 3 cataflam 2 3 0 1 1.5 cataflam
8 9 6 6 7.25 n/a 5 5 5 1 4 mypaid
3 6 1 1 2.75 voltaren 2 3 0 2 1.75 n/a
4 7 0 5 4 cataflam 6 8 4 5 5.75 cataflam
5 8 1 3 4.25 myprodol 3 5 0 1 2.25 myprodol
5 6 2 5 4.5 myprodol 8 8 5 8 7.25 myprodol
6 7 1 1 3.75 n/a 4 6 4 4 4.5 n/a
5 6 1 3 3.75 n/a 3 5 1 1 2.5 n/a
8 9 3 8 7 cataflam 7 8 2 2 4.75 cataflam
148 
Day 3 - average VASD y 3- worstDay 3- leastDay 3- nowDay 3- PSSDay 3- medsDay 4- averageDay 4- worstDay 4- leastDay 4- nowDay 4- PSSDay 4- meds
1 4 0 0 1.25 n/a 0 1 0 0 0.25 n/a
7 8 4 5 6 n/a 4 5 4 4 4.25 n/a
4 6 0 0 2.5 n/a 2 2 0 0 1 n/a
5 5 5 5 5 n/a 4 4 4 4 4 n/a
3 3 2 2 2.5 n/a 2 2 1 1 1.5 n/a
1 3 0 0 1 n/a 0 1 0 0 0.25 n/a
7 8 4 4 5.75 n/a 4 5 4 4 4.25 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
1 2 0 0 0.75 n/a 0 0 0 0 0 n/a
6 7 6 6 6.25 n/a 4 5 3 3 3.75 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
1 1 0 0 0.5 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
5 7 3 6 5.25 n/a 3 5 1 2 2.75 n/a
6 7 3 4 5 n/a 3 4 1 2 2.5 n/a
2 3 1 1 1.75 n/a 1 1 1 1 1 n/a
5 7 4 4 5 n/a 4 5 3 3 3.75 n/a
5 6 5 5 5.25 n/a 4 4 4 4 4 n/a
1 4 0 0 1.25 n/a 0 1 0 0 0.25 n/a
6 7 3 6 5.5 n/a 2 3 1 1 1.75 n/a
2 3 1 1 1.75 n/a 1 1 0 0 0.5 n/a
2 3 0 0 1.25 n/a 2 3 0 0 1.25 n/a
3 3 0 2 2 ibuprofen 2 2 0 1 1.25 n/a
4 4 4 4 4 n/a 2 2 1 1 1.5 n/a
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 Day 3 - average VASD y 3- worstDay 3- leastDay 3- nowDay 3- PSSDay 3- medsDay 4- averageDay 4- worstDay 4- leastDay 4- nowDay 4- PSSDay 4- meds
2 3 2 2 2.25 n/a 1 2 1 1 1.25 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
4 5 1 3 3.25 slowmag 2 3 1 1 1.75 n/a
2 3 0 0 1.25 n/a 1 2 0 0 0.75 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
5 7 3 6 5.25 n/a 3 5 1 2 2.75 n/a
5 9 1 1 4 n/a 3 3 0 0 1.5 n/a
6 7 3 6 5.5 mypaid 6 6 3 6 5.25 mypaid
6 7 3 6 5.5 n/a 6 6 3 6 5.25 n/a
2 3 0 2 1.75 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
6 6 5 6 5.75 n/a 4 4 3 4 3.75 n/a
4 5 1 2 3 n/a 2 3 1 1 1.75 n/a
3 4 1 1 2.25 n/a 1 1 1 1 1 n/a
4 5 1 2 3 n/a 2 3 1 1 1.75 n/a
2 4 1 2 2.25 n/a 0 0 0 0 0 n/a
2 3 1 0 1.5 n/a 1 2 1 0 1 n/a
1 1 1 1 1 n/a 0 0 0 0 0 n/a
5 7 3 6 5.25 n/a 3 5 1 2 2.75 n/a
2 3 0 0 1.25 n/a 0 0 0 0 0 n/a
3 5 2 3 3.25 n/a 2 2 0 1 1.25 n/a
4 5 3 4 4 arnica gel 3 4 2 2 2.75 arnica gel
6 7 4 5 5.5 n/a 6 7 4 6 5.75 n/a
2 3 0 2 1.75 n/a 0 0 0 0 0 n/a
7 9 6 6 7 ibuprofen 3 4 2 2 2.75 n/a
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Day 3 - average VASD y 3- worstDay 3- leastDay 3- nowDay 3- PSSDay 3- medsDay 4- averageDay 4- worstDay 4- leastDay 4- nowDay 4- PSSDay 4- meds
0 1 0 0 0.25 n/a 0 0 0 0 0 n/a
2 3 1 2 2 n/a 2 3 1 1 1.75 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
5 6 2 4 4.25 n/a 4 5 2 2 3.25 n/a
7 8 4 6 6.25 n/a 0 0 0 0 0 n/a
3 3 2 2 2.5 n/a 2 2 1 2 1.75 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
1 2 0 1 1 n/a 1 2 0 2 1.25 n/a
6 6 4 6 5.5 cataflam 5 6 4 5 5 panado
2 2 2 2 2 n/a 1 2 1 1 1.25 n/a
7 7 5 7 6.5 myprodol 9 10 7 7 8.25 n/a
0 0 1 0 0.25 n/a 0 0 0 0 0 n/a
4 5 3 4 4 n/a 4 4 2 3 3.25 n/a
1 1 0 0 0.5 n/a 0 0 0 0 0 n/a
1 1 1 1 1 n/a 0 0 0 0 0 n/a
3 3 1 2 2.25 n/a 1 1 1 1 1 n/a
6 7 3 6 5.5 mypaid 6 6 3 6 5.25 mypaid
1 1 1 1 1 n/a 0 0 0 0 0 n/a
2 2 2 2 2 n/a 1 1 1 1 1 n/a
7 8 4 6 6.25 mypaid 1 1 1 1 1 n/a
3 3 2 2 2.5 n/a 2 2 1 1 1.5 n/a
2 3 1 1 1.75 n/a 2 2 1 1 1.5 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
6 7 4 5 5.5 myprodol 6 7 4 5 5.5 myprodal
3 5 3 3 3.5 n/a 2 3 1 1 1.75 n/a
2 2 0 0 1 n/a 0 0 0 0 0 n/a
5 5 2 4 4 cataflam 4 5 2 2 3.25 n/a
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Day 5- averageDay 5- worstDay 5- leastDay 5- nowDay 5- PSSDay 5- medsDay 6- averageDay 6- worstDay 6- leastDay 6- nowDay 6- PSSDay 6- meds
0 0 0 0 0 n/a 0 0 0 0 0 n/a
4 5 3 3 3.75 n/a 5 7 3 6 5.25 ibuprofen
0 0 0 0 0 n/a 0 0 0 0 0 n/a
3 3 3 3 3 n/a 1 1 1 1 1 n/a
1 1 1 1 1 n/a 1 1 1 1 1 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
4 5 3 2 3.5 n/a 5 3 0 0 2 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
3 3 2 2 2.5 n/a 1 1 1 1 1 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
2 4 1 2 2.25 n/a 2 1 0 1 1 n/a
2 3 1 2 2 n/a 1 2 1 1 1.25 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
2 2 1 2 1.75 n/a 1 2 0 1 1 n/a
3 3 3 2 2.75 n/a 1 1 1 1 1 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
1 2 0 0 0.75 n/a 1 2 0 0 0.75 n/a
1 2 0 1 1 n/a 1 1 0 1 0.75 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
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Day 5- averageDay 5- worstDay 5- leastDay 5- nowDay 5- PSSDay 5- medsDay 6- averageDay 6- worstDay 6- leastDay 6- nowDay 6- PSSDay 6- meds
1 3 1 1 1.5 n/a 1 2 1 1 1.25 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 1 0 0 0.25 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
2 4 1 2 2.25 n/a 2 1 0 0 0.75 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
5 6 3 6 5 mypaid 5 5 2 4 4 mypaid
5 6 3 6 5 n/a 5 5 2 4 4 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
4 5 4 4 4.25 n/a 4 4 3 3 3.5 n/a
0 1 0 0 0.25 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
1 2 1 0 1 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
2 4 1 2 2.25 n/a 2 1 0 0 0.75 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
1 1 0 1 0.75 n/a 0 0 0 0 0 n/a
2 3 1 1 1.75 arnica gel 3 4 2 2 2.75 arnica gel
4 5 3 4 4 n/a 4 4 3 2 3.25 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
1 1 0 0 0.5 n/a 0 0 0 0 0 n/a
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 Day 5- averageDay 5- worstDay 5- leastDay 5- nowDay 5- PSSDay 5- medsDay 6- averageDay 6- worstDay 6- leastDay 6- nowDay 6- PSSDay 6- meds
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
3 4 1 2 2.5 n/a 2 3 1 1 1.75 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
1 2 1 1 1.25 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
4 5 3 4 4 n/a 3 4 2 1 2.5 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
6 8 4 5 5.75 n/a 2 3 1 1 1.75 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
2 2 2 2 2 n/a 1 1 1 1 1 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
1 1 0 1 0.75 n/a 1 1 0 1 0.75 n/a
5 6 3 5 4.75 mypaid 5 5 2 4 4 mypaid
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
1 1 1 1 1 n/a 0 1 0 0 0.25 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
4 5 2 4 3.75 myprodal 4 4 3 2 3.25 myprodal
1 1 1 1 1 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
3 4 1 2 n/a 2 2 1 1 1.5 n/a
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Day 7- averageDay 7- worstDay 7- leastDay 7- nowDay 7- PSSDay 7- medsDay 8- averageDay 8- worstDay 8- leastDay 8- nowDay 8- PSSDay 8- meds
0 0 0 0 0 n/a 0 0 0 0 0 n/a
5 8 3 5 5.25 parcetomal 8 9 4 6 6.75 ibuprofen
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
1 1 1 1 1 n/a 1 1 1 1 1 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
1 1 0 1 0.75 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
1 1 0 0 0.5 n/a 0 1 0 0 0.25 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
1 1 0 0 0.5 n/a 0 0 0 0 0 n/a
1 1 0 1 0.75 n/a 1 1 0 1 0.75 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
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 Day 7- averageDay 7- worstDay 7- leastDay 7- nowDay 7- PSSDay 7- medsDay 8- averageDay 8- worstDay 8- leastDay 8- nowDay 8- PSSDay 8- meds
1 1 1 1 1 n/a 1 1 1 1 1 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
4 5 2 4 3.75 mypaid 3 4 2 3 3 mypaid
4 4 2 4 3.5 n/a 3 4 2 3 3 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
3 3 3 3 3 myprodol 3 3 3 3 3 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
2 3 1 1 1.75 arnica gel 1 2 0 0 0.75 n/a
2 2 2 1 1.75 n/a 0 1 0 0 0.25 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
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Day 7- averageDay 7- worstDay 7- leastDay 7- nowDay 7- PSSDay 7- medsDay 8- averageDay 8- worstDay 8- leastDay 8- nowDay 8- PSSDay 8- meds
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
1 1 1 1 1 n/a 0 1 0 0 0.25 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
2 2 1 0 1.25 n/a 1 1 1 0 0.75 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
1 1 1 1 1 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 1 0 0 0.25 n/a 0 1 0 0 0.25 n/a
4 5 2 4 3.75 mypaid 3 4 2 3 3 mypaid
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
2 2 1 1 1.5 n/a 1 1 1 1 1 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
1 1 0 0 0.5 n/a 0 1 0 0 0.25 n/a
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Day 9 - averageD y 9- worstDay 9- leastDay 9- nowDay 9- PSSDay 9- medsDay 10- averageD y 10- worstDay 10- leastDay 10- nowDay 10- PSSDay 10- meds
0 0 0 0 0 n/a 0 0 0 0 0 n/a
8 9 5 7 7.25 norflex, vimovo, myprocam8 9 4 7 7 norflex, vimovo, myprocam
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
1 1 1 1 1 n/a 1 1 1 1 1 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
1 1 0 1 0.75 n/a 1 1 0 1 0.75 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
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Day 9 - averageD y 9- worstDay 9- leastDay 9- nowDay 9- PSSDay 9- medsDay 10- averageD y 10- worstDay 10- leastDay 10- nowDay 10- PSSDay 10- meds
1 1 1 1 1 n/a 1 1 1 1 1 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
3 3 1 2 2.25 mypaid 3 2 1 2 2 mypaid
3 3 0 2 2 n/a 3 2 0 2 1.75 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
3 3 2 2 2.5 n/a 3 3 3 3 3 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
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Day 9 - averageD y 9- worstDay 9- leastDay 9- nowDay 9- PSSDay 9- medsDay 10- averageD y 10- worstDay 10- leastDay 10- nowDay 10- PSSDay 10- meds
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 1 0 0 0.25 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 1 0 0 0.25 n/a 0 0 0 0 0 n/a
3 3 1 2 2.25 mypaid 3 2 1 2 2 mypaid
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
0 0 0 0 0 n/a 0 0 0 0 0 n/a
